CN112135528A - Composition of steviol glycoside and/or polysaccharide derivative thereof - Google Patents
Composition of steviol glycoside and/or polysaccharide derivative thereof Download PDFInfo
- Publication number
- CN112135528A CN112135528A CN201980030635.7A CN201980030635A CN112135528A CN 112135528 A CN112135528 A CN 112135528A CN 201980030635 A CN201980030635 A CN 201980030635A CN 112135528 A CN112135528 A CN 112135528A
- Authority
- CN
- China
- Prior art keywords
- gsg
- reb
- group
- rebaudioside
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 450
- 235000019202 steviosides Nutrition 0.000 title claims abstract description 290
- 150000008144 steviol glycosides Chemical class 0.000 title claims abstract description 239
- 239000004383 Steviol glycoside Substances 0.000 title claims abstract description 235
- 235000019411 steviol glycoside Nutrition 0.000 title claims abstract description 234
- 229930182488 steviol glycoside Natural products 0.000 title claims abstract description 234
- 229920001282 polysaccharide Chemical class 0.000 title description 3
- 239000005017 polysaccharide Chemical class 0.000 title description 3
- 150000004676 glycans Chemical class 0.000 title 1
- 239000000796 flavoring agent Substances 0.000 claims abstract description 46
- 235000019634 flavors Nutrition 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 23
- 235000019640 taste Nutrition 0.000 claims abstract description 20
- 230000001965 increasing effect Effects 0.000 claims abstract description 6
- 229930188195 rebaudioside Natural products 0.000 claims description 123
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 58
- 229940013618 stevioside Drugs 0.000 claims description 57
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 56
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 claims description 42
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 40
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 37
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims description 36
- 239000000284 extract Substances 0.000 claims description 36
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims description 36
- 239000008103 glucose Substances 0.000 claims description 33
- 239000004615 ingredient Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 229920001353 Dextrin Polymers 0.000 claims description 29
- 239000004375 Dextrin Substances 0.000 claims description 27
- 229930186291 Dulcoside Natural products 0.000 claims description 27
- 235000019425 dextrin Nutrition 0.000 claims description 27
- 229910001868 water Inorganic materials 0.000 claims description 26
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims description 24
- 235000019203 rebaudioside A Nutrition 0.000 claims description 24
- SHZGCJCMOBCMKK-UHFFFAOYSA-N 6-methyloxane-2,3,4,5-tetrol Chemical group CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 18
- 244000228451 Stevia rebaudiana Species 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 239000001512 FEMA 4601 Substances 0.000 claims description 14
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims description 14
- 229930182470 glycoside Natural products 0.000 claims description 12
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical group C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 11
- JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 10
- OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 claims description 10
- CANAPGLEBDTCAF-UHFFFAOYSA-N dulcoside a Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC23C(CC4(C2)C(C2(C)C(C(CCC2)(C)C(=O)OC2C(C(O)C(O)C(CO)O2)O)CC4)CC3)=C)OC(CO)C(O)C1O CANAPGLEBDTCAF-UHFFFAOYSA-N 0.000 claims description 10
- 150000002338 glycosides Chemical class 0.000 claims description 10
- 238000006206 glycosylation reaction Methods 0.000 claims description 10
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 claims description 10
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 claims description 9
- 230000013595 glycosylation Effects 0.000 claims description 9
- 229940032084 steviol Drugs 0.000 claims description 9
- 239000011541 reaction mixture Substances 0.000 claims description 7
- GSGVXNMGMKBGQU-PHESRWQRSA-N rebaudioside M Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GSGVXNMGMKBGQU-PHESRWQRSA-N 0.000 claims description 7
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 6
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 claims description 5
- 229910052796 boron Inorganic materials 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 claims description 5
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 claims description 4
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 claims description 4
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 claims description 2
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 claims 2
- 238000001223 reverse osmosis Methods 0.000 claims 1
- 238000001694 spray drying Methods 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 description 90
- 239000003765 sweetening agent Substances 0.000 description 89
- 235000002639 sodium chloride Nutrition 0.000 description 79
- -1 steviol glycoside salts Chemical class 0.000 description 69
- 150000003839 salts Chemical class 0.000 description 61
- 235000013339 cereals Nutrition 0.000 description 39
- 235000013305 food Nutrition 0.000 description 33
- 239000002585 base Substances 0.000 description 31
- 239000003921 oil Substances 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 31
- 235000000346 sugar Nutrition 0.000 description 30
- 235000009508 confectionery Nutrition 0.000 description 29
- 239000000047 product Substances 0.000 description 29
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 27
- 229960001031 glucose Drugs 0.000 description 27
- 150000001875 compounds Chemical class 0.000 description 26
- 229920002472 Starch Polymers 0.000 description 25
- 235000019698 starch Nutrition 0.000 description 24
- 239000003963 antioxidant agent Substances 0.000 description 23
- 235000006708 antioxidants Nutrition 0.000 description 23
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 23
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 23
- 239000003925 fat Substances 0.000 description 22
- 235000019197 fats Nutrition 0.000 description 22
- 239000012467 final product Substances 0.000 description 22
- 239000008107 starch Substances 0.000 description 22
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 21
- 229930006000 Sucrose Natural products 0.000 description 21
- 244000299461 Theobroma cacao Species 0.000 description 21
- 239000000654 additive Substances 0.000 description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 235000013312 flour Nutrition 0.000 description 21
- 229910052500 inorganic mineral Inorganic materials 0.000 description 21
- 235000010755 mineral Nutrition 0.000 description 21
- 239000011707 mineral Substances 0.000 description 21
- 229960004793 sucrose Drugs 0.000 description 21
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 20
- 235000013355 food flavoring agent Nutrition 0.000 description 20
- 239000005720 sucrose Substances 0.000 description 20
- 229940088594 vitamin Drugs 0.000 description 20
- 239000011782 vitamin Substances 0.000 description 20
- 235000001014 amino acid Nutrition 0.000 description 19
- 230000003078 antioxidant effect Effects 0.000 description 19
- 235000015218 chewing gum Nutrition 0.000 description 19
- 229930003231 vitamin Natural products 0.000 description 19
- 235000013343 vitamin Nutrition 0.000 description 19
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 18
- 229940112822 chewing gum Drugs 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 229920005862 polyol Polymers 0.000 description 15
- 150000003077 polyols Chemical class 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 244000269722 Thea sinensis Species 0.000 description 14
- 239000002253 acid Substances 0.000 description 14
- 235000013399 edible fruits Nutrition 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 244000078534 Vaccinium myrtillus Species 0.000 description 13
- 235000019219 chocolate Nutrition 0.000 description 13
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 235000020357 syrup Nutrition 0.000 description 12
- 239000006188 syrup Substances 0.000 description 12
- 108010009736 Protein Hydrolysates Proteins 0.000 description 11
- 229960002737 fructose Drugs 0.000 description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 11
- 235000013824 polyphenols Nutrition 0.000 description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 10
- 229930091371 Fructose Natural products 0.000 description 10
- 239000005715 Fructose Substances 0.000 description 10
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 10
- 241000220225 Malus Species 0.000 description 10
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 10
- 240000008042 Zea mays Species 0.000 description 10
- 239000003995 emulsifying agent Substances 0.000 description 10
- 125000003147 glycosyl group Chemical group 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 10
- 239000008267 milk Substances 0.000 description 10
- 210000004080 milk Anatomy 0.000 description 10
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 10
- 229940012843 omega-3 fatty acid Drugs 0.000 description 10
- 239000003531 protein hydrolysate Substances 0.000 description 10
- 235000015067 sauces Nutrition 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 229940083542 sodium Drugs 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 9
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 9
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 9
- 235000012970 cakes Nutrition 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 150000007524 organic acids Chemical class 0.000 description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- 241000207199 Citrus Species 0.000 description 8
- 229920000858 Cyclodextrin Polymers 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 8
- 235000011430 Malus pumila Nutrition 0.000 description 8
- 235000015103 Malus silvestris Nutrition 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 235000009470 Theobroma cacao Nutrition 0.000 description 8
- 240000006365 Vitis vinifera Species 0.000 description 8
- 235000014787 Vitis vinifera Nutrition 0.000 description 8
- 235000013361 beverage Nutrition 0.000 description 8
- 235000008429 bread Nutrition 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 8
- 235000020971 citrus fruits Nutrition 0.000 description 8
- 239000003086 colorant Substances 0.000 description 8
- 229920002770 condensed tannin Polymers 0.000 description 8
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 8
- 239000000945 filler Substances 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 229920001308 poly(aminoacid) Polymers 0.000 description 8
- 239000011591 potassium Substances 0.000 description 8
- 229960003975 potassium Drugs 0.000 description 8
- 229910052700 potassium Inorganic materials 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 240000009088 Fragaria x ananassa Species 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 240000007651 Rubus glaucus Species 0.000 description 7
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 7
- 235000009754 Vitis X bourquina Nutrition 0.000 description 7
- 235000012333 Vitis X labruscana Nutrition 0.000 description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 7
- 235000019658 bitter taste Nutrition 0.000 description 7
- 235000021014 blueberries Nutrition 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 235000005822 corn Nutrition 0.000 description 7
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Natural products NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 7
- 229940067606 lecithin Drugs 0.000 description 7
- 235000010445 lecithin Nutrition 0.000 description 7
- 239000000787 lecithin Substances 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 235000019533 nutritive sweetener Nutrition 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 235000010436 thaumatin Nutrition 0.000 description 7
- 239000000892 thaumatin Substances 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 240000001717 Vaccinium macrocarpon Species 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 6
- 230000001055 chewing effect Effects 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 229940091250 magnesium supplement Drugs 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- 239000006014 omega-3 oil Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 235000005875 quercetin Nutrition 0.000 description 6
- 229960001285 quercetin Drugs 0.000 description 6
- 235000020095 red wine Nutrition 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 6
- 235000011888 snacks Nutrition 0.000 description 6
- 235000014214 soft drink Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- MADZMXIFUWFDJK-AEARDBQCSA-N soyasapogenol B Natural products CC1(C)C[C@@H](O)[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@H]2C1 MADZMXIFUWFDJK-AEARDBQCSA-N 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 5
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 5
- 235000016623 Fragaria vesca Nutrition 0.000 description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 5
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 5
- 244000294611 Punica granatum Species 0.000 description 5
- 235000014360 Punica granatum Nutrition 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 235000011034 Rubus glaucus Nutrition 0.000 description 5
- 235000009122 Rubus idaeus Nutrition 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 241001593968 Vitis palmata Species 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 5
- 235000010208 anthocyanin Nutrition 0.000 description 5
- 239000004410 anthocyanin Substances 0.000 description 5
- 229930002877 anthocyanin Natural products 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 5
- 229940074393 chlorogenic acid Drugs 0.000 description 5
- 235000001368 chlorogenic acid Nutrition 0.000 description 5
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 5
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 235000013409 condiments Nutrition 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 150000002206 flavan-3-ols Chemical group 0.000 description 5
- 235000011987 flavanols Nutrition 0.000 description 5
- 229930182830 galactose Natural products 0.000 description 5
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical group OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 5
- 235000019534 high fructose corn syrup Nutrition 0.000 description 5
- 230000000887 hydrating effect Effects 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 235000015094 jam Nutrition 0.000 description 5
- 235000015110 jellies Nutrition 0.000 description 5
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 5
- 235000010449 maltitol Nutrition 0.000 description 5
- 239000000845 maltitol Substances 0.000 description 5
- 229940035436 maltitol Drugs 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 150000007522 mineralic acids Chemical class 0.000 description 5
- 235000021096 natural sweeteners Nutrition 0.000 description 5
- 229940033080 omega-6 fatty acid Drugs 0.000 description 5
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 4
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 4
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- 229920000881 Modified starch Polymers 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- 235000009827 Prunus armeniaca Nutrition 0.000 description 4
- 244000018633 Prunus armeniaca Species 0.000 description 4
- 241001290151 Prunus avium subsp. avium Species 0.000 description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 description 4
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 4
- 240000001890 Ribes hudsonianum Species 0.000 description 4
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 4
- 235000001466 Ribes nigrum Nutrition 0.000 description 4
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 235000011941 Tilia x europaea Nutrition 0.000 description 4
- 240000006909 Tilia x europaea Species 0.000 description 4
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 235000010233 benzoic acid Nutrition 0.000 description 4
- 235000021028 berry Nutrition 0.000 description 4
- 235000014121 butter Nutrition 0.000 description 4
- 235000019693 cherries Nutrition 0.000 description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 4
- 235000021019 cranberries Nutrition 0.000 description 4
- 235000012754 curcumin Nutrition 0.000 description 4
- 239000004148 curcumin Substances 0.000 description 4
- 229940109262 curcumin Drugs 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 4
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 229920001968 ellagitannin Polymers 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 239000001530 fumaric acid Substances 0.000 description 4
- 235000011087 fumaric acid Nutrition 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 150000002314 glycerols Chemical class 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 4
- 235000008696 isoflavones Nutrition 0.000 description 4
- 235000010439 isomalt Nutrition 0.000 description 4
- 239000000905 isomalt Substances 0.000 description 4
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 4
- 239000008274 jelly Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 229960000448 lactic acid Drugs 0.000 description 4
- 235000010448 lactitol Nutrition 0.000 description 4
- 239000000832 lactitol Substances 0.000 description 4
- 229960003451 lactitol Drugs 0.000 description 4
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 4
- 239000004571 lime Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 229940099690 malic acid Drugs 0.000 description 4
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 4
- 229940052490 naringin Drugs 0.000 description 4
- 229930019673 naringin Natural products 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 229960000292 pectin Drugs 0.000 description 4
- 230000008447 perception Effects 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 235000018192 pine bark supplement Nutrition 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 229940106796 pycnogenol Drugs 0.000 description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 235000021283 resveratrol Nutrition 0.000 description 4
- 229940016667 resveratrol Drugs 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000011975 tartaric acid Substances 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- 229960001367 tartaric acid Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical class CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 235000021119 whey protein Nutrition 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 3
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Chemical class OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical class CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 3
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- 235000003351 Brassica cretica Nutrition 0.000 description 3
- 235000003343 Brassica rupestris Nutrition 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- 235000002568 Capsicum frutescens Nutrition 0.000 description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 3
- 241001672694 Citrus reticulata Species 0.000 description 3
- 240000000560 Citrus x paradisi Species 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 3
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- 244000008991 Curcuma longa Species 0.000 description 3
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 3
- DORPKYRPJIIARM-UHFFFAOYSA-N Decaffeoylacteoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(OCCC=2C=C(O)C(O)=CC=2)OC(CO)C1O DORPKYRPJIIARM-UHFFFAOYSA-N 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000001263 FEMA 3042 Chemical class 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 3
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000005135 Micromeria juliana Nutrition 0.000 description 3
- 108050004114 Monellin Proteins 0.000 description 3
- 240000005561 Musa balbisiana Species 0.000 description 3
- 235000009421 Myristica fragrans Nutrition 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Chemical class OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000005809 Prunus persica Species 0.000 description 3
- 229920000241 Punicalagin Polymers 0.000 description 3
- 235000019484 Rapeseed oil Nutrition 0.000 description 3
- 235000007315 Satureja hortensis Nutrition 0.000 description 3
- 240000002114 Satureja hortensis Species 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 3
- 235000007303 Thymus vulgaris Nutrition 0.000 description 3
- 240000002657 Thymus vulgaris Species 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 235000009499 Vanilla fragrans Nutrition 0.000 description 3
- 244000263375 Vanilla tahitensis Species 0.000 description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 3
- DORPKYRPJIIARM-GYAWPQPFSA-N Verbasoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](OCCC=2C=C(O)C(O)=CC=2)O[C@H](CO)[C@H]1O DORPKYRPJIIARM-GYAWPQPFSA-N 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 235000010358 acesulfame potassium Nutrition 0.000 description 3
- 239000000619 acesulfame-K Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 3
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 235000019209 bilberry extract Nutrition 0.000 description 3
- 229940102480 bilberry extract Drugs 0.000 description 3
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 3
- 235000015895 biscuits Nutrition 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 235000021029 blackberry Nutrition 0.000 description 3
- 235000015496 breakfast cereal Nutrition 0.000 description 3
- KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 235000013736 caramel Nutrition 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- 235000019868 cocoa butter Nutrition 0.000 description 3
- 229940110456 cocoa butter Drugs 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 235000014510 cooky Nutrition 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 239000002385 cottonseed oil Substances 0.000 description 3
- 235000003373 curcuma longa Nutrition 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000008191 folinic acid Nutrition 0.000 description 3
- 239000011672 folinic acid Substances 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 229960002743 glutamine Drugs 0.000 description 3
- 235000004554 glutamine Nutrition 0.000 description 3
- 235000013761 grape skin extract Nutrition 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 229940025878 hesperidin Drugs 0.000 description 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 3
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- KFVUFODCZDRVSS-XGBBNYNSSA-N iso-steviol Chemical compound C([C@]12C[C@@](C(C2)=O)(CC[C@H]11)C)C[C@H]2[C@@]1(C)CCC[C@@]2(C)C(O)=O KFVUFODCZDRVSS-XGBBNYNSSA-N 0.000 description 3
- KFVUFODCZDRVSS-UHFFFAOYSA-N isosteviol Natural products C1C(=O)C(C)(CCC23)CC21CCC1C3(C)CCCC1(C)C(O)=O KFVUFODCZDRVSS-UHFFFAOYSA-N 0.000 description 3
- 229960001691 leucovorin Drugs 0.000 description 3
- 229960005375 lutein Drugs 0.000 description 3
- 235000012680 lutein Nutrition 0.000 description 3
- 239000001656 lutein Substances 0.000 description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 235000011147 magnesium chloride Nutrition 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 229960001855 mannitol Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- 235000010460 mustard Nutrition 0.000 description 3
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 3
- 235000007625 naringenin Nutrition 0.000 description 3
- 229940117954 naringenin Drugs 0.000 description 3
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229960003104 ornithine Drugs 0.000 description 3
- 239000003346 palm kernel oil Substances 0.000 description 3
- 235000019865 palm kernel oil Nutrition 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 235000014594 pastries Nutrition 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 235000021018 plums Nutrition 0.000 description 3
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 108010055896 polyornithine Proteins 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229920002414 procyanidin Polymers 0.000 description 3
- ZJVUMAFASBFUBG-OGJBWQGYSA-N punicalagin Chemical compound C([C@H]1O[C@@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]2[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O ZJVUMAFASBFUBG-OGJBWQGYSA-N 0.000 description 3
- LMIBIMUSUFYFJN-RSVYENFWSA-N punicalagin Natural products O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)cc5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8c(O)c(O)c(O)cc8C(=O)O[C@H]2[C@@H]9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)O[C@@H]19 LMIBIMUSUFYFJN-RSVYENFWSA-N 0.000 description 3
- ZRKSVMFLACVUIU-UHFFFAOYSA-N punicalagin isomer Natural products OC1=C(O)C(=C2C3=4)OC(=O)C=4C4=C(O)C(O)=C3OC(=O)C2=C1C1=C(O)C(O)=C(O)C=C1C(=O)OC1C2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)OC1COC(=O)C1=CC4=C(O)C(O)=C1O ZRKSVMFLACVUIU-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 235000019204 saccharin Nutrition 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 229940081974 saccharin Drugs 0.000 description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 235000019408 sucralose Nutrition 0.000 description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- 229920002258 tannic acid Chemical class 0.000 description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical class OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 3
- 229940033123 tannic acid Drugs 0.000 description 3
- 239000001585 thymus vulgaris Substances 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 235000011178 triphosphate Nutrition 0.000 description 3
- 239000001226 triphosphate Substances 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 235000019160 vitamin B3 Nutrition 0.000 description 3
- 239000011708 vitamin B3 Substances 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- JMGCAHRKIVCLFW-UHFFFAOYSA-N 1-O-Galloylcastalagin Natural products Oc1cc(cc(O)c1O)C(=O)OC2C3OC(=O)c4c2c(O)c(O)c(O)c4c5c(O)c(O)c(O)c6c5C(=O)OC3C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OCC7OC(=O)c%10cc(O)c(O)c(O)c6%10 JMGCAHRKIVCLFW-UHFFFAOYSA-N 0.000 description 2
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 2
- FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- UIAFKZKHHVMJGS-UHFFFAOYSA-N 2,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1O UIAFKZKHHVMJGS-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 239000004377 Alitame Substances 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- 235000006576 Althaea officinalis Nutrition 0.000 description 2
- 244000208874 Althaea officinalis Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- 235000013695 Chenopodium pallidicaule Nutrition 0.000 description 2
- 240000008616 Chenopodium pallidicaule Species 0.000 description 2
- 240000006162 Chenopodium quinoa Species 0.000 description 2
- 235000019743 Choline chloride Nutrition 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000175448 Citrus madurensis Species 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 2
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 2
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 2
- HSNZZMHEPUFJNZ-QMTIVRBISA-N D-keto-manno-heptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-QMTIVRBISA-N 0.000 description 2
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 2
- 240000000896 Dyera costulata Species 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 2
- 206010056474 Erythrosis Diseases 0.000 description 2
- 235000017317 Fortunella Nutrition 0.000 description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 235000017048 Garcinia mangostana Nutrition 0.000 description 2
- 240000006053 Garcinia mangostana Species 0.000 description 2
- 240000001238 Gaultheria procumbens Species 0.000 description 2
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 244000270834 Myristica fragrans Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000004384 Neotame Substances 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- GPLOTACQBREROW-UHFFFAOYSA-N Phlegmanol A-acetat Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC1=2)C=C(O)C(=O)C1=C(O)C(O)=CC=2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GPLOTACQBREROW-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 description 2
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 2
- 235000010401 Prunus avium Nutrition 0.000 description 2
- 235000014441 Prunus serotina Nutrition 0.000 description 2
- 240000008296 Prunus serotina Species 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 244000151637 Sambucus canadensis Species 0.000 description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- 241000245026 Scoliopus bigelovii Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 240000006394 Sorghum bicolor Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- KMJPKUVSXFVQGZ-UHFFFAOYSA-N TF2B Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 KMJPKUVSXFVQGZ-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000019714 Triticale Nutrition 0.000 description 2
- 235000004240 Triticum spelta Nutrition 0.000 description 2
- 240000003834 Triticum spelta Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 229960003190 adenosine monophosphate Drugs 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 235000019409 alitame Nutrition 0.000 description 2
- 108010009985 alitame Proteins 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 229910001508 alkali metal halide Inorganic materials 0.000 description 2
- 150000008045 alkali metal halides Chemical class 0.000 description 2
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000007961 artificial flavoring substance Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 235000012791 bagels Nutrition 0.000 description 2
- JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000016614 betalains Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- 235000007123 blue elder Nutrition 0.000 description 2
- 235000019216 blueberry extract Nutrition 0.000 description 2
- 229940055416 blueberry extract Drugs 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 235000012467 brownies Nutrition 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- 229960003178 choline chloride Drugs 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000012495 crackers Nutrition 0.000 description 2
- 235000004634 cranberry Nutrition 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 108010010165 curculin Proteins 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 229940109275 cyclamate Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 235000011850 desserts Nutrition 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 229940120503 dihydroxyacetone Drugs 0.000 description 2
- 235000010300 dimethyl dicarbonate Nutrition 0.000 description 2
- 239000004316 dimethyl dicarbonate Substances 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 235000012489 doughnuts Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 2
- 235000007124 elderberry Nutrition 0.000 description 2
- JMGCAHRKIVCLFW-CNWXVVPTSA-N ellagitannin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2C3=C4C(=O)O[C@@H]2[C@@H]2[C@@H]5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OC[C@H]5OC(=O)C5=CC(O)=C(O)C(O)=C5C=5C(O)=C(O)C(O)=C(C=5C(=O)O2)C4=C(O)C(O)=C3O)=C1 JMGCAHRKIVCLFW-CNWXVVPTSA-N 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- NNMXSTWQJRPBJZ-UHFFFAOYSA-K europium(iii) chloride Chemical compound Cl[Eu](Cl)Cl NNMXSTWQJRPBJZ-UHFFFAOYSA-K 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000010855 food raising agent Nutrition 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- MEANOSLIBWSCIT-UHFFFAOYSA-K gadolinium trichloride Chemical compound Cl[Gd](Cl)Cl MEANOSLIBWSCIT-UHFFFAOYSA-K 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 235000011868 grain product Nutrition 0.000 description 2
- 235000019674 grape juice Nutrition 0.000 description 2
- 235000002532 grape seed extract Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 235000013928 guanylic acid Nutrition 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 235000020717 hawthorn extract Nutrition 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 150000002454 idoses Chemical class 0.000 description 2
- 235000013902 inosinic acid Nutrition 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229960004903 invert sugar Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 229960002510 mandelic acid Drugs 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 description 2
- 235000001035 marshmallow Nutrition 0.000 description 2
- 235000010746 mayonnaise Nutrition 0.000 description 2
- 239000008268 mayonnaise Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 125000005341 metaphosphate group Chemical group 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 235000012459 muffins Nutrition 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- 235000019412 neotame Nutrition 0.000 description 2
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 2
- 108010070257 neotame Proteins 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- 150000002826 nitrites Chemical class 0.000 description 2
- 239000001702 nutmeg Substances 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- KPYHRMNYOUGKKI-UHFFFAOYSA-N phosphoric acid;1h-pyrimidine-2,4-dione Chemical compound OP(O)(O)=O.O=C1C=CNC(=O)N1 KPYHRMNYOUGKKI-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000008373 pickled product Nutrition 0.000 description 2
- 235000020741 pine bark extract Nutrition 0.000 description 2
- 229940106587 pine bark extract Drugs 0.000 description 2
- 235000012830 plain croissants Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000004224 potassium gluconate Substances 0.000 description 2
- 235000013926 potassium gluconate Nutrition 0.000 description 2
- 229960003189 potassium gluconate Drugs 0.000 description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 description 2
- 235000011151 potassium sulphates Nutrition 0.000 description 2
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 2
- 235000013606 potato chips Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 235000021013 raspberries Nutrition 0.000 description 2
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 2
- 235000019675 red grape juice Nutrition 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 235000019600 saltiness Nutrition 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000021317 sensory perception Effects 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000000176 sodium gluconate Substances 0.000 description 2
- 235000012207 sodium gluconate Nutrition 0.000 description 2
- 229940005574 sodium gluconate Drugs 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 235000021012 strawberries Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- GFISHBQNVWAVFU-UHFFFAOYSA-K terbium(iii) chloride Chemical compound Cl[Tb](Cl)Cl GFISHBQNVWAVFU-UHFFFAOYSA-K 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000011731 tocotrienol Substances 0.000 description 2
- 229930003802 tocotrienol Natural products 0.000 description 2
- 235000019148 tocotrienols Nutrition 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940035936 ubiquinone Drugs 0.000 description 2
- 235000019583 umami taste Nutrition 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 235000019159 vitamin B9 Nutrition 0.000 description 2
- 239000011727 vitamin B9 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- 241000228158 x Triticosecale Species 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- SDOFMBGMRVAJNF-SLPGGIOYSA-N (2r,3r,4r,5s)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-SLPGGIOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 1
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- WYLYIWCGKHBHJW-VWMHFEHESA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;dodecanoic acid Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.CCCCCCCCCCCC(O)=O WYLYIWCGKHBHJW-VWMHFEHESA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Chemical class 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- HVGRZDASOHMCSK-UHFFFAOYSA-N (Z,Z)-13,16-docosadienoic acid Natural products CCCCCC=CCC=CCCCCCCCCCCCC(O)=O HVGRZDASOHMCSK-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- QGJDXUIYIUGQGO-UHFFFAOYSA-N 1-[2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)NC(C)C(=O)N1CCCC1C(O)=O QGJDXUIYIUGQGO-UHFFFAOYSA-N 0.000 description 1
- AMMPLVWPWSYRDR-UHFFFAOYSA-N 1-methylbicyclo[2.2.2]oct-2-ene-4-carboxylic acid Chemical compound C1CC2(C(O)=O)CCC1(C)C=C2 AMMPLVWPWSYRDR-UHFFFAOYSA-N 0.000 description 1
- OXEDXHIBHVMDST-UHFFFAOYSA-N 12Z-octadecenoic acid Natural products CCCCCC=CCCCCCCCCCCC(O)=O OXEDXHIBHVMDST-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LOVYCUYJRWLTSU-UHFFFAOYSA-N 2-(3,4-dichlorophenoxy)-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=C(Cl)C(Cl)=C1 LOVYCUYJRWLTSU-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- MLMQPDHYNJCQAO-UHFFFAOYSA-N 3,3-dimethylbutyric acid Chemical compound CC(C)(C)CC(O)=O MLMQPDHYNJCQAO-UHFFFAOYSA-N 0.000 description 1
- XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 1
- FXJVNINSOKCNJP-UHFFFAOYSA-N 4-methylbenzenesulfinic acid Chemical compound CC1=CC=C(S(O)=O)C=C1 FXJVNINSOKCNJP-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- ZEASWHWETFMWCV-UHFFFAOYSA-N 7-O-(2-O-Acetyl-6-O-Methyl-beta-D-glucuronoside)-4',5,7-Trihydroxyflavone Natural products C=1C(O)=C(O)C2=C(O)C(=O)C=C(C3C(CC4=C(O)C=C(O)C=C4O3)OC(=O)C=3C=C(O)C(O)=C(O)C=3)C=C2C=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 ZEASWHWETFMWCV-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000107 Acetylated distarch adipate Polymers 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 241001499808 Allium atrorubens Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 229920001685 Amylomaize Polymers 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 description 1
- UXEVCMUDEVWXJF-WZTVWXICSA-N CC[N+](CC)(CC)CC.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound CC[N+](CC)(CC)CC.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO UXEVCMUDEVWXJF-WZTVWXICSA-N 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 235000015493 Chenopodium quinoa Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 241001137307 Cyprinodon variegatus Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical class OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 101710119265 DNA topoisomerase 1 Proteins 0.000 description 1
- 241001269235 Danis Species 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 240000008570 Digitaria exilis Species 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 240000005153 Dodonaea viscosa Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 244000140063 Eragrostis abyssinica Species 0.000 description 1
- 235000014966 Eragrostis abyssinica Nutrition 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 239000001689 FEMA 4674 Substances 0.000 description 1
- 239000001776 FEMA 4720 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000019715 Fonio Nutrition 0.000 description 1
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 description 1
- HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical class OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 229920003012 Hydroxypropyl distarch phosphate Polymers 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- JPXZQMKKFWMMGK-KQYNXXCUSA-N IDP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 JPXZQMKKFWMMGK-KQYNXXCUSA-N 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- HAEJPQIATWHALX-KQYNXXCUSA-N ITP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 HAEJPQIATWHALX-KQYNXXCUSA-N 0.000 description 1
- 235000003325 Ilex Nutrition 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Chemical class OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 108700035965 MEG3 Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- YWQSXCGKJDUYTL-UHFFFAOYSA-N Mangiferin Natural products CC(CCC=C(C)C)C1CC(C)C2C3CCC4C(C)(C)CCCC45CC35CCC12C YWQSXCGKJDUYTL-UHFFFAOYSA-N 0.000 description 1
- 240000002636 Manilkara bidentata Species 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 235000010804 Maranta arundinacea Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241000378467 Melaleuca Species 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 235000012851 Myrica pensylvanica Nutrition 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241001495453 Parthenium argentatum Species 0.000 description 1
- 229920002123 Pentastarch Polymers 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 235000006990 Pimenta dioica Nutrition 0.000 description 1
- 240000008474 Pimenta dioica Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 235000003406 Polymnia sonchifolia Nutrition 0.000 description 1
- 244000134540 Polymnia sonchifolia Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000819847 Pomella Species 0.000 description 1
- 102100023075 Protein Niban 2 Human genes 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
- 235000000661 Rosa laevigata Nutrition 0.000 description 1
- 241001278833 Rosa laevigata Species 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-O S-methyl-L-methionine Chemical compound C[S+](C)CC[C@H]([NH3+])C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-O 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001253754 Scolopia mundii Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 244000145580 Thalia geniculata Species 0.000 description 1
- 235000012419 Thalia geniculata Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- BVMDSEFJGKQBKJ-UHFFFAOYSA-N Theaflavin 3'-gallate Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O BVMDSEFJGKQBKJ-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- 229930182647 Trilobatin Natural products 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 235000011720 Vaccinium uliginosum Nutrition 0.000 description 1
- 241000978782 Vachellia seyal Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229920002486 Waxy potato starch Polymers 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 1
- BNIAKAQSIZOVSN-UHFFFAOYSA-N [Na].CC(O)CO Chemical compound [Na].CC(O)CO BNIAKAQSIZOVSN-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 125000002252 acyl group Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical class 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 239000001361 adipic acid Chemical class 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-MROZADKFSA-N aldehydo-L-ribose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-MROZADKFSA-N 0.000 description 1
- 229910052936 alkali metal sulfate Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- RIVXQHNOKLXDBP-UHFFFAOYSA-K aluminum;hydrogen carbonate Chemical compound [Al+3].OC([O-])=O.OC([O-])=O.OC([O-])=O RIVXQHNOKLXDBP-UHFFFAOYSA-K 0.000 description 1
- ZQKXOSJYJMDROL-UHFFFAOYSA-H aluminum;trisodium;diphosphate Chemical compound [Na+].[Na+].[Na+].[Al+3].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O ZQKXOSJYJMDROL-UHFFFAOYSA-H 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 229960004104 amiloride hydrochloride Drugs 0.000 description 1
- LTKVFMLMEYCWMK-UHFFFAOYSA-N amiloride hydrochloride dihydrate Chemical compound [H+].O.O.[Cl-].NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N LTKVFMLMEYCWMK-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940045687 antimetabolites folic acid analogs Drugs 0.000 description 1
- 235000004458 antinutrient Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000016302 balata Nutrition 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940029830 benefiber Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- WPYMKLBDIGXBTP-VQEHIDDOSA-N benzoic acid Chemical compound OC(=O)C1=CC=C[13CH]=C1 WPYMKLBDIGXBTP-VQEHIDDOSA-N 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229940114055 beta-resorcylic acid Drugs 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000000842 betacyanins Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000012180 bread and bread product Nutrition 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- 235000021544 chips of chocolate Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical class OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 229940119429 cocoa extract Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical class OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940099371 diacetylated monoglycerides Drugs 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- ILYCWAKSDCYMBB-OPCMSESCSA-N dihydrotachysterol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1/C[C@@H](O)CC[C@@H]1C ILYCWAKSDCYMBB-OPCMSESCSA-N 0.000 description 1
- 229960000465 dihydrotachysterol Drugs 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- MKZUDFZKTZOCRS-UHFFFAOYSA-N diphosphono hydrogen phosphate;1h-pyrimidine-2,4-dione Chemical compound O=C1C=CNC(=O)N1.OP(O)(=O)OP(O)(=O)OP(O)(O)=O MKZUDFZKTZOCRS-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- BUCMCXRUIRJPKS-UHFFFAOYSA-L dipotassium;2,3-dihydroxybutanedioate;hydrate Chemical compound O.[K+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O BUCMCXRUIRJPKS-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013804 distarch phosphate Nutrition 0.000 description 1
- 239000001245 distarch phosphate Substances 0.000 description 1
- CVCXSNONTRFSEH-UHFFFAOYSA-N docosa-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCCCCC=CC=CC(O)=O CVCXSNONTRFSEH-UHFFFAOYSA-N 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000021271 drinking Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 1
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 1
- 235000011797 eriodictyol Nutrition 0.000 description 1
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 235000012438 extruded product Nutrition 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- UHUSDOQQWJGJQS-UHFFFAOYSA-N glycerol 1,2-dioctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC UHUSDOQQWJGJQS-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- 125000001188 haloalkyl group Chemical class 0.000 description 1
- 125000001475 halogen functional group Chemical class 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- XMCTYDOFFXSNQJ-UHFFFAOYSA-N hexadecyl(methyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[NH2+]C XMCTYDOFFXSNQJ-UHFFFAOYSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- DVROLKBAWTYHHD-UHFFFAOYSA-N hydroxy propyl distarch phosphate Chemical compound OC1C(O)C(OC)OC(CO)C1OC(O)CCOC1C(OC2C(C(O)C(OC3C(C(OP(O)(=O)OC4C(C(O)C(OC)OC4CO)O)C(C)OC3CO)O)OC2COC2C(C(O)C(OC)C(CO)O2)O)O)OC(CO)C(OC)C1O DVROLKBAWTYHHD-UHFFFAOYSA-N 0.000 description 1
- 235000013825 hydroxy propyl distarch phosphate Nutrition 0.000 description 1
- 239000001310 hydroxy propyl distarch phosphate Substances 0.000 description 1
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 1
- 229940089491 hydroxycitric acid Drugs 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 235000003248 hydroxytyrosol Nutrition 0.000 description 1
- 229940095066 hydroxytyrosol Drugs 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910001504 inorganic chloride Inorganic materials 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 150000002630 limonoids Chemical class 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 229920001427 mPEG Polymers 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 229960002366 magnesium silicate Drugs 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 229940043357 mangiferin Drugs 0.000 description 1
- 229940099262 marinol Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical group 0.000 description 1
- 229910001463 metal phosphate Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 125000002073 methionyl group Chemical group 0.000 description 1
- 229960005173 methiosulfonium chloride Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000000250 methylamino group Chemical class [H]N(*)C([H])([H])[H] 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000014569 mints Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229930191869 mogroside IV Natural products 0.000 description 1
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 1
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000010935 mono and diglycerides of fatty acids Nutrition 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910000150 monocalcium phosphate Inorganic materials 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- LPUQAYUQRXPFSQ-UHFFFAOYSA-M monosodium glutamate Chemical compound [Na+].[O-]C(=O)C(N)CCC(O)=O LPUQAYUQRXPFSQ-UHFFFAOYSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- XTUAJSCMFSCRIV-UHFFFAOYSA-N n'-(2,2-diphenylethyl)ethane-1,2-diamine Chemical compound C=1C=CC=CC=1C(CNCCN)C1=CC=CC=C1 XTUAJSCMFSCRIV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015145 nougat Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000021441 organic meat Nutrition 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229940101738 pentastarch Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 1
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 1
- 125000000394 phosphonato group Chemical group [O-]P([O-])(*)=O 0.000 description 1
- RAYIFMWTQKNDNK-UHFFFAOYSA-N phosphono dihydrogen phosphate;1h-pyrimidine-2,4-dione Chemical compound O=C1C=CNC(=O)N1.OP(O)(=O)OP(O)(O)=O RAYIFMWTQKNDNK-UHFFFAOYSA-N 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 108010011110 polyarginine Proteins 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010958 polyglycerol polyricinoleate Nutrition 0.000 description 1
- 239000003996 polyglycerol polyricinoleate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229940109529 pomegranate extract Drugs 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000012437 puffed product Nutrition 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000021487 ready-to-eat food Nutrition 0.000 description 1
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 description 1
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 description 1
- 235000013526 red clover Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229940119224 salmon oil Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000021108 sauerkraut Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 229930190082 siamenoside Natural products 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- OABYVIYXWMZFFJ-ZUHYDKSRSA-M sodium glycocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 OABYVIYXWMZFFJ-ZUHYDKSRSA-M 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
- 229940045946 sodium taurodeoxycholate Drugs 0.000 description 1
- YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000012457 sweet doughs Nutrition 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- IKLDTEFDTLKDRK-UHFFFAOYSA-N theaflavin 3'-gallate Natural products OC1Cc2c(O)cc(O)cc2OC1c3cc4C=C(C=C(O)C(=O)c4c(O)c3O)C5Oc6cc(O)cc(O)c6CC5OC(=O)c7cc(O)c(O)c(O)c7 IKLDTEFDTLKDRK-UHFFFAOYSA-N 0.000 description 1
- AATSUYYYTHJRJO-UHFFFAOYSA-N theaflavin 3-gallate Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC(=O)C(O)=C1C(O)=C2O)C=C1C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-UHFFFAOYSA-N 0.000 description 1
- 235000002365 theaflavin-3'-gallate Nutrition 0.000 description 1
- AATSUYYYTHJRJO-RZYARBFNSA-N theaflavin-3-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=C(O)C(O)=C2C(=O)C(O)=CC(=CC2=C1)[C@H]1OC2=CC(O)=CC(O)=C2C[C@H]1O)C(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-RZYARBFNSA-N 0.000 description 1
- 235000007900 theaflavin-3-gallate Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000008118 thearubigins Nutrition 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Chemical class OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000015149 toffees Nutrition 0.000 description 1
- 235000015113 tomato pastes and purées Nutrition 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
- PMMYEEVYMWASQN-IMJSIDKUSA-N trans-4-Hydroxy-L-proline Natural products O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 1
- AQWHMKSIVLSRNY-UHFFFAOYSA-N trans-Octadec-5-ensaeure Natural products CCCCCCCCCCCCC=CCCCC(O)=O AQWHMKSIVLSRNY-UHFFFAOYSA-N 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Chemical class OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000021470 vitamin B5 (pantothenic acid) Nutrition 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 150000008501 α-D-glucopyranosides Chemical group 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/12—Chemical features of tobacco products or tobacco substitutes of reconstituted tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Seasonings (AREA)
Abstract
The present application provides compositions comprising one or more Glycosylated Steviol Glycosides (GSG) and/or one or more Steviol Glycosides (SG). The present application also provides, in other aspects, (1) methods of making SG/GSG compositions; (2) a method of increasing the sweetness of an orally consumable composition; and (3) methods of improving the taste profile or flavor of orally consumable compositions.
Description
This application claims priority to U.S. provisional application 62/668553 filed on 8.5.2018, which is incorporated herein by reference in its entirety.
Technical Field
The present invention relates generally to sweetening and flavoring compositions, and in particular, to sweetening and flavoring compositions comprising steviol glycosides and/or polysaccharide-based steviol glycosides.
Background
Steviol Glycosides (SG) are high intensity sweeteners and have been widely used as sweeteners in food and beverage products. Various SGs, such as Stevioside (ST), rebaudioside a (ra), rebaudioside c (rc), and rebaudioside d (rd), have been isolated and identified.
SG is generally poorly soluble. Furthermore, the taste of some SG such as RA is also in need of improvement. Thus, there is a need in the food and beverage industry for SG compositions with improved solubility and taste profile.
Disclosure of Invention
In one aspect, the compositions of the present application include one or more Steviol Glycosides (SG).
In another aspect, the compositions of the present application include one or more Glycosylated Steviol Glycosides (GSG).
In another aspect, the compositions of the present application include one or more SG and one or more GSG.
In some embodiments, one or more SG are selected from table a or table B. In certain embodiments, the one or more SG comprises at least one SG selected from the group consisting of: related SG # 1, SG-4, isosteviolbioside, related SG # 3, rebaudioside R1, stevioside F, SG-Unk1, dulcoside B, SG-3, isorebaudioside B, isosteviolbioside, rebaudioside KA, SG-13, stevioside B, rebaudioside R, SG-Unk2, SG-Unk3, rebaudioside F3, rebaudioside F2, rebaudioside C2, stevioside E2, SG-10, rebaudioside L1, SG-2, rebaudioside A3, isorebaudioside A2, rebaudioside A2, rebaudioside E, rebaudioside H1, related SG #2, related SG #5, rebaudioside U2, rebaudioside T, rebaudioside W2, rebaudioside W3, rebaudioside W68612, SG # 9-K8653, SG-828653, rebaudioside K8653, rebaudioside K5, rebaudioside K-82 3, rebaudioside A, rebaudioside D-4, rebaudioside D, rebaudioside A, rebaudioside D-K-5, rebaudioside D-4, rebaudioside A, rebaudioside D-I, rebaudioside E-D-, SG-Unk6, rebaudioside Q2, rebaudioside Q3, rebaudioside I2, rebaudioside T1, related SG #4, rebaudioside V2, rebaudioside Y, 15 α -OH-rebaudioside M, rebaudioside O2, and combinations thereof.
In some embodiments, one or more SG are provided as a stevia extract selected from the group consisting of: RA20, RA40, RA50, RA60, RA80, RA90, RA95, RA97, RA98, RA99, RA99.5, RB8, RB10, RB15, RC15, RD6, and combinations thereof. The one or more SG may correspond to at least one SG group selected from SG-1G, SG-2G, SG-3G, SG-4G, SG-5G, SG-6G, SG-1G1R, SG-2G1R, SG-3G1R, SG-4G1R, SG-5G1R, SG-6G1R, SG-1G1X, SG-2G1X, SG-3G1X, SG-4G1X, SG-5G1X, and combinations thereof.
In some embodiments, the one or more SGs comprise at least one SG having a molecular weight less than or equal to 965 daltons, or less than or equal to 804 daltons.
In some embodiments, one or more SGs comprise a molecular weight greater than 804 daltons; greater than 965 daltons; greater than or equal to 1127 daltons; or at least one SG of 1259 daltons or greater.
One or more SG are present in the composition in a total amount of 0.1 to 99.5 wt% of the composition. In certain embodiments, the total amount of one or more SG in the composition is less than 25 wt%, from 10 to 25 wt%, or from 14 to 16 wt%.
In some embodiments, the one or more GSGs comprise at least one GSG represented as a SG further glycosylation product in table a or table B. In some embodiments, the one or more GSGs comprise at least one GSG of a SG further glycosylation product selected from the group consisting of: related SG # 1, SG-4, isosteviolbioside, related SG # 3, rebaudioside R1, stevioside F, SG-Unk1, dulcoside B, SG-3, isorebaudioside B, isosteviolbioside, rebaudioside KA, SG-13, stevioside B, rebaudioside R, SG-Unk2, SG-Unk3, rebaudioside F3, rebaudioside F2, rebaudioside C2, stevioside E2, SG-10, rebaudioside L1, SG-2, rebaudioside A3, isorebaudioside A2, rebaudioside A2, rebaudioside E, rebaudioside H1, related SG #2, related SG #5, rebaudioside U2, rebaudioside T, rebaudioside W2, rebaudioside W3, rebaudioside W68612, SG # 9-K8653, SG-828653, rebaudioside K8653, rebaudioside K5, rebaudioside K-82 3, rebaudioside A, rebaudioside D-4, rebaudioside D, rebaudioside A, rebaudioside D-K-5, rebaudioside D-4, rebaudioside A, rebaudioside D-I, rebaudioside E-D-, SG-Unk6, rebaudioside Q2, rebaudioside Q3, rebaudioside I2, rebaudioside T1, related SG #4, rebaudioside V2, rebaudioside Y, 15 α -OH-rebaudioside M, rebaudioside O2, and combinations thereof.
In some embodiments, the one or more GSGs comprise one or more additional glucose moieties and are selected from the group consisting of GSG-1G-1, GSG-1G-2, GSG-1G-3, GSG-1G-4, GSG-1G-5, GSG-2G-1, GSG-2G-2, GSG-2G-3, GSG-2G-4, GSG-3G-1, GSG-3G-2, GSG-3G-3, GSG-4G-1, GSG-4G-2, GSG-5G-1, and combinations thereof.
In some embodiments, one or more of the GSGs comprises one or more additional glucose moieties and is a member selected from the group consisting of GSG-3G-2, GSG-3G-3, GSG-3G-4, GSG-3G-7, GSG-3G-8, GSG-4G-1, GSG-4G-2, GSG-4G-3, GSG-4G-7, GSG-5G-1, GSG-5G-2, GSG-5G-3, GSG-5G-4, GSG-5G-5, GSG-6G-3, and combinations thereof.
In some embodiments, the one or more GSGs comprise one or more rhamnose moieties, one or more deoxyhexose moieties, or a combination thereof.
In certain specific embodiments, the one or more GSGs are selected from the group consisting of GSG-1G1R-1, GSG-1G1R-2, GSG-2G1R-1, GSG-1G1R-3, GSG-2G1R-2, GSG-3G1R-1, GSG-1G1R-4, GSG-2G1R-3, GSG-3G1R-2, GSG-4G-1R-1, GSG-1G1R-5-1, GSG-2G1R-4, GSG-3G1R-3a, GSG-3G1R-3b, GSG-4G1R-2, GSG-5G1R-1, and combinations thereof.
In other embodiments, the one or more GSGs are selected from: GSG-3G1R-3a, GSG-3G1R-3b, GSG-4G1R-2, GSG-4G1R-3, GSG-4G1R-4, GSG-4G1R-6, GSG-5G1R-4, GSG-6G1R-1a, GSG-6G1R-1b, GSG-6G1R-2 and combinations thereof.
In some embodiments, the one or more GSGs comprise one or more xylose moieties, arabinose moieties or a combination thereof.
In certain specific embodiments, the one or more GSGs are selected from: GSG-1G1X-1, GSG-1G1X-2, GSG-1G1X-3, GSG-1G1X-4, GSG-2G1X-1, GSG-2G1X-2, GSG-2G1X-3, GSG-3G1X-1, GSG-3G1X-2, GSG-4G1X-1 and combinations thereof.
In certain particular embodiments, the one or more GSGs are selected from: GSG-3G1X-4, GSG-3G1X-5, GSG-4G1X-1, GSG-4G1X-2, GSG-4G1X-3, GSG-4G1X-4 and combinations thereof.
In some embodiments, at least one of the one or more GSGs has a molecular weight of less than or equal to 1128 daltons; less than or equal to 966 daltons; or less than or equal to 804 daltons.
In some embodiments, at least one of the one or more GSGs has a molecular weight greater than 1128 daltons; greater than or equal to 1260 daltons; greater than or equal to 1422 daltons; greater than or equal to 1746 daltons; or greater than or equal to 1922 daltons.
The total content of one or more GSGs in the composition may be 0.1-99.5 wt%. In some embodiments, the total content of one or more GSGs in the composition is from 50 to 70 wt%, alternatively from 55 to 65 wt%.
The composition may also include one or more dextrins. In some embodiments, the dextrin is selected from the group consisting of tapioca dextrin, potato dextrin, cereal dextrin, yellow dextrin, white dextrin, and borax dextrin. In other embodiments, the dextrin is a cyclodextrin or a maltodextrin.
In some embodiments, the composition further comprises thaumatin.
Additionally, or alternatively, the composition may also include one or more salts. In some embodiments, the salt comprises one or more steviol glycoside salts. In some embodiments, the one or more steviol glycoside salts comprise steviolbioside salt. In other embodiments, the one or more steviol glycoside salts comprise a sodium salt of RB. In other embodiments, the one or more salts comprise NaCl and/or KCl.
The composition may also include one or more non-stevia sweeteners. In some embodiments, the non-stevia sweetener includes one or more sweeteners selected from the group consisting of: cyclamate and salts thereof, sucralose, aspartame, saccharin and salts thereof, xylitol, acesulfame-K, neotame, N- [3- (3-hydroxy-4-methoxyphenyl) propyl ] -alpha-aspartyl ] -L-phenylalanine 1-methyl ester (ANS9801), glycyrrhizin, thaumatin, monellin, and combinations thereof.
In other embodiments, the non-stevia sweetener includes one or more carbohydrate sweeteners and/or one or more non-carbohydrate sweeteners. In some embodiments, the composition comprises one or more carbohydrate sweeteners selected from the group consisting of sucrose, glyceraldehyde, dihydroxyacetone, erythrose, threose, erythrulose, arabinose, lyxose, ribose, xylose, ribulose, xylulose, allose, altrose, galactose, glucose, gulose, idose, mannose, talose, fructose, psicose, sorbose, tagatose, mannoheptulose, sedoheptulose, octulose, fucose, rhamnose, arabinose, turkey, sialose, and combinations thereof.
In other embodiments, the composition comprises one or more non-stevia sweeteners, wherein the one or more non-stevia sweeteners comprise a protein sweetener, such as thaumatin.
In one embodiment, the SG composition comprises 25 to 35 wt% Reb-a, 0.4 to 4 wt% Reb-B, 5 to 15 wt% Reb-C, 1 to 10 wt% Reb-D, 2 to 5 wt% Reb-F, 1 to 5 wt% Reb-K, and 20 to 40 wt% stevioside. In certain embodiments, the SG composition further comprises at least 20, at least 21, at least 22, at least 23, or at least 24 ingredients selected from the group consisting of 1 to 5 wt% rubusoside, 1 to 3 wt% dulcoside a, 0.01 to 3 wt% steviolbioside, 0.2 to 1.5 wt% dulcoside B, 00.01 to 2 wt% Reb-O, 0.01 to 2 wt% Reb-S, 0.01 to 1.2 wt% Reb-T, 0.01 to 0.8 wt% Reb-R, 0.01 to 0.7 wt% Reb-J, 0.01 to 0.7 wt% Reb-W, 0.01 to 0.7 wt% Reb-V, 0.01 to 0.6 wt% Reb-V2, 0.01 to 0.5 wt% Reb-G, 0.01 to 0.5 wt% Reb-H, 0.01 to 0.5 wt% Reb-V, 0.01 to 0.5 wt% Reb-G, 0.5 wt% Reb-0.7 wt% Reb-V, 0.3 wt% Reb-3 wt% 3 to 0.5 wt% Reb-3 wt% 2U, 0.3 wt% Reb-3 wt%, 0.01-0.5 wt.% Rel SG # 4, 0.01-0.5 wt.% Rel SG # 5, 0.01-0.4 wt.% Reb-M, 0.01-0.4 wt.% Reb-N, 0.01-0.4 wt.% Reb-E, 0.01-0.4 wt.% Reb-F1, 0.01-0.4 wt.% Reb-Y, and combinations thereof.
In another embodiment, the SG-B composition includes 45-55 wt% Reb-A, 20-40 wt% stevioside, 2-6 wt% Reb-C, 0.5-3 wt% Reb-B, and 0.5-3 wt% Reb-D. In certain embodiments, the SG-B composition further comprises one or more ingredients selected from the group consisting of 0.1 to 3 wt% related SG # 5, 0.05 to 1.5 wt% Reb-R1, 0.0.05 to 1.5 wt% Reb-K2, 0.05 to 1.5 wt% Reb-E, 0.01 to 1 wt% dulcoside a, 0.01 to 1 wt% dulcoside B, 0.01 to 1 wt% rubusoside, and combinations thereof. In certain embodiments, the SG-B composition further comprises one or more ingredients selected from the group consisting of 0.01 to 1 wt% steviol bioside, 0.01 to 1 wt% isosteviol bioside, 0.01 to 1 wt% stevioside-B, 0.01 to 1 wt% related SG # 3, 0.01 to 1 wt% related SG # 2, 0.01 to 1 wt% Reb-G, 0.01 to 1 wt% Reb-F, 0.01 to 1 wt% Reb-W, and combinations thereof.
In another embodiment, the SG-C composition comprises 35 to 45 wt% Reb-a, 10 to 25 wt% stevioside, 4 to 12 wt% Reb-B, 4 to 12 wt% dulcoside a, 0.5 to 4 wt% Reb-C, and 0.1 to 4 wt% Reb-O. In certain embodiments, the SG-C composition further comprises 0.3 to 3 wt% rubusoside, 0.1 to 3 wt% Reb-D, 0.1 to 3 wt% Reb-G, 0.1 to 3 wt% Reb-I, 0.1 to 3 wt% stevioside B, 0.1 to 3 wt% related SG # 3, 0.05 to 1.5 wt% Reb-E, 0.05 to 2 wt% Reb-R, 0.05 to 1 wt% dulcoside B, 0.01 to 1 wt% Reb-N, 0.01 to 1 wt% Reb-Y, 0.01 to 1 wt% steviol bioside, 0.01 to 1 wt% dulcoside B, and combinations thereof.
In another embodiment, a GSG-a composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 1-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.2-5 wt% GSG-3G-7, and 1-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-15 wt% GSG-4G-1, 1-2 wt% GSG-4G-2, 0.5-2.5 wt% GSG-4G-3, and 2-10 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.1-0.5 wt% GSG-5G-1, 0.05-0.5 wt% GSG-5G-2, 0.5-3 wt% GSG-5G-3, 0.05-0.5 wt% GSG-5G-4, and 0.2-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.5-5.5 wt% GSG-3G1R-33a and 2-6 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-5 wt% GSG-4G1R4, and 0.5-10 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 2-1.2 wt% GSG-6G1R-1a, 0.2-2 wt% GSG-6G1R-1b and 0.3-2.5 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-8 wt% GSG-3G1X-4 and 0.5-3 wt% GSG-3G 1X-5;
(j) One or more SG-4GX group components selected from the group consisting of 0.5-3 wt% GSG-4G1X-1, 0.5-3 wt% GSG-4G1X-2, 1-6 wt% GSG-4G1X-3, and 0.2-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In another embodiment, a GSG-B composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 2-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-2 wt% GSG-3G-4, 0.2-3 wt% GSG-3G-7, and 1-4 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.3-1.5 wt% GSG-4G-2, 0.5-1.5 wt% GSG-4G-3, and 2.5-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.4 wt% GSG-5G-2, 0.75-2 wt% GSG-5G-3, 0.05-0.3 wt% GSG-5G-4, and 0.4-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.2-3 wt% GSG-3G1R-3a and 1.5-5 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.05-0.75 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.5-6.5 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) One or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.2-2 wt% GSG-6G1R-1b, and 0.3-2.5 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4GX group components selected from the group consisting of 0.5-2 wt% GSG-4G1X-1, 0.5-2 wt% GSG-4G1X-2, 1.5-5 wt% GSG-4G1X-3, and 0.2-1.5 wt% GSG-4G 1X-4;
(k)1-2.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-B composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 1.5 to 12.5 wt% Reb-a, 0.2 to 1.5 wt% Reb-B, 0.5 to 4 wt% Reb-C, 0.3 to 1 wt% Reb-D, 0.1 to 2.5 wt% Reb-F, 0.05 to 2.5 wt% rubusoside, and 1.5 to 6.5 wt% stevioside.
In another embodiment, a GSG-C composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 3-6 wt% GSG-3G-2, 1.5-3.5 wt% GSG-3G-3, 1-3 wt% GSG-3G-4, 2-5 wt% GSG-3G-7, and 2-5 wt% GSG-3G-8;
(b) One or more SG-4G group components selected from the group consisting of 6-10 wt% GSG-4G-1, 0.5-1.5 wt% GSG-4G-2, 1-3 wt% SG-4G3, and 3-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.3 wt% GSG-5G-2, 1-2 wt% GSG-5G-3, 0.08-0.2 wt% GSG-5G-4, and 1.5-4.5 wt% GSG-5G-5;
(d)0.5-1.5wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 2-5 wt% GSG-3G1R-3a and 2-4 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.2-0.6 wt% GSG-4G1R3, 1.5-4 wt% GSG-4G1R4, and 3-10 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.5-1.5 wt% GSG-6G1R-1a,0.5-1.5 wt% GSG-6G1R-1b and 0.5-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) one or more SG-4GX group components selected from the group consisting of 0.3-1.5 wt% GSG-4G1X-1, 1-3.5 wt% GSG-4G1X-2, 1.5-4 wt% GSG-4G1X-3, and 0.5-2 wt% GSG-4G 1X-4; and
(k)1.5-3wt%GSG-5G1X-1,
Wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-C composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 0.5 to 2.5 wt% Reb-a, 0.2 to 1 wt% Reb-B, 0.2 to 0.8 wt% Reb-C, 0.2 to 0.6 wt% Reb-D, 0.05 to 0.25 wt% Reb-F, 0.05 to 0.6 wt% rubusoside, and 0.05 to 2 wt% stevioside.
In another embodiment, a GSG-D composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 5-15 wt% GSG-3G-2, 1-6 wt% GSG-3G-3, 0.5-3.5 wt% GSG-3G-4, 0.5-3.5 wt% GSG-3G-7, and 1.5-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 10-18 wt% GSG-4G-1, 0.5-3.5 wt% GSG-4G-2, 0.5-3.5 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.15-1.5 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.5-3.5 wt% GSG-5G-3, 0.05-0.35 wt% GSG-5G-4, and 0.1-1.5 wt% GSG-5G-5;
(d)0.3-2.5wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from 0.5-2 wt% GSG-3G1R-3a and 3-5 wt% GSG-3G1R-3 b;
(f) One or more SG-4G-1R group components selected from the group consisting of 0.25-2.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.3-3 wt% GSG-4G1R 6;
(g)1.5-7.5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-2 wt% GSG-6G1R-1a,0.1-2 wt% GSG-6G1R-1b and 0.1-2 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) at least one SG-4G1X group component selected from the group consisting of 0.5-5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1.5-6 wt% GSG-4G1X-3, and 0.5-2.5 wt% GSG-4G 1X-4; and
(k)0.5-4.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-D composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 1-6 wt% Reb-a, 0.2-2 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.05-2 wt% Reb-F, 0.05-1 wt% rubusoside, and 0.05-3.5 wt% stevioside.
In other embodiments, the GSG-D composition comprises at least 4, 5, 6 or 7 unreacted steviol glycosides selected from the group consisting of 3 to 10 wt% Reb-A, 0.05 to 2 wt% Reb-C, 0.05 to 2 wt% Reb-D, 0.05 to 1.5 wt% Reb-G, 0.05 to 0.5 wt% Reb-O, 0.05 to 0.5 wt% rubusoside, and 0.05 to 4 wt% stevioside.
In another embodiment, a GSG-E composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 1-5 wt% GSG-3G-2, 1-5 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-4 wt% GSG-3G-7, and 2-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.2-3 wt% GSG-4G-2, 0.2-3 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1.5 wt% GSG-5G-1, 0.05-1.5 wt% GSG-5G-2, 0.1-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.5-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 1-3 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R-2, 0.05-1 wt% GSG-4G1R-3, 1-3 wt% GSG-4G1R-4, and 5-10 wt% GSG-4G 1R-6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.1-1 wt% GSG-6G1R-1b and 0.2-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) One or more SG-4G1X group components selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1-3 wt% GSG-4G1X-3, and 0.3-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 of groups (a) - (k),
in certain embodiments, the GSG-E composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 6 to 12 wt% Reb-a, 0.1 to 1.5 wt% Reb-B, 0.5 to 3.5 wt% Reb-C, 0.1 to 1.5 wt% Reb-D, 0.8 to 3 wt% Reb-F, 0.5 to 2.5 wt% rubusoside, and 2 to 6 wt% stevioside.
In another embodiment, a GSG-F composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 1-4 wt% GSG-3G-2, 1-4 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-3 wt% GSG-3G-7, and 0.5-3.5 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 3-8 wt% GSG-4G-1, 0.1-2 wt% GSG-4G-2, 0.1-2 wt% SG-4G3, and 1-4 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.3-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.1-2 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) One or more SG-3G1R group components selected from the group consisting of 0.2-2 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-3 wt% GSG-4G1R4, and 1-3 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.05-1 wt% GSG-6G1R-1a,0.05-1 wt% GSG-6G1R-1b and 0.1-1.2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4G1X group components selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 0.5-2.5 wt% GSG-4G1X-3, and 023-2 wt% GSG-4G 1X-4; and
(k)1-3wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-F composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 15 to 25 wt% Reb-a, 0.05 to 1 wt% Reb-B, 1 to 3 wt% Reb-C, 0.1 to 1.5 wt% Reb-D, 0.8 to 3 wt% Reb-F, 0.3 to 2 wt% rubusoside, and 6 to 12 wt% stevioside.
In another aspect, the orally consumable composition comprises one or more SG and/or GSG of the present application.
In some embodiments, the orally consumable composition is a sweetener. In other embodiments, the orally consumable composition is a flavoring agent.
In another aspect, a method of increasing the sweetness of an orally consumable composition comprises adding an effective amount of a sweetening composition to the orally consumable composition.
In another aspect, a method of improving the taste profile or flavor of an orally consumable composition comprises adding an effective amount of a sweetening composition to the orally consumable composition.
In another aspect, a method of preparing a GSG composition comprises the steps of: (a) dissolving a glucose donor material in water to form a dissolved glucose donor material; (b) adding a SG composition to the dissolved glucose donor material to obtain a reaction mixture; (c) adding an effective amount of an enzyme to the reaction mixture, wherein the enzyme facilitates the transfer of glucose from the glucose donor molecule to SG added to the SG composition in the mixture; (d) incubating at the desired temperature for a predetermined reaction time to glycosylate the SG of the SG composition with the glucose moiety present in the glucose donor material; (e) inactivating the enzyme; (f) removing the enzyme from the reaction mixture; and (g) drying the resulting solution of GSG, residual SG and dextrin.
In some embodiments, the SG composition is a stevia extract. In some embodiments, the weight ratio of glucose donor molecule to SG composition is 10:90 to 90:10, 20:80 to 80:20, 30:70 to 70:30, or 40:60 to 60: 40.
In another aspect, a method of increasing sweetness of an orally consumable composition comprising the step of adding an effective amount of one or more SG and/or one or more GSG to the orally consumable composition.
In another aspect, a method of increasing the taste or flavor of an orally consumable composition comprising the step of adding an effective amount of one or more SG and/or one or more GSG to the orally consumable composition.
Drawings
Figure 1 shows a schematic of sweetness plotted against the concentration of GSG-RA 50.
FIG. 2 shows a schematic representation of the contribution of GSG-RA50 (per ppm) to SE.
FIGS. 3 and 4 show taste profiles of GSG-RA50/RA97 compositions.
Figure 5 shows a schematic of sweetness plotted against the concentration of GSG-RA 95.
FIG. 6 shows a schematic representation of the contribution of GSG-RA95 (per ppm) to SE.
FIGS. 7 and 8 show taste profiles of GSG-RA95/RA97 compositions.
Fig. 9 shows a schematic sweetness profile of GSG-RA50 and RA 97.
FIG. 10 shows a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 350ppm GSG-RA50 and RA 97.
FIG. 11 shows a schematic representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 400ppm GSG-RA50 and RA 97.
FIG. 12 shows a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 450ppm GSG-RA50 and RA 97.
Fig. 13 shows a schematic sweetness profile of GSG-RA95 and RA 97.
FIG. 14 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 350ppm GSG-RA95 and RA 97.
FIG. 15 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 400ppm GSG-RA95 and RA 97.
FIG. 16 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 450ppm GSG-RA95 and RA 97.
FIG. 17 is an optimized HPLC profile of GSG-RA 50.
FIG. 18 is an optimized HPLC profile of GSG-RA 80.
FIG. 19 is an optimized HPLC profile of GSG-RA 95.
FIG. 20 is an optimized HPLC profile of GSG-RA 20.
FIG. 21 is an optimized HPLC profile of GSG-RA 40.
FIG. 22 is an optimized HPLC profile of GSG-RA 85.
FIG. 23 is an optimized HPLC profile of GSG-RA 90.
FIG. 24 shows sweetness profiles of GSG-RA50 and RA 97.
FIG. 25 shows a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 200ppm GSG-RA50 and RA 97.
FIG. 26 shows a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 350ppm GSG-RA50 and RA 97.
FIG. 27 shows a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 400ppm GSG-RA50 and RA 97.
FIG. 28 is a graph showing the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 450ppm GSG-RA50 and RA 97.
FIG. 29 shows a schematic of sweetness calculated and measured in a composition of 500ppm GSG-RA50 and RA 97.
FIG. 30 shows a schematic sweetness profile of GSG-RA60 and RA 97.
FIG. 31 shows a graphical representation of the calculated and measured sweetness of GSG-RA60 (per ppm) in a combination of 350ppm GSG-RA60 and RA 97.
FIG. 32 shows sweetness profiles of GSG-RA70 and RA 97.
FIG. 33 shows a graphical representation of the calculated and measured sweetness of GSG-RA70 (per ppm) in a combination of 350ppm GSG-RA70 and RA 97.
FIG. 34 shows a schematic sweetness profile of GSG-RA80 and RA 97.
FIG. 35 shows a graphical representation of the calculated and measured sweetness of GSG-RA80 (per ppm) in a combination of 350ppm GSG-RA80 and RA 97.
FIG. 36 shows sweetness profiles of GSG-RA90 and RA 97.
FIG. 37 shows a graphical representation of the calculated and measured sweetness of GSG-RA90 (per ppm) in a combination of 350ppm GSG-RA90 and RA 97.
FIG. 38 shows sweetness profiles of GSG-RA95 and RA 97.
FIG. 39 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 200ppm GSG-RA95 and RA 97.
FIG. 40 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 350ppm GSG-RA95 and RA 97.
FIG. 41 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 400ppm GSG-RA95 and RA 97.
FIG. 42 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 450ppm GSG-RA95 and RA 97.
FIG. 43 is a schematic representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a composition of 500ppm GSG-RA95 and RA 97.
FIG. 44 shows sweetness profiles of GSG- (RA50+ RC5) and RA 97.
FIG. 45 is a graphical representation of the sweetness level of GSG-RA80 (per ppm) calculated and measured in a combination of 400ppm GSG- (RA50+ RC5) and RA 97.
FIG. 46 shows sweetness profiles of GSG- (RA30+ RC15) and RA 97.
FIG. 47 is a graphical representation of the calculated and measured sweetness per ppm of GSG- (RA50+ RC5) in a combination of 400ppm GSG- (RA50+ RC5) and RA 97.
FIG. 48 shows a schematic sweetness profile of GSG- (RA40+ RB8) and RA 97.
FIG. 49 shows a graphical representation of the calculated and measured sweetness per ppm of GSG- (RA40+ RB8) in a combination of 400ppm GSG- (RA40+ RB8) and RA 97.
FIG. 50 shows a schematic sweetness profile of GSG-RA20 and RA/RB/RD.
FIG. 51 is a graph showing the sweetness of GSG-RA20 (per ppm) calculated and measured in a combination of 400ppm GSG-RA20 and RA/RB/RD.
FIG. 52 shows a schematic sweetness profile of GSG-RA95 and RA75/RB 15.
FIG. 53 is a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 400ppm GSG-RA95 and RA75/RB 15.
FIG. 54 shows sweetness profiles of GSG-RA95 and RA/RD.
FIG. 55 shows a graphical representation of the calculated and measured sweetness of GSG-RA95 (per ppm) in a combination of 400ppm GSG-RA95 and RA/RD.
FIG. 56 shows a schematic sweetness profile of GSG-RA95 and RA80/RB10/RD 6.
FIG. 57 is a graphical representation of the sweetness of GSG-RA95 (per ppm) calculated and measured in a combination of 400ppm GSG-RA95 and RA80/RB10/RD 6.
FIG. 58 shows a schematic sweetness profile of GSG-RA80 and RA75/RB 15.
FIG. 59 shows a graphical representation of the calculated and measured sweetness of GSG-RA80 (per ppm) in a combination of 400ppm GSG-RA80 and RA75/RB 15.
FIG. 60 shows sweetness profiles of GSG-RA80 and RA/RD.
FIG. 61 is a graphical representation of the calculated and measured sweetness of GSG-RA80 (per ppm) in a combination of 400ppm GSG-RA80 and RA/RD.
FIG. 62 shows a schematic sweetness profile of GSG-RA80 and RA80/RB10/RD 6.
FIG. 63 is a graphical representation of the sweetness of GSG-RA80 (per ppm) calculated and measured in a combination of 400ppm GSG-RA80 and RA80/RB10/RD 6.
FIG. 64 shows a schematic sweetness profile of GSG-RA50 and RA75/RB 15.
FIG. 65 is a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 400ppm GSG-RA50 and RA75/RB 15.
FIG. 66 shows a schematic sweetness profile of GSG-RA50 and RA/RD.
FIG. 67 is a graphical representation of the calculated and measured sweetness of GSG-RA50 (per ppm) in a combination of 400ppm GSG-RA50 and RA/RD.
FIG. 68 shows a schematic sweetness profile of GSG-RA50 and RA80/RB10/RD 6.
FIG. 69 is a graphical representation of the sweetness of GSG-RA50 (per ppm) calculated and measured in a combination of 400ppm GSG-RA50 and RA80/RB10/RD 6.
FIG. 70 shows a schematic sweetness profile of GSG-RA40 and RA75/RB 15.
FIG. 71 shows a graphical representation of the calculated and measured sweetness of GSG-RA40 (per ppm) in a combination of 400ppm GSG-RA40 and RA75/RB 15.
FIG. 72 shows sweetness profiles of GSG-RA40 and RA/RD.
FIG. 73 is a graph showing the sweetness of GSG-RA40 (per ppm) calculated and measured in a combination of 400ppm GSG-RA40 and RA/RD.
FIG. 74 shows a schematic sweetness profile of GSG-RA40 and RA80/RB10/RD 6.
FIG. 75 is a graphical representation of the sweetness of GSG-RA40 (per ppm) as calculated and measured in a combination of 400ppm GSG-RA40 and RA80/RB10/RD 6.
FIG. 76 shows a schematic sweetness profile of GSG-RA20 and RA75/RB 15.
FIG. 77 is a graphical representation of the sweetness level of GSG-RA20 (per ppm) calculated and measured in a combination of 400ppm GSG-RA20 and RA75/RB 15.
FIG. 78 shows sweetness profiles of GSG-RA20 and RA/RD.
FIG. 79 shows a graphical representation of the calculated and measured sweetness of GSG-RA20 (per ppm) in a combination of 400ppm GSG-RA20 and RA/RD.
FIG. 80 shows a schematic sweetness profile of GSG-RA20 and RA80/RB10/RD 6.
FIG. 81 is a graphical representation of the sweetness of GSG-RA20 (per ppm) as calculated and measured in a combination of 400ppm GSG-RA20 and RA80/RB10/RD 6.
FIG. 82 shows a schematic of an analytical method for determining stevia glycosides and their amounts in a sample composition.
Fig. 83 and 84 are graphical illustrations showing sweetness threshold spent on sucrose in lemon-carbonated soft drinks.
Detailed Description
Definition of
In the specification and claims, the terms "include" and "comprise" are open-ended terms and should be understood to mean "including, but not limited to. These terms encompass the more limiting terms "consisting essentially of and" consisting of.
It should be noted that, as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Furthermore, the terms "a", "an", "one or more" and "at least one" may be used interchangeably herein. It should also be noted that the terms "comprising," "including," "characterized by," and "having" may be used interchangeably.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. All publications and patents mentioned herein are hereby incorporated by reference for all purposes including describing and disclosing the chemicals, instruments, statistical analyses and methods reported in the publications which might be associated with the invention. All references cited in this specification are to be taken as being indicative of the level of skill in the art. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.
The term "steviol glycoside" or "SG" as used herein refers to a glycoside of steviol, which is a diterpene compound represented by formula I. Non-limiting examples of steviol glycosides are shown in Table A or B below. The rebaudioside used in the present application does not limit its origin or origin. Steviol glycosides can be extracted from stevia rebaudiana leaves, synthesized enzymatically, synthesized chemically, or produced by fermentation.
As used herein, the term "stevioside composition" or "SG composition" refers to a composition comprising one or more SGs.
As used herein, the term "glycosylated stevioside" or "GSG" refers to SG with an additional glucose residue added relative to the parent SG present in, for example, stevia leaves. "GSG" may also be synthesized enzymatically by any known or unknown SG, synthesized chemically, or produced by fermentation.
As used herein, the term "glycosylated stevioside composition" or "GSG composition" refers to any material comprising one or more GSGs.
The term "SG/GSG composition" as used herein refers to a general composition that may include one or more SGs and/or one or more GSGs.
The phrase "total glycosides" refers to the total amount of GSG and SG in the composition.
An abbreviation of the class "YYxx" refers to a composition wherein YY represents a given compound (e.g., RA) or collection of compounds (e.g., SG), "xx" is generally a weight percent having a value between 1 and 100 and represents the purity of a given compound (e.g., RA) or collection of compounds; the weight percentage of YY in the dry product is equal to or greater than xx. The acronym "YYxx + WWzz" refers to a composition, where each of "YY" and "WW" refers to a given compound (e.g., RA) or set of compounds (e.g., SG), and where "xx" and "zz" refer to weight percentages between 1 and 100 that represent purity levels for the given compound (e.g., RA) or set of compounds, where the weight percentage of YY in the dried product is equal to or greater than xx, and the weight percentage of WW in the dried product is equal to or greater than zz.
If not otherwise specified, the abbreviation "RAx" means a stevia composition having an RA content of ≧ x% and < (x + 10)% with the following exceptions: the abbreviation "RA 100" refers specifically to pure RA; the abbreviation RA99.5 refers to a composition with RA content more than or equal to 99.5 wt% and less than 100 wt%; the abbreviation "RA 99" refers to a composition with RA content of more than 99 wt% and less than 100 wt%; the abbreviation "RA 98" refers to compositions with RA content of more than or equal to 98 wt% and less than 99 wt%; the abbreviation "RA 97" refers to compositions with RA content of more than or equal to 97 wt% and less than 98 wt%; the abbreviation "RA 95" refers to a composition with RA content of more than or equal to 95 wt% and less than 97 wt%; the abbreviation "RA 85" refers to compositions with RA content of more than or equal to 85 wt% and less than 90 wt%; the abbreviation "RA 75" refers to a composition with RA content of more than or equal to 75 wt% and less than 80 wt%; the abbreviation "RA 65" refers to compositions with RA content of more than or equal to 65 wt% and less than 70 wt%; the abbreviation "RA 20" refers to compositions having an RA content of 15 wt.% or more and less than 30 wt.%.
The abbreviation "GSG-RAxx" refers to GSG compositions prepared by an enzymatic glycosylation process using RAxx as the SG starting material. More broadly, an abbreviation of the class "GSG-YYxx" refers to a composition herein, wherein YY represents a compound (e.g., RA, RB, RC or RD), a composition (e.g., RA20), or a mixture of compositions (e.g., RA40+ RB 8). For example, GSG-RA20 refers to the glycosylated product formed with RA 20.
The phrase "sensory profile" is defined as a temporal profile of all the basic tastes of a sweetener. When a sweetener is consumed, the test is felt by a trained human taster and given in a short time from the contact with the taster's tongue ("start") to the cut-off point (typically 180s after start), the onset and decay of sweetness is referred to as the "temporal profile of sweetness". These human tasters are called "sensory panels". In addition to sweetness, sensory panels can also evaluate other "base taste" temporal profiles, bitterness, saltiness, sourness, pungency (also known as acridness), and umami (also known as aroma or meaty). When a sweetener is consumed, a test is given in a short time from the very beginning of the perception of the taste to the end of the perception of the aftertaste at the end of the cut-off, as perceived by a trained human taster, the onset and decay of the bitter taste is called the "time profile of the bitter taste".
The phrase "sucrose equivalent" or "SE" is the amount of non-sugar sweetener that is required to provide a given percentage of sucrose sweetness in the same food, beverage, or solution. For example, typically, a sugar-containing soft drink contains 12g of sucrose, i.e., 12% sucrose, per 100ml of water. This means that, to be commercially acceptable, a sugarless soft drink must have the same sweetness as a 12% sucrose soft drink, i.e. a sugarless soft drink must have a 12% SE. The soft drink ingredient device was set to 12% SE because such a device was configured for use with a sucrose-based syrup.
The phrase "taste profile" is defined as the temporal profile of all the basic tastes of a sweetener. When a sweetener is consumed, the test is felt by a trained human taster and given in a short time from the contact with the taster's tongue ("start") to the cut-off point (typically 180s after start), the onset and decay of sweetness is referred to as the "temporal profile of sweetness". These human tasters are called "sensory panels". In addition to sweetness, sensory panels can also evaluate other "base taste" temporal profiles, bitterness, saltiness, sourness, pungency (also known as acridness), and umami (also known as aroma or meaty). When a sweetener is consumed, a test is given in a short time from the very beginning of the perception of the taste to the end of the perception of the aftertaste at the end of the cut-off, as perceived by a trained human taster, the onset and decay of the bitter taste is called the "time profile of the bitter taste".
The term "flavor" or "flavor profile" as used herein is the overall sensory perception of taste, odor and or texture elements. As used herein, the term "enhancing" encompasses increasing (intensifying), intensifying (intensifying), emphasizing (intensifying), amplifying (amplifying), and amplifying (enriching) the sensory perception of a flavor feature without altering its nature or nature. As used herein, the term "altering" alters the sensory perception of (altering), changing (varying), suppressing (suppressing), decreasing (depressing), enhancing (enforcing), and supplementing (supplementing) a flavor feature when the flavor feature lacks quality or duration.
The term "rebaudioside" as used herein may be abbreviated as "Reb" or "R". For example, the term "rebaudioside a" is synonymous with "Reb a" and "RA". "Ducoside" may be abbreviated as "Dul" or "D", e.g., DA1 or DB.
1. SG/GSG compositions of the present application
In one aspect, the present application relates to a composition comprising (1) one or more SGs, and/or (2) one or more GSGs. In some embodiments, the composition further comprises one or more dextrins, one or more non-SG sweeteners, and/or one or more other additives.
The inventors of the present application found that: the compositions of the present application have improved taste profile and/or solubility over previously reported stevia compositions.
A. SG and SG composition
SG is the glycoside of steviol and is a diterpene compound represented by formula I.
As shown in formula II, SG is composed of steviol molecules glycosylated at the C13 and/or C19 positions.
Table a non-limitingly lists about 80 SG groups classified by molecular weight.
TABLE A SG groups according to molecular weight
Description of the drawings: SG-1 to 16: SG without a specific name; SG-Unk 1-6: SG without detailed structural evidence; glc is glucose; rha is rhamnose; xyl is xylose; ara arabinose.
Table B shows groups of SG classified according to the number of specific sugar groups at positions C-19 and C-13, where "x" in SG-xG denotes the number of glucose groups at positions C-19 and C-13, "x" in SG-xR denotes the number of rhamnose and/or deoxyhexose groups at positions C-19 and C-13, "x" in SG-xX denotes the number of xylose and/or arabinose groups at positions C-19 and C-13, "x" in SG-xFru denotes the number of fructose groups at positions C-19 and C-13, and "x" in SG-xGal denotes the number of galactose groups at positions C-19 and C-13. In addition, the number between-1 and-8 followed by the last letter corresponding to a sugar (e.g., G, R, X) indicates the number of glucose molecules added to this last sugar during the enzymatic treatment. Thus, for example, "SG-4G-2" means SG having 4 glucose molecules to which 2 glucose molecules have been added during the enzymatic treatment; "SG-3G 1R-4" means SG having 3 glucose molecules and 1 rhamnose/deoxyhexose molecule to which 4 glucose molecules are added during the enzymatic treatment; "SG-4G 1X-3" means SG having 4 glucose molecules and 1 xylose/arabinose molecule, 3 glucose molecules being added to the xylose/arabinose molecule during the enzymatic treatment.
TABLE B
Description of the drawings: SG-1 to 16: SG without a specific name; SG-Unk 1-6: SG without detailed structural evidence; glc is glucose; rha is rhamnose; xyl is xylose; ara is arabinose; fru is fructose; gal is galactose.
In some embodiments, the compositions of the present application comprise one or more rebaudioside selected from table a and/or table B.
In one embodiment, the SG composition comprises one or more SGs, each in an amount between 0.01 and 2 wt%, wherein the one or more SGs are selected from the group consisting of: isosteviol bioside, Reb-E, Reb-F1, Reb-G, Reb-H, Reb-H1, Reb-I, Reb-I2, Reb-J, Reb-KA, Reb-K2, Reb-M, Reb-N, Reb-O, Reb-O2, Reb-Q, Reb-R, Reb-R1, Reb-S, Reb-T, Reb-U2, Reb-V, Reb-V2, Reb-W, Reb-W2/3, Reb-Y, Rel SG # 1, Rel SG # 2, Rel SG # 3, Rel SG # 4, Rel SG # 5, and combinations thereof.
In another embodiment, the GSG composition comprises one or more GSGs derived from one or more SG selected from the group consisting of Reb-D, Reb-I, Reb-L, Reb-Q and Reb-I2, wherein the one or more GSGs are selected from the group consisting of: GSG-5G-1, GSG-5G-2, GSG-5G-3, GSG-5G-4 and GSG-5G-5. These GSGs were from the SG-5G group.
In other embodiments, the compositions include a plurality of SGs in the form of stevia leaf extracts, including, but not limited to, RA20, RA40, RA50, RA60, RA80, RA 90, RA95, RA97, RA98, RA99, RA99.5, RB8, RB10, RB15, RC15, RD6, and combinations thereof.
Stevia extracts include various SG at various concentrations. For example, the results of an analysis of the RA50 extract according to the method described in example 63 below show the following SG distributions and concentrations shown in table C. Table C shows the analysis of the combined extracts including RA40+ RB 8.
Distribution and concentration of SG in RA50
Distribution and concentration of SG in Table D.RA40/RB8
In one embodiment, the SG-a composition comprises 25 to 35 wt% Reb-a, 0.4 to 4 wt% Reb-B, 5 to 15 wt% Reb-C, 1 to 10 wt% Reb-D, 2 to 5 wt% Reb-F, 1 to 5 wt% Reb-K, and 20 to 40 wt% stevioside. In certain embodiments, the SG composition further comprises at least 20, at least 21, at least 22, at least 23, or at least 24 selected from the group consisting of 1-5 wt% rubusoside, 1-3 wt% dulcoside a, 0.01-3 wt% steviolbioside, 0.2-1.5 wt% dulcoside B, 00.01-2 wt% Reb-O, 0.01-2 wt% Reb-S, 0.01-1.2 wt% Reb-T, 0.01-0.8 wt% Reb-R, 0.01-0.7 wt% Reb-J, 0.01-0.7 wt% Reb-W, 0.01-0.7 wt% Reb-V, 0.01-0.6 wt% Reb-V2, 0.01-0.5 wt% Reb-G, 0.01-0.5 wt% Reb-H, 0.01-0.5 wt% Reb-V, 0.01-0.5 wt% Reb-3 wt% Reb-0.3 wt% Reb-3, 0.3 wt% Reb-3 wt% Reb, 0.01-0.5 wt% Rel SG #4, 0.01-0.5 wt% Rel SG #5, 0.01-0.4 wt% Reb-M, 0.01-0.4 wt% Reb-N, 0.01-0.4 wt% Reb-E, 0.01-0.4 wt% Reb-F1, 0.01-0.4 wt% Reb-Y and combinations thereof.
In another embodiment, the SG-B composition includes 45-55 wt% Reb-A, 20-40 wt% stevioside, 2-6 wt% Reb-C, 0.5-3 wt% Reb-B, and 0.5-3 wt% Reb-D. In certain embodiments, the SG-B composition further comprises one or more ingredients selected from the group consisting of 0.1 to 3 wt% related SG # 5, 0.05 to 1.5 wt% Reb-R1, 0.0.05 to 1.5 wt% Reb-K2, 0.05 to 1.5 wt% Reb-E, 0.01 to 1 wt% dulcoside a, 0.01 to 1 wt% dulcoside B, 0.01 to 1 wt% rubusoside, and combinations thereof. In certain embodiments, the SG-B composition further comprises one or more ingredients selected from the group consisting of 0.01 to 1 wt% steviol bioside, 0.01 to 1 wt% isosteviol bioside, 0.01 to 1 wt% stevioside-B, 0.01 to 1 wt% related SG # 3, 0.01 to 1 wt% related SG # 2, 0.01 to 1 wt% Reb-G, 0.01 to 1 wt% Reb-F, 0.01 to 1 wt% Reb-W, and combinations thereof.
B. GSG and GSG compositions
GSG is SG modified by the addition of other sugar groups at different positions of the SG molecule. Additional glycosyl groups may be added during the enzymatic glycosylation. The abbreviation "GX" can denote the number of added sugar groups on SG, wherein "X" is 1-20, corresponding to the number of sugar groups added by the enzymatic method on the GSG molecule. Thus, glycosylated steviol material with 1 other sugar group is called G1, material with 2 other sugar groups is called G2, and so on. For example, ST G1(ST-G1) has 1 glycosyl group, called "G1", ST-G2 has 2 glycosyl groups, ST-G3 has 3 glycosyl groups, ST-G4 has 4 glycosyl groups, ST-G5 has 5 glycosyl groups, ST-G6 has 6 glycosyl groups, ST-G7 has 7 glycosyl groups, ST-G8 has 8 glycosyl groups, ST-G9 has 9 glycosyl groups. There is no limitation on the number of sugar groups, and even more sugar-based GSG can be produced. Glycosylation of molecules can be determined by HPLC-MS as described herein and exemplified in example 17.
Any SG in tables a-D, e.g., steviol, STB, ST, RA, RB, RC, RD, rebaudioside e (re), rebaudioside f (rf), rebaudioside m (rm), rubusoside, and dulcoside a, can be enzymatically modified to give, e.g., their corresponding glycosylated glycosides as follows: steviol-G1, steviol-G2, steviol-G3, steviol-G4, steviol-G5, steviol-G6, steviol-G7, steviol-G8, steviol-G9, STB-G1, STB-G2, STB-G3, STB-G4, STB-G5, STB-G6, STB-G7, STB-G8, STB-G9, RB-G1, RB-G2, RC-G2, RD-G2, RD-G5, RD-G6, RD-G7, RD-G8, RD-G9, RE-G1, RE-G2, RE-G3, RE-G4, RE-G5, RE-G6, RE-G7, RE-G8, RE-G9, RF-G1, RF-G2, RF-G3, RF-G4, RM-G4, sweet tea glycoside, Dulcoside A-G1, dulcoside A-G2, dulcoside A-G3, dulcoside A-G4, dulcoside A-G5, dulcoside A-G6, dulcoside A-G7, dulcoside A-G8 and dulcoside A-G9.
For example, G1 and G2 for steviol, STB, ST, RA, RB, RC, RD, RE, RF, RM, rubusoside, and dulcoside A are shown below.
Broader non-limiting examples of GSGs are shown in tables E, F and G.
Table E shows the GSG groups corresponding to the parent SG with the glucose ("G"; i.e., the second G after the hyphen) portion added thereto.
TABLE E
Table F shows the GSG groups corresponding to the parent SG with glucose ("G"; i.e., the second G after the hyphen) and one rhamnose or deoxyhexose moiety ("R") added thereto.
TABLE F
Table G shows the GSG groups corresponding to the parent SG with glucose ("G"; i.e., the second G after the hyphen) and a xylose or deoxyhexose moiety ("X") added thereto.
Watch G
Non-limiting examples of typical GSGs include stevia leaf extracts including, but not limited to, GSG-RA20, GSG-RA30, GSG-RA40, GSG-RA50, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90, GSG-RA95, GSG-RA97, GSG- (RA50+ RB8), GSG- (RA30+ RC15), and GSG- (RA40+ RB 8).
In some embodiments, the compositions of the present application comprise one or more SGs having a molecular weight greater than or equal to 966 daltons and/or one or more GSGs made from one or more SGs having a molecular weight greater than or equal to 966 daltons.
In some embodiments, the compositions of the present application comprise one or more SGs having a molecular weight greater than or equal to 1259 daltons and/or one or more GSGs made from one or more SGs having a molecular weight greater than or equal to 1259 daltons.
In certain embodiments, each of said one or more GSGs in said composition comprises GSG from SG in an amount of 0-99%, 0-30%, 0-25%, 0-20%, 0-15%, 0-10%, 0-8%, 0-5%, 0-2%, 0-1%, 0-0.5%, 0.1-30%, 0.1-25%, 0.1-20%, 0.1-15%, 0.1-10%, 0.1-8%, 0.1-5%, 0.1-2%, 0.1-1%, 0.1-0.5%, 0.5-30%, 0.5-25%, 0.5-20%, 0.5-15%, 0.5-10%, 0.5-8%, 0.5-5%, 0.5-2 wt%, 0.5-1 wt%, 1-30 wt%, 1-25 wt%, 1-20 wt%, 1-15 wt%, 1-10 wt%, 1-8 wt%, 1-5 wt%, 1-2 wt%, 1.5-30 wt%, 1.5-25 wt%, 1.5-20 wt%, 1.5-15 wt%, 1.5-10 wt%, 1.5-8 wt%, 1.5-5 wt%, 5-30 wt%, 5-25 wt%, 5-20 wt%, 5-15 wt%, 5-10 wt%, 5-8 wt%, 10-30 wt%, 10-25 wt%, 10-20 wt%, 10-15 wt%, 15-30 wt%, 15-25 wt%, 15-20 wt%, 20-30 wt%, 20-25 wt%, or 25-30 wt%, and combinations thereof. In other embodiments, the composition is free of GSG from SG or substantially free of it.
In one embodiment, the GSG composition comprises one or more GSGs from one or more SGs selected from the group consisting of: Reb-B, iso-Reb-B, Reb-G, Reb-KA, SG-13, stevioside, iso-stevioside, and stevioside B (SG-15), wherein the one or more GSGs are selected from the group consisting of: GSG-3G-2, GSG-3G-3, GSG-3G-4, GSG-3G-7, GSG-3G-8. These GSGs were from the SG-3G group.
In another embodiment, the GSG composition comprises one or more GSGs from one or more SGs selected from the group consisting of: Reb-A, Reb-A2(SG-7), Reb-A3(SG-8), iso-Reb-A, Reb-E, and Reb-H1, wherein the one or more GSGs are selected from: GSG-4G-1, GSG-4G-2, GSG-4G-3, and GSG-4G-4. These GSGs were from the SG-4G group.
In another embodiment, the GSG composition comprises one or more GSGs from one or more SGs selected from the group consisting of: Reb-D, Reb-I2(SG-6), Reb-I3, Reb-L, Reb-Q (SG-5), Reb-Q2, Reb-Q3, Reb-T1, related SG # 4, and SG-Unk6, wherein the one or more GSGs are selected from the group consisting of: GSG-5G-1, GSG-5G-2, GSG-5G-3, GSG-5G-4, and GSG-5G-5. These GSGs were from the SG-5G group.
In another embodiment, the GSG composition comprises GSG from Reb-M, wherein said GSG is GSG-6G-3. Thus, GSG-6G-3 is from the SG-6G group.
In another embodiment, the GSG composition comprises one or more GSGs from one or more SGs selected from the group consisting of: Reb-C, Reb-C2/Reb-S, stevioside E2, stevioside E (SG-9), Reb-H, Reb-L1, SG-2 and SG-10, wherein GSG is GSG-3G1R-3a or GSG-3G1R-3 b. These GSGs were from group SG-3G 1R.
In another embodiment, the GSG composition comprises one or more GSGs from one or more SGs selected from the group consisting of: Reb-J, Reb-K2, SG-12, SG-Unk4, and SG-Unk5, wherein the one or more GSGs are selected from the group consisting of: GSG-4G1R-2, GSG-4G1R-3, GSG-4G1R-4, and GSG-4G 1R-6. These GSGs were from the SG-4G1R group.
In another embodiment, a GSG composition comprises GSG from Reb-N, wherein said GSG is GSG-5G1R-4, thus GSG-5G1R-4 is from said SG-5G1R group.
In another embodiment, the GSG composition comprises one or more GSGs derived from Reb-O or Reb-O2, wherein the one or more GSGs are selected from the group consisting of: GSG-6G1R-1a, GSG-6G1R-1b and GSG-6G 1R-2. These GSGs originated from group SG-6G 1R.
In another embodiment, a GSG composition comprises more than one GSG from the group consisting of Reb-F, Reb-F2(SG-14), Reb-F3(SG-11), SG-Unk2, and SG-Unk3, wherein said more than one GSG is selected from the group consisting of GSG-3G1X-4 and GSG-3G 1X-5. These GSGs are derived from the SG-3G1X group.
In another embodiment, the GSG composition comprises one or more GSGs from one or more SGs selected from the group consisting of: Reb-U, Reb-U2, Reb-T, Reb-W, Reb-W2, and Reb-W3, wherein the one or more GSGs are selected from the group consisting of: GSG-4G1X-1, GSG-4G1X-2, GSG-4G1X-3, and GSG-4G 1X-4. These GSGs are derived from the SG-4G1X group.
In another embodiment, a GSG composition comprises GSG from Reb-V, wherein said GSG is GSG-5G1X-4, therefore, GSG-5G1R-4 is from said SG-5G1X group.
In some embodiments, the compositions of the present application include GSG compositions produced from SG compositions comprising RA, RB, and/or RC. In one embodiment, the compositions of the present application include GSG compositions produced from SG compositions comprising about 20 wt% to about 97 wt% RA, about 0 wt% to about 10 wt% RB, and/or about 5 wt% to about 20 wt% RC.
In another embodiment, the compositions herein include a GSG composition produced from a SG composition comprising about 30 wt% to about 60 wt% RA, about 0.5 wt% to about 8 wt% RB, and/or about 5 wt% to about 18 wt% RC.
Any SG and/or GSG, including any one of tables a-E, may be present, individually or collectively, in the compositions herein in an amount of from about 0.1 wt% to about 99.5 wt%, including intervals defined by any combination of integers from 1 to 99.
In a given embodiment, SG and/or GSG are present in the compositions of the present application in an amount of about 1 wt%, about 2 wt%, about 3 wt%, about 4 wt%, about 5 wt%, about 6 wt%, about 7 wt%, about 8 wt%, about 9 wt%, about 10 wt%, about 11 wt%, about 12 wt%, about 13 wt%, about 14 wt%, about 15 wt%, about 16 wt%, about 17 wt%, about 18 wt%, about 19 wt%, 20 wt%, about 21 wt%, about 22 wt%, about 23 wt%, about 24 wt%, about 25 wt%, about 26 wt%, about 27 wt%, about 28 wt%, about 29 wt%, about 30 wt%, about 31 wt%, about 32 wt%, about 33 wt%, about 34 wt%, about 35 wt%, about 36 wt%, about 37 wt%, about 38 wt%, about 39 wt%, about 40 wt%, about 41 wt%, about 42 wt%, about 43 wt%, about 44 wt%, about 45 wt%, about 46 wt%, about 47 wt%, about 48 wt%, about 49 wt%, about 50 wt%, about 51 wt%, about 52 wt%, about 53 wt%, about 54 wt%, about 55 wt%, about 56 wt%, about 57 wt%, about 58 wt%, about 59 wt%, about 60 wt%, about 61 wt%, about 62 wt%, about 63 wt%, about 64 wt%, about 65 wt%, about 66 wt%, about 67 wt%, about 68 wt%, about 69 wt%, about 70 wt%, about 71 wt%, about 72 wt%, about 73 wt%, about 74 wt%, about 75 wt%, about 76 wt%, about 77 wt%, about 78 wt%, about 79 wt%, about 80 wt%, about 81 wt%, about 82 wt%, about 83 wt%, about 84 wt%, about 85 wt%, about 86 wt%, about 87 wt%, about 88 wt%, about 89 wt%, about 90 wt%, about 91 wt%, about 92 wt%, about 93 wt%, about 94 wt%, about 95 wt%, about 96 wt%, about 97 wt%, about 98 wt%, about 99 wt%, about 100 wt%, or any range between any pair of integers in this paragraph.
In some embodiments, the total content of SG and/or GSG in the sweet or flavor composition is less than about 99.5 wt%, less than about 99 wt%, less than about 98 wt%, less than about 95 wt%, less than about 90 wt%, less than about 85 wt%, less than about 80 wt%, less than about 75 wt%, less than about 70 wt%, less than about 65 wt%, less than about 60 wt%, less than about 55 wt%, less than about 50 wt%, less than about 45 wt%, less than about 40 wt%, less than about 35 wt%, less than about 30 wt%, less than about 25 wt%, less than about 20 wt%, less than about 15 wt%, less than about 10 wt%, less than about 5 wt%, less than about 2 wt%, less than about 1 wt%, less than about 0.5 wt%, less than about 0.2 wt%, less than about 0.1 wt%, less than about 0.05 wt%, or less than about 0.02 wt%.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions herein in an amount of about 1 wt% to about 5 wt%, about 1 wt% to about 10 wt%, about 1 wt% to about 15 wt%, about 1 wt% to about 20 wt%, about 1 wt% to about 25 wt%, about 1 wt% to about 30 wt%, about 1 wt% to about 35 wt%, about 1 wt% to about 40 wt%, about 1 wt% to about 45 wt%, about 1 wt% to about 50 wt%, about 1 wt% to about 55 wt%, about 1 wt% to about 60 wt%, about 1 wt% to about 65 wt%, about 1 wt% to about 70 wt%, about 1 wt% to about 75 wt%, about 1 wt% to about 80 wt%, about 1 wt% to about 85 wt%, about 1 wt% to about 90 wt%, about 1 wt% to about 95 wt%, about 1 wt% to about 97 wt%, about 1 wt% to about 99 wt%, about 1 wt% to about 5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions of the present application, the amount is about 10 wt% to about 15 wt%, about 10 wt% to about 20 wt%, about 10 wt% to about 25 wt%, about 10 wt% to about 30 wt%, about 10 wt% to about 35 wt%, about 10 wt% to about 40 wt%, about 10 wt% to about 45 wt%, about 10 wt% to about 50 wt%, about 10 wt% to about 55 wt%, about 10 wt% to about 60 wt%, about 10 wt% to about 65 wt%, about 10 wt% to about 70 wt%, about 10 wt% to about 75 wt%, about 10 wt% to about 80 wt%, about 10 wt% to about 85 wt%, about 10 wt% to about 90 wt%, about 10 wt% to about 95 wt%, about 10 wt% to about 97 wt%, about 10 wt% to about 99 wt%, about 10 wt% to about 99.5 wt%, or any range covering any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions herein in an amount of about 20 wt% to about 25 wt%, about 20 wt% to about 30 wt%, about 20 wt% to about 35 wt%, about 20 wt% to about 40 wt%, about 20 wt% to about 45 wt%, about 20 wt% to about 50 wt%, about 20 wt% to about 55 wt%, about 20 wt% to about 60 wt%, about 20 wt% to about 65 wt%, about 20 wt% to about 70 wt%, about 20 wt% to about 75 wt%, about 20 wt% to about 80 wt%, about 20 wt% to about 85 wt%, about 20 wt% to about 90 wt%, about 20 wt% to about 95 wt%, about 20 wt% to about 97 wt%, about 20 wt% to about 99 wt%, about 20 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions herein in an amount of about 30 wt% to about 35 wt%, 30 wt% to about 40 wt%, about 30 wt% to about 45 wt%, about 30 wt% to about 50 wt%, about 30 wt% to about 55 wt%, about 30 wt% to about 60 wt%, about 30 wt% to about 65 wt%, about 30 wt% to about 70 wt%, 30 wt% to about 75 wt%, about 30 wt% to about 80 wt%, about 30 wt% to about 85 wt%, about 30 wt% to about 90 wt%, about 30 wt% to about 95 wt%, about 30 wt% to about 97 wt%, about 30 wt% to about 99 wt%, about 30 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions herein in an amount of about 40 wt% to about 45 wt%, about 40 wt% to about 50 wt%, about 40 wt% to about 55 wt%, about 40 wt% to about 60 wt%, about 40 wt% to about 65 wt%, about 40 wt% to about 70 wt%, about 40 wt% to about 75 wt%, about 40 wt% to about 80 wt%, about 40 wt% to about 85 wt%, about 40 wt% to about 90 wt%, about 40 wt% to about 95 wt%, about 40 wt% to about 97 wt%, about 40 wt% to about 99 wt%, about 40 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions of the present application in an amount of about 45 wt% to about 50 wt%, about 45 wt% to about 55 wt%, about 45 wt% to about 60 wt%, about 45 wt% to about 65 wt%, about 45 wt% to about 70 wt%, about 45 wt% to about 75 wt%, about 45 wt% to about 80 wt%, about 45 wt% to about 85 wt%, about 45 wt% to about 90 wt%, about 45 wt% to about 95 wt%, about 45 wt% to about 97 wt%, about 45 wt% to about 99 wt%, about 45 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions of the present application in an amount of about 50 wt% to about 55 wt%, about 50 wt% to about 60 wt%, about 50 wt% to about 65 wt%, about 50 wt% to about 70 wt%, about 50 wt% to about 75 wt%, about 50 wt% to about 80 wt%, about 50 wt% to about 85 wt%, about 50 wt% to about 90 wt%, about 50 wt% to about 95 wt%, about 50 wt% to about 97 wt%, about 50 wt% to about 99 wt%, about 50 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions of the present application in an amount from about 55 wt% to about 60 wt%, 55 wt% to about 65 wt%, 55 wt% to about 70 wt%, 55 wt% to about 75 wt%, 55 wt% to about 80 wt%, 55 wt% to about 85 wt%, 55 wt% to about 90 wt%, 55 wt% to about 95 wt%, 55 wt% to about 97 wt%, 55 wt% to about 99 wt%, about 55 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions of the present application in an amount from about 60 wt% to about 65 wt%, from 60 wt% to about 70 wt%, from 60 wt% to about 75 wt%, from 60 wt% to about 80 wt%, from 60 wt% to about 85 wt%, from 60 wt% to about 90 wt%, from 60 wt% to about 95 wt%, from 60 wt% to about 97 wt%, from 60 wt% to about 99 wt%, from about 60 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions of the present application in an amount from about 65 wt% to about 70 wt%, from 65 wt% to about 75 wt%, from 65 wt% to about 80 wt%, from 65 wt% to about 85 wt%, from 65 wt% to about 90 wt%, from 65 wt% to about 95 wt%, from 65 wt% to about 97 wt%, from 65 wt% to about 99 wt%, from about 65 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG, individually or collectively, may be present in the compositions of the present application in an amount from about 70 wt% to about 75 wt%, from 70 wt% to about 80 wt%, from 70 wt% to about 85 wt%, from 70 wt% to about 90 wt%, from 70 wt% to about 95 wt%, from 70 wt% to about 97 wt%, from 70 wt% to about 99 wt%, from about 70 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG, individually or collectively, may be present in the compositions of the present application in an amount of from about 75 wt% to about 80 wt%, from 75 wt% to about 85 wt%, from 75 wt% to about 90 wt%, from 75 wt% to about 95 wt%, from 75 wt% to about 97 wt%, from 75 wt% to about 99 wt%, from about 75 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG, individually or collectively, may be present in the compositions of the present application in an amount from about 80 wt% to about 85 wt%, 80 wt% to about 90 wt%, 80 wt% to about 95 wt%, 80 wt% to about 97 wt%, 80 wt% to about 99 wt%, about 80 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG, either alone or collectively, may be present in the compositions of the present application in an amount from about 85 wt% to about 90 wt%, from 85 wt% to about 95 wt%, from 85 wt% to about 97 wt%, from 85 wt% to about 99 wt%, from about 85 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG may be present individually or collectively in the compositions herein in an amount of from about 90 wt% to about 95 wt%, from 90 wt% to about 97 wt%, from 90 wt% to about 99 wt%, from about 90 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph.
In some embodiments, SG and/or GSG, either alone or collectively, may be present in the compositions of the present application in an amount of from about 95 wt% to about 97 wt%, and from 95 wt% to about 99 wt%, to about 95 wt% to about 99.5 wt%, or any range covered by any integer in this paragraph. In some embodiments, the total glycoside is present in the compositions of the present application in an amount of 1 to 99.5 wt%, 5 to 99.5 wt%, 10 to 99.5 wt%, 15 to 99.5 wt%, 20 to 99.5 wt%, 25 to 99.5 wt%, 30 to 99.5 wt%, 35 to 99.5 wt%, 40 to 99.5 wt%, 45 to 99.5 wt%, 50 to 99.5 wt%, 55 to 99.5 wt%, 60 to 99.5 wt%, 65 to 99.5 wt%, 70 to 99.5 wt%, 75 to 99.5 wt%, 80 to 99.5 wt%, 85 to 99.5 wt%, 90 to 99.5 wt%, 95 to 99.5 wt%, 1 to 95 wt%, 5 to 95 wt%, 10 to 95 wt%, 15 to 95 wt%, 20 to 95 wt%, 25 to 95 wt%, 30 to 95 wt%, 35 to 95 wt%, 40 to 95 wt%, 45 to 95 wt%, 50-95 wt%, 55-95 wt%, 60-95 wt%, 65-95 wt%, 70-95 wt%, 75-95 wt%, 80-95 wt%, 85-95 wt%, 90-95 wt%, 1-90 wt%, 5-90 wt%, 10-90 wt%, 15-90 wt%, 20-90 wt%, 25-90 wt%, 30-90 wt%, 35-90 wt%, 40-90 wt%, 45-90 wt%, 50-90 wt%, 55-90 wt%, 60-90 wt%, 65-90 wt%, 70-90 wt%, 75-90 wt%, 80-90 wt%, 85-90 wt%.
While not wishing to be bound by theory, it is believed that: the combination of SG and GSG produced a synergistic effect in sweetness. More specifically, the SG/GSG composition achieves a theoretical sweetness value after glycosylation that is greater than the sum of the corresponding sweetness values of SG alone and GSG alone.
In one embodiment, the a GSG composition comprises 10 to 30 wt% SG, 50 to 70 wt% GSG, and 60 to 90 wt% total glycosides.
In another embodiment, a GSG-a composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 1-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.2-5 wt% GSG-3G-7, and 1-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-15 wt% GSG-4G-1, 1-2 wt% GSG-4G-2, 0.5-2.5 wt% GSG-4G-3, and 2-10 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.1-0.5 wt% GSG-5G-1, 0.05-0.5 wt% GSG-5G-2, 0.5-3 wt% GSG-5G-3, 0.05-0.5 wt% GSG-5G-4, and 0.2-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.5-5.5 wt% GSG-3G1R-33a and 2-6 wt% GSG-3G1R-3 b;
(f) One or more SG-4G-1R group components selected from the group consisting of 0.3-1.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-5 wt% GSG-4G1R4, and 0.5-10 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.2-1.2 wt% GSG-6G1R-1a,0.2-2 wt% GSG-6G1R-1b and 0.3-3 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-8 wt% GSG-3G1X-4 and 0.5-3 wt% GSG-3G 1X-5;
(j) one or more SG-4GX group components selected from the group consisting of 0.5-3 wt% GSG-4G1X-1, 0.5-3 wt% GSG-4G1X-2, 1-6 wt% GSG-4G1X-3, and 0.2-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-a composition further comprises at least 5, 6, 7, or 8 unreacted steviol glycoside moiety selected from: 1-8 wt% Reb-A, 0.1-1.5 wt% Reb-B, 0.05-3 wt% Reb-C, 0.05-1 wt% Reb-D, 0.05-0.3 wt% Reb-F, 0.05-0.25 wt% Reb-K, 0.05-0.5 wt% rubusoside, and 0.05-3 wt% stevioside.
In another embodiment, a GSG-B composition comprises:
(a) One or more SG-3G group components selected from the group consisting of 2-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-2 wt% GSG-3G-4, 0.2-3 wt% GSG-3G-7, and 1-4 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.3-1.5 wt% GSG-4G-2, 0.5-1.5 wt% GSG-4G-3, and 2.5-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.4 wt% GSG-5G-2, 0.75-2 wt% GSG-5G-3, 0.05-0.3 wt% GSG-5G-4, and 0.4-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.2-3 wt% GSG-3G1R-3a and 1.5-5 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.05-0.75 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.5-6.5 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.2-2 wt% GSG-6G1R-1b, and 0.3-3 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) One or more SG-4GX group components selected from the group consisting of 0.5-2 wt% GSG-4G1X-1, 0.5-2 wt% GSG-4G1X-2, 1.5-5 wt% GSG-4G1X-3, and 0.2-1.5 wt% GSG-4G 1X-4; and
(k)1-2.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-B composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycoside moieties selected from: 1.5-12.5 wt% Reb-a, 0.2-1.5 wt% Reb-B, 0.5-4 wt% Reb-C, 0.3-1 wt% Reb-D, 0.1-2.5 wt% Reb-F, 0.05-2.5 wt% rubusoside, and 1.5-6.5 wt% stevioside.
In another embodiment, a GSG-C composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 3-6 wt% GSG-3G-2, 1.5-3.5 wt% GSG-3G-3, 1-3 wt% GSG-3G-4, 2-5 wt% GSG-3G-7, and 2-5 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 6-10 wt% GSG-4G-1, 0.5-1.5 wt% GSG-4G-2, 1-3 wt% SG-4G3, and 3-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.3 wt% GSG-5G-2, 1-2 wt% GSG-5G-3, 0.08-0.2 wt% GSG-5G-4, and 1.5-4.5 wt% GSG-5G-5;
(d)0.5-1.5wt%GSG-6G-3;
(e) One or more SG-3G-1R group components selected from the group consisting of 2-5 wt% GSG-3G1R-3a and 2-4 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.2-0.6 wt% GSG-4G1R3, 1.5-4 wt% GSG-4G1R4, and 3-10 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.5-1.5 wt% GSG-6G1R-1 and 0.5-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) one or more SG-4GX group components selected from the group consisting of 0.3-1.5 wt% GSG-4G1X-1, 1-3.5 wt% GSG-4G1X-2, 1.5-4 wt% GSG-4G1X-3, and 0.5-2 wt% GSG-4G 1X-4; and
(k)1.5-3wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-C composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycoside moieties selected from: 0.5-2.5 wt% Reb-A, 0.2-1 wt% Reb-B, 0.2-0.8 wt% Reb-C, 0.2-0.6 wt% Reb-D, 0.05-0.25 wt% Reb-F, 0.05-0.6 wt% rubusoside, and 0.05-2 wt% stevioside.
In another embodiment, a GSG-D composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 5-15 wt% GSG-3G-2, 1-6 wt% GSG-3G-3, 0.5-3.5 wt% GSG-3G-4, 0.5-3.5 wt% GSG-3G-7, and 1.5-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 10-18 wt% GSG-4G-1, 0.5-3.5 wt% GSG-4G-2, 0.5-3.5 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.15-1.5 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.5-3.5 wt% GSG-5G-3, 0.05-0.35 wt% GSG-5G-4, and 0.1-1.5 wt% GSG-5G-5;
(d)0.3-2.5wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 0.5-2 wt% GSG-3G1R-3a and 3-5 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.25-2.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.3-3 wt% GSG-4G1R 6;
(g)1.5-7.5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-2 wt% GSG-6G1R-1a,0.1-2 wt% GSG-6G1R-1b, and 0.1-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) One or more SG-4G1X group components selected from the group consisting of 0.5-5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1.5-6 wt% GSG-4G1X-3, and 0.5-2.5 wt% GSG-4G 1X-4; and
(k)0.5-4.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-D composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycoside moieties selected from: 1-6 wt% Reb-A, 0.2-2 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.05-2 wt% Reb-F, 0.05-1 wt% rubusoside, and 0.05-3.5 wt% stevioside.
In other embodiments, the GSG-D composition comprises at least 4, 5, 6, or 7 unreacted steviol glycoside moieties selected from: 3-10 wt% Reb-A, 0.05-2 wt% Reb-C, 0.05-2 wt% Reb-D, 0.05-1.5 wt% Reb-G, 0.05-0.5 wt% Reb-O, 0.05-0.5 wt% rubusoside, and 0.05-4 wt% stevioside.
In another embodiment, a GSG-E composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 1-5 wt% GSG-3G-2, 1-5 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-4 wt% GSG-3G-7, and 2-6 wt% GSG-3G-8;
(b) One or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.2-3 wt% GSG-4G-2, 0.2-3 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1.5 wt% GSG-5G-1, 0.05-1.5 wt% GSG-5G-2, 0.1-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.5-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 1-3 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R-2, 0.05-1 wt% GSG-4G1R-3, 1-3 wt% GSG-4G1R-4, and 5-10 wt% GSG-4G 1R-6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.1-1 wt% GSG-6G1R-1b, and 0.2-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4G1X group components selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1-3 wt% GSG-4G1X-3, and 0.3-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
Wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-E composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycoside moieties selected from: 6-12 wt% Reb-A, 0.1-1.5 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.8-3 wt% Reb-F, 0.5-2.5 wt% rubusoside, and 2-6 wt% stevioside.
In another embodiment, a GSG-F composition comprises:
(a) one or more SG-3G group components selected from the group consisting of 1-4 wt% GSG-3G-2, 1-4 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-3 wt% GSG-3G-7, and 0.5-3.5 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 3-8 wt% GSG-4G-1, 0.1-2 wt% GSG-4G-2, 0.1-2 wt% SG-4G3, and 1-4 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.3-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.1-2 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 0.2-2 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) One or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-3 wt% GSG-4G1R4, and 1-3 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.05-1 wt% GSG-6G1R-1a,0.05-1 wt% GSG-6G1R-1b and 0.1-1.2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4G1X group components selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 0.5-2.5 wt% GSG-4G1X-3, and 0.2-2 wt% GSG-4G 1X-4; and
(k)1-3wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
In certain embodiments, the GSG-F composition further comprises at least 4, 5, 6, or 7 unreacted steviol glycoside moieties selected from: 15-25 wt% Reb-A, 0.05-1 wt% Reb-B, 1-3 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.8-3 wt% Reb-F, 0.3-2 wt% rubusoside, and 6-12 wt% stevioside.
All of the components of the compositions disclosed herein can be purchased or produced by methods well known to those of ordinary skill in the art and then combined (e.g., precipitation/co-precipitation, mixing, stirring, milling, painting and pestal, micro-emulsification, thermal dissolution, sonochemical treatment, etc.) or otherwise processed by the methods defined herein.
Although not limited, the compositions herein can be amorphous, each individually in the form of a polymorph, each individually in the form of a hydrate, or mixtures thereof. In some embodiments, the compositions of the present application are amorphous solids.
In some embodiments, the compositions of the present application are sweetener compositions comprising (1) one or more SG in table a and/or table B; and (2) one or more GSGs, each GSG formed by an in vitro enzymatic method with SG from Table A and/or Table B. In other embodiments, the sweetener compositions comprise (1) a plurality of GSGs formed from stevia leaf extract, in combination with (2) one or more SG selected from steviol, ST, STB, RA, RB, RC, RD, RE, RF, RM, rubusoside, and dulcoside A to form a GSG composition selected from GSG-RA20, GSG-RA30, GSG-RA40, GSG-RA50, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90, GSG-RA95, GSG-RA97, GSG- (RA50+ RB8), GSG- (RA30+ RC15), and GSG- (RA40+ RB 8).
In some embodiments, the sweetener composition is in the form of a solution, and the final concentration of GSG in the solution (wt/wt) is 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, or a range defined by any pair of integers above. Likewise, the final concentration of SG in solution (wt/wt) can be 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, or a range defined by any pair of integers above. Thus, the final concentration (wt/wt) of the whole glycoside (i.e., GSG + SG) in the sweetener composition may be 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 99%, 100%, or a range defined by any pair of integers above.
In some embodiments, the sweetener composition is such that: the content of GSG and/or SG aggregates in the final product (e.g., palatable product) is 100-50000 ppm. In some embodiments, the GSG and/or SG aggregate is present in the final product in an amount from about 100ppm to about 20000ppm, from about 100ppm to about 5000ppm, from about 100ppm to about 2000ppm, from about 100ppm to about 500ppm, from about 100ppm to about 200ppm, from about 500ppm to about 20000ppm, from about 500ppm to about 5000ppm, from about 500ppm to about 2000ppm, from about 2000ppm to about 20000ppm, or from about 2000ppm to about 5000 ppm.
In some embodiments, the sweetener composition is such that: the GSG and/or SG collective content in the final product (e.g., beverage) is 100-2000ppm, preferably from about 200ppm to about 1000ppm, more preferably from about 300ppm to about 500ppm and any value within or any range between these values, particularly 350ppm, 400ppm or 450 ppm.
In some embodiments, the compositions of the present application are flavor compositions comprising (1) a plurality of GSGs in the form of a GSG composition selected from the group consisting of GSG-RA20, GSG-RA30, GSG-RA40, GSG-RA50, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90, GSG-RA95, GSG-RA97, GSG- (RA50+ RB8), GSG- (RA30+ RC15), and GSG- (RA40+ RB8), and (2) one or more SGs selected from the group consisting of alcohol, ST, STB, RA, RB, RC, RD, RE, RF, RM, rubusoside, and dulcoside a. .
In some embodiments, the flavoring composition is in the form of a solution, and the GSG is present in the solution in an amount of 0.1ppm, 1ppm, 10ppm, 50ppm, 100ppm, 150ppm, 200ppm, 250ppm, 300ppm, 350ppm, 400ppm, 450ppm, 500ppm, 550ppm, 600ppm, 650ppm, 700ppm, 750ppm, 800ppm, 850ppm, 900ppm, 950ppm, 1000ppm, or any value within or any range between any pair of integers above. Likewise, the final concentration of SG in the flavoring composition solution can be 0.1ppm, 1ppm, 10ppm 50ppm, 100ppm, 150ppm, 200ppm, 250ppm, 300ppm, 350ppm, 400ppm, 450ppm, 500ppm, 550ppm, 600ppm, 650ppm, 700ppm, 750ppm, 800ppm, 850ppm, 900ppm, 950ppm, 1000ppm, such that the concentration of the whole glycoside in the solution is from about 1ppm to about 2000ppm, preferably from about 200ppm to about 1000ppm, more preferably from about 300ppm to about 500ppm, and any value within or between these values.
In some embodiments, the flavor composition is such that: the content of GSG and/or SG in the final product (e.g. palatable drink product) is 0.1-1000 ppm. In some embodiments, the GSG and/or SG set is present in the final product in an amount of from about 1 to about 200ppm, from about 1ppm to about 50ppm, from about 10ppm to about 50ppm, from about 20ppm to about 50ppm, from about 1ppm to about 100ppm, from about 10ppm to about 100ppm, from about 50ppm to about 100ppm, from about 1ppm to about 150ppm, from about 10ppm to about 150ppm, from about 20ppm to about 150ppm, from about 50ppm to about 150ppm, from about 100ppm to about 150ppm, from about 1ppm to about 200ppm, from about 10ppm to about 200ppm, from about 20ppm to about 200ppm, from about 50ppm to about 200ppm, from about 100ppm to about 200ppm, or from about 150ppm to about 200 ppm.
In some embodiments, the solubility of the compositions of the present application in water (g/100g) is 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, or 25g per 100g of water dissolved and remains stable in water at room temperature for more than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 14, 21, or 28 days.
Dextrin
In embodiments including GSG, the composition generally includes one or more dextrins that remain after the glycosylation reaction. Dextrins are hydrolysates of starch, providing a matrix for glycosylation to produce more efficacious SG/GSG compositions with improved solubility and/or taste profiles.
In some embodiments, the dextrin is produced from starch. The starch used may be a natural starch such as potato starch, waxy potato starch, cereal starch, rice starch, pea starch, banana starch, horse chestnut starch, wheat starch, amylose, high amylose starch, starch essence, amylopectin, lactose and combinations thereof. However, modified starches such as pregelatinized starch, thinned starch, oxidized starch, citrate starch, high fructose corn syrup, hydrogenated starch hydrolysate, hydroxyethyl starch, hydroxypropyl distarch phosphate, maltitol, acetate starch, acetylated distarch adipate, starch ether, starch ester, starch phosphate, phosphorylated distarch phosphate and penta starch may also be used. There is in principle no restriction on the choice of starch. The starch may have, for example, a low viscosity, a medium viscosity, or a high viscosity, may be cationic or anionic, and may be cold water soluble or hot water soluble.
Dextrins can be linear or cyclic. The dextrin may be selected from tapioca dextrin, potato dextrin, corn dextrin, yellow dextrin, white dextrin, borax dextrin, maltodextrin and Cyclodextrin (CD) such as alpha, beta and/or gamma cyclodextrin. In certain preferred embodiments, the dextrin is CD or tapioca dextrin. CD is a series of compounds of cyclic oligosaccharides composed of sugar molecules bonded together in a ring. They consist of 5 or more 1- >4 linked alpha-D-glucopyranoside units, such as amylose. CD is also known as cyclic amylose.
The dextrin may be present in the composition in an amount of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 wt%, and all ranges between 1 and 99 wt%, such as from about 1 to about 99 wt%, from about 1 to about 98 wt%, from about 1 to about 97 wt%, from about 1 to about 95 wt%, from about 1 to about 90 wt%, from about 1 to about 80 wt%, from about 1 to about 70 wt%, from about 1 to about 60 wt%, from about 1 to about 50 wt%, about 1 wt% to about 40 wt%, about 1 wt% to about 30 wt%, about 1 wt% to about 20 wt%, about 1 wt% to about 10 wt%, about 1 wt% to about 5 wt%, about 2 wt% to about 99 wt%, about 2 wt% to about 98 wt%, about 2 wt% to about 97 wt%, about 2 wt% to about 95 wt%, about 2 wt% to about 90 wt%, about 2 wt% to about 80 wt%, about 2 wt% to about 70 wt%, about 2 wt% to about 60 wt%, about 2 wt% to about 50 wt%, about 2 wt% to about 40 wt%, about 2 wt% to about 30 wt%, about 2 wt% to about 20 wt%, about 2 wt% to about 10 wt%, about 2 wt% to about 5 wt%, about 3 wt% to about 99 wt%, about 3 wt% to about 98 wt%, about 3 wt% to about 97 wt%, about 3 wt% to about 95 wt%, about 3 wt% to about 90 wt%, about 3 wt% to about 80 wt%, about 3 wt% to about 70 wt%, about 3 wt% to about 60 wt%, about 3 wt% to about 50 wt%, about 3 wt% to about 40 wt%, about 3 wt% to about 30 wt%, about 3 wt% to about 20 wt%, about 3 wt% to about 10 wt%, about 3 wt% to about 5 wt%, about 5 wt% to about 99 wt%, about 5 wt% to about 98 wt%, about 5 wt% to about 97 wt%, about 5 wt% to about 95 wt%, about 5 wt% to about 90 wt%, about 5 wt% to about 80 wt%, about 5 wt% to about 70 wt%, about 5 wt% to about 60 wt%, about 5 wt% to about 50 wt%, about 5 wt% to about 40 wt%, about 5 wt% to about 30 wt%, about 5 wt% to about 20 wt%, about 5 wt% to about 10 wt%, about 10 wt% to about 99 wt%, about 10 wt% to about 98 wt%, about 10 wt% to about 97 wt%, about 10 wt% to about 95 wt%, about 10 wt% to about 80 wt%, about 10 wt% to about 70 wt%, about 10 wt% to about 60 wt%, about 10 wt% to about 50 wt%, about 10 wt% to about 40% w/wt, about 10 wt% to about 30 wt%, and about 10 wt% to about 20 wt%.
In some embodiments, the compositions of the present application may be dissolved in an aqueous solution. The aqueous solution can include water and/or an alcohol, such as one or more of methanol, ethanol, propanol, isopropanol, n-butanol, isobutanol, sec-butanol, tert-butanol, n-pentanol, isopentanol, neopentyl alcohol, or combinations thereof.
The alcohol may be present in the hydroalcoholic solution in an amount less than 60%, less than 50%, less than 40%, less than 30%, less than 20%, less than 10%, less than 5%, less than 2%, or less than 1% by volume.
C. Non-steviol glycoside sweeteners (non-SG sweeteners)
The compositions of the present application may also include one or more non-SG sweeteners. Examples of non-SG sweeteners include, but are not limited to, natural sweeteners, natural high potency sweeteners, synthetic sweeteners, or combinations thereof.
The term "natural sweetener" as used herein refers to sweeteners found in nature, but does not include SG. The phrase "natural high potency sweetener" refers to any sweetener found in nature that has a sweetness potency greater than sucrose, fructose, or glucose, but a lower caloric value. The phrase "synthetic sweetener" refers to any composition that does not exist in nature and that has a sweetness potency greater than sucrose, fructose, or glucose, but a lower caloric value. The terms "natural sweetener", "natural high potency sweetener" and "synthetic sweetener" are used herein to distinguish them from SG.
In certain embodiments, the non-SG sweetener comprises at least one carbohydrate sweetener. Examples of carbohydrate sweeteners are selected from, but are not limited to, sucrose, glyceraldehyde, dihydroxyacetone, erythrose, threose, erythrulose, arabinose, lyxose, ribose, xylose, ribulose, xylulose, allose, altrose, galactose, glucose, gulose, idose, mannose, talose, fructose, psicose, sorbose, tagatose, mannoheptulose, sedoheptulose, octulose, fucose, rhamnose, arabinose, turkey, sialose, and combinations thereof.
Other suitable non-SG sweeteners may be selected from mogroside IV, mogroside V, Lo Han Guo sweeteners, siamenoside, Menatin and its salts (Menatin SS, RR, RS, SR), Curculin (curculin), glycyrrhizic acid (glycyrrhicid) and its salts, thaumatin (thaumatin), monellin (monellin), mabinlin (mabinlin), bolin (brezzezedin), yandulcin (hernandulcin), theophyllin (phyllodulin), glycocalyxin (glycophyrophyllin), phlorizin (phloridzin), tylosin (trilobatin), baiyunoside (baiyunoside), oslaidin (osladin), caramel, poliomycoside A, myriocide I (narioside A), griseoside A, myriocidin (narioside I), peridolin (leucovorin (mangiferin), griseoside A, myriocide I (narioside A), griseolude (narioside A, myriocidin (narioside I), grisein (leucovorin, myriocide I), grisein (leucovoricidin (leucovorin, myriocide I), griseoside A, myriocide I, myriocide (I), or a, myriocide I, benocide I, or a, Sucralose, acesulfame and salts thereof such as acesulfame-K and acesulfame potassium; L-alpha-aspartyl-L-phenylalanine methyl ester (aspartame), N- [ N- [3- (3-hydroxy-4-methoxyphenyl) propyl group ]-alpha-aspartyl]-L-phenylalanine (saccharin), N- [ N- [3- (3-hydroxy-4-methoxyphenyl) propyl]-alpha-aspartyl]-L-phenylalanine 1-methyl ester (ANS9801), alitame (alitame), saccharin and its salts, neohesperidin dihydrochalcone, cyclamate and its salts, neotame, trehalose, raffinose, sodium caseinate, sodium cyclamate, sodium cycl,Cellobiose, tagatose, DOLCIA PRIMATMAllulose, inulin, and combinations thereof.
In some embodiments, the compositions of the present application comprise thaumatin. In some embodiments, the thaumatin is present in the composition in an amount from about 0.01 wt% to about 10 wt%, from about 0.01 wt% to about 5 wt%, from about 0.01 wt% to about 2 wt%, from about 0.01 wt% to about 1 wt%, from about 0.01 wt% to about 0.5 wt%, from about 0.01 wt% to about 0.2 wt%, from about 0.01 wt% to about 0.1 wt%, from about 0.01 wt% to about 0.05 wt%, from about 0.01 wt% to about 0.02 wt%, from about 0.02 wt% to about 10 wt%, from about 0.02 wt% to about 5 wt%, from about 0.02 wt% to about 2 wt%, from about 0.02 wt% to about 1 wt%, from about 0.02 wt% to about 0.5 wt%, from about 0.02 wt% to about 0.2 wt%, from about 0.02 wt% to about 0.1 wt%, from about 0.02 wt% to about 0.05 wt%, from about 0.05 wt% to about 0.05 wt%, from about 0.05 wt%, about 0.1 wt% to about 5 wt%, about 0.1 wt% to about 2 wt%, about 0.1 wt% to about 1 wt%, about 0.1 wt% to about 0.5 wt%, about 0.2 wt% to about 10 wt%, about 0.2 wt% to about 5 wt%, about 0.2 wt% to about 2 wt%, about 0.2 wt% to about 1 wt%, about 0.2 wt% to about 0.5 wt%, about 0.5 wt% to about 10 wt%, about 0.5 wt% to about 5 wt%, about 0.5 wt% to about 2 wt%, about 0.5 wt% to about 1 wt%, about 1 wt% to about 10 wt%, about 1 wt% to about 5 wt%, about 1 wt% to about 2 wt%, about 2 wt% to about 10 wt%, about 2 wt% to about 5 wt%, about 5 wt% to about 10 wt%.
In some embodiments, the composition further comprises sugar or caramel 5% (wt/wt) in an amount between about 0.001% to about 25%, about 0.05% to about 15%, about 0.01% to about 10%, or about 0.01% to about 10%.
In some embodiments, the non-SG sweetener is a caloric sweetener or a mixture of caloric sweeteners. Examples of caloric sweeteners include sucrose, fructose, glucose, high fructose corn/starch slurry, beet sugar, cane sugar, and combinations thereof.
In some embodiments, the non-SG sweetener is a rare sugar selected from the group consisting of sorbose, lyxose, ribulose, xylose, xylulose, D-allose, L-ribose, D-tagatose, L-glucose, L-fucose, L-arabinose, turkey, and combinations thereof. The rare sugar may be present in the sweetener composition in an amount from about 0.5 wt% to about 3.0 wt%, for example, from about 0.5 wt% to about 2.5 wt%, from about 0.5 wt% to about 2.0 wt%, from about 0.5 wt% to about 1.5 wt%, from about 0.5 wt% to about 1.0 wt%, from about 1.0 wt% to about 3.0 wt%, from about 1.0 wt% to about 2.5 wt%, from about 1.0 wt% to about 2.0 wt%, from about 1.0 wt% to about 1.5 wt%, from about 2.0 wt% to about 3.0 wt%, and from about 2.0 wt% to about 2.5 wt%.
The amount of one or more non-SG sweeteners in the compositions of this application may be any value between about 0.1 wt% and about 50 wt% of the SG composition, and in particular, may be about 0.01 wt%, about 0.02 wt%, about 0.05 wt%, about 0.07 wt%, about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1 wt%, about 2 wt%, about 3 wt%, about 4 wt%, about 5 wt%, about 6 wt%, about 7 wt%, about 8 wt%, about 9 wt%, about 10 wt%, about 11 wt%, about 12 wt%, about 13 wt%, about 14 wt%, about 15 wt%, about 16 wt%, about 17 wt%, about 18 wt%, about 19 wt%, about 20 wt%, about 21 wt%, about 22 wt%, about 23 wt%, about 24 wt%, about 25 wt%, about 26 wt%, about 28 wt%, about 29 wt%, about 30 wt%, about 31 wt%, about 32 wt%, about 33 wt%, about 34 wt%, about 35 wt%, about 36 wt%, about 37 wt%, about 38 wt%, about 39 wt%, about 40 wt%, about 41 wt%, about 42 wt%, about 43 wt%, about 44 wt%, about 45 wt%, about 46 wt%, about 47 wt%, about 48 wt%, about 49 wt%, about 50 wt%, about 51 wt%, about 52 wt%, about 53 wt%, about 54 wt%, about 55 wt%, about 56 wt%, about 57 wt%, about 58 wt%, about 59 wt%, about 60 wt%, about 61 wt%, about 62 wt%, about 63 wt%, about 64 wt%, about 65 wt%, about 66 wt%, about 67 wt%, about 68 wt%, about 69 wt%, about 70 wt%, about 71 wt%, about 72 wt%, about 73 wt%, about 74 wt%, about 75 wt%, about 76 wt%, about 77 wt%, about 78 wt%, about 79 wt%, about 80 wt%, and all ranges between these values include from about 0.01 wt% to about 20 wt%, from about 0.03 wt% to about 20 wt%, from about 0.05 wt% to about 20 wt%, from about 0.07 wt% to about 20 wt%, from about 0.1 wt% to about 20 wt%, from about 0.3 wt% to about 20 wt%, from about 0.5 wt% to about 20 wt%, from about 0.7 wt% to about 20 wt%, from about 1 wt% to about 20 wt%, from about 3 wt% to about 20 wt%, from about 5 wt% to about 20 wt%, from about 7 wt% to about 20 wt%, from about 10 wt% to about 20 wt%, from about 15 wt% to about 20 wt%, from about 0.01 wt% to about 10 wt%, from about 0.03 wt% to about 10 wt%, from about 0.05 wt% to about 10 wt%, from about 0.07 wt% to about 10 wt%, from about 0.1 wt% to about 10 wt%, from about 0.3 wt% to about 10 wt%, from about 0.03 wt% to about 10 wt%, from about 0.05 wt% to about 10 wt%, from about 10 wt%, about 7 wt% to about 10 wt%, about 0.01 wt% to about 5 wt%, about 0.03 wt% to about 5 wt%, about 0.05 wt% to about 5 wt%, about 0.07 wt% to about 5 wt%, about 0.1 wt% to about 5 wt%, about 0.3 wt% to about 5 wt%, about 0.5 wt% to about 5 wt%, about 0.7 wt% to about 5 wt%, about 1 wt% to about 5 wt%, about 3 wt% to about 5 wt%, about 0.01 wt% to about 2.5 wt%, about 0.03 wt% to about 2.5 wt%, about 0.05 wt% to about 2.5 wt%, about 0.07 wt% to about 2.5 wt%, about 0.1 wt% to about 2.5 wt%, about 0.3 wt% to about 2.5 wt%, about 0.5 wt% to about 2.5 wt%, about 0.7 wt% to about 2.5 wt%, about 1 wt% to about 30 wt%, or about 30 wt%.
D. Other additives
In other embodiments, the compositions of the present application further comprise one or more other additives. Other additives include, but are not limited to, salts, flavoring agents, minerals, organic and inorganic acids, polyols, nucleotides, bitter compounds, astringent compounds, proteins or protein hydrolysates, surfactants, gums and waxes, antioxidants, polymers, fatty acids, vitamins, preservatives, and hydrating agents, as described in more detail below.
I. Salt (salt)
The compositions of the present application may include one or more salts. The term "salt" is used herein to denote a salt that retains the desired chemical activity of the compositions of the present application and is safe for human or animal consumption within generally acceptable limits.
The one or more salts may be organic or inorganic salts. Non-limiting examples of salts include sodium carbonate, sodium bicarbonate, sodium chloride, potassium chloride, magnesium chloride, sodium sulfate, magnesium sulfate, and potassium sulfate, or any edible salt such as calcium salts, alkali metal halides, alkali metal carbonates, alkali metal bicarbonates, alkali metal phosphates, alkali metal sulfates, hydrogen phosphates, pyrophosphates, triphosphates, metaphosphates, and hydrogen metabisulfates.
In some embodiments, the one or more salts are salts of metal cations such as calcium, bismuth, barium, magnesium, aluminum, copper, cobalt, nickel, cadmium, sodium, potassium, and the like, or cations formed from ammonia, N-diphenylethylethylenediamine, D-glucamine, ethanolamine, diethanolamine, triethanolamine, N-methylglucamine tetraethylammonium, or ethylenediamine.
In some embodiments, the one or more salts are formed from inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, and the like; or a salt formed from an organic acid such as acetic acid, propionic acid, hexanoic acid, cyclopentanepropionic acid, glycolic acid, pyruvic acid, lactic acid, malonic acid, succinic acid, malic acid, maleic acid, fumaric acid, tartaric acid, citric acid, benzoic acid, 3- (4-hydroxybenzoyl) benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, 1, 2-ethane-disulfonic acid, 2-hydroxyethanesulfonic acid, benzenesulfonic acid, 4-chlorobenzenesulfonic acid, 2-naphthalenesulfonic acid, 4-toluenesulfinic acid, camphorsulfonic acid, 4-methylbicyclo [2.2.2] -oct-2-ene-1-carboxylic acid, glucoheptonic acid, 3-phenylpropionic acid, trimethylacetic acid, tert-butylacetic acid, lauryl sulfuric acid, gluconic acid, glutamic acid, hydroxynaphthoic acid, salicylic acid, citric acid, mandelic acid, and the like, Stearic acid and muconic acid.
In particular embodiments, non-limiting inorganic acids may be selected from the group consisting of sodium chloride, sodium carbonate, sodium bicarbonate, sodium acetate, sodium sulfide, sodium sulfate, sodium phosphate, potassium chloride, potassium citrate, potassium carbonate, potassium bicarbonate, potassium acetate, europium chloride (EuCl)3) Gadolinium chloride (GdCl)3) Terbium chloride (TbCl)3) Magnesium sulfate, aluminum sulfate, magnesium chloride, mono-, di-, tri-basic sodium or potassium phosphate (e.g., inorganic phosphate), hydrochloride (e.g., inorganic chloride), sodium carbonate, sulfurSodium hydrogen carbonate and sodium bicarbonate. Examples of organic salts may be selected from choline chloride, sodium alginate (sodium alginate), sodium glucoheptonate, sodium gluconate (sodium gluconate), potassium gluconate (potassium gluconate), guanidine hydrochloride, amiloride hydrochloride, monosodium glutamate (MSG), adenosine monophosphate, magnesium gluconate, potassium tartrate (monohydrate) and sodium tartrate (dihydrate).
In certain embodiments, the salt is a metal or alkali metal halide, a metal or alkali metal carbonate or bicarbonate, or a metal or alkali metal phosphate, hydrogen phosphate, pyrophosphate, triphosphate, metaphosphate, or hydrogen metabisulfate. In certain specific embodiments, the salt is an inorganic salt comprising sodium, potassium, calcium, or magnesium. In some embodiments, the salt is a sodium or potassium salt.
Salts of these forms may be added to the sweetener composition in the same amounts as the acid or base salts thereof.
Alternative salts include various hydrochlorides or sulfates such as sodium chloride, potassium chloride, magnesium chloride, sodium sulfate, magnesium sulfate and potassium sulfate, or any edible salt.
In some embodiments, the one or more salts include one or more steviol glycoside salts (SG salts) and/or glycosylated steviol glycoside salts (GSG salts). In some embodiments, the one or more salts include salts of RB and/or STB.
In some embodiments, the one or more salts comprise one or more amino acid salts. In some embodiments, the one or more salts comprise one or more salts of polyamino acids.
In some embodiments, the one or more salts comprise one or more sugar acid salts.
The amount of one or more salts in the compositions of the present application can be any value from about 0.01 wt% to about 30 wt%, and specifically can be about 0.01 wt%, about 0.02 wt%, about 0.03 wt%, about 0.04 wt%, about 0.05 wt%, about 0.06 wt%, about 0.07 wt%, about 0.08 wt%, about 0.09 wt%, 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, about 0.9 wt%, about 1 wt%, about 2 wt%, about 3 wt%, about 4 wt%, about 5 wt%, about 6 wt%, about 7 wt%, about 8 wt%, about 9 wt%, about 10 wt%, about 11 wt%, about 12 wt%, about 13 wt%, about 14 wt%, about 15 wt%, about 16 wt%, about 17 wt%, about 18 wt%, about 19 wt%, about 20 wt%, about 23 wt%, about 22 wt%, about 26 wt%, about 27 wt%, about 28 wt%, about 29 wt%, about 30 wt%, about 31 wt%, about 32 wt%, about 33 wt%, about 34 wt%, about 35 wt%, about 36 wt%, about 37 wt%, about 38 wt%, about 39 wt%, about 40 wt%, about 41 wt%, about 42 wt%, about 43 wt%, about 44 wt%, about 45 wt%, about 46 wt%, about 47 wt%, about 48 wt%, about 49 wt%, about 50 wt%, and all ranges between these values, including about 0.01 wt% to about 10 wt%, about 0.03 wt% to about 10 wt%, about 0.05 wt% to about 10 wt%, about 0.07 wt% to about 10 wt%, about 0.1 wt% to about 10 wt%, about 0.3 wt% to about 10 wt%, about 0.5 wt% to about 10 wt%, about 0.7 wt% to about 10 wt%, about 1 wt% to about 10 wt%, about 3 wt% to about 10 wt%, about 5 wt% to about 10 wt%, about 0.01 wt%, about 3 wt% to about 10 wt%, about 0.03 wt% to about 3 wt%, about 0.05 wt% to about 3 wt%, about 0.07 wt% to about 3 wt%, about 0.1 wt% to about 3 wt%, about 0.3 wt% to about 3 wt%, about 0.5 wt% to about 3 wt%, about 0.7 wt% to about 3 wt%, about 1 wt% to about 3 wt%, about 0.01 wt% to about 1 wt%, about 0.03 wt% to about 1 wt%, about 0.05 wt% to about 1 wt%, about 0.07 wt% to about 1 wt%, about 0.1 wt% to about 1 wt%, about 0.3 wt% to about 1 wt%, about 0.5 wt% to about 1 wt%, about 0.7 wt% to about 1 wt%, about 0.01 wt% to about 0.3 wt%, about 0.03 wt% to about 0.3 wt%, about 0.05 wt% to about 0.0.0 wt%, about 0.05 wt% to about 1 wt%, about 0.0.01 wt% to about 0.0.1 wt%, about 0.0.0.0.03 wt%, about 0.0.1 wt%, about 0.0.05 wt% to about 0.0.0.0 wt%, about 0.1 wt%, about 0.0.0.1 wt%, about 0.05 wt%, about 0.0.0.0.0 wt%, about 0.0.0.1 wt%, about 0.01 wt% to about 0.05 wt%, about 0.01 wt% to about 0.07 wt%, about 5 wt% to about 30 wt%, about 10 wt% to about 30 wt%, or about 20 wt% to about 30 wt%.
Whatever salt is used in the compositions herein, the amount of salt in the composition is calculated based on sodium chloride. More specifically, the salt content (based on the weight of NaCl) can be determined by measuring the total ash content of the sample by the general method for measuring the total ash content as taught by FAO JECFA MONOGRAPHS (Vol. 2007, 4). The weight of sodium oxide was multiplied by 1.89 to determine the weight of sodium chloride. For example, if the total ash content of 100g of the composition of the present application is 1g, the salt content of the composition of the present application is 1.89 wt%.
II. Flavoring agent
As used herein, "flavoring agent" or "flavoring agent" refers to a compound or ingestable salt or solvate thereof that imparts a flavor or taste to an animal or human. The flavoring agent may be natural, semi-synthetic or synthetic. Flavoring agents and flavor ingredient additives suitable for use in the compositions of the present application include, but are not limited to, vanillin, vanilla extract, mango extract, cinnamomum zeylanicum, citrus, coconut, ginger, melaleuca, almond, bay, thyme, cedar leaf, nutmeg, allspice, sage, mace, menthol (including menthol without mint), essential oils such as oils made from plants or fruits such as peppermint, spearmint, other mint, clove, cinnamon, wintergreen, or almond oils; plant extracts, fruit extracts or fruit essences, grape skin extracts, grape seed extracts, apples, bananas, watermelons, pears, peaches, grapes, strawberries, raspberries, cherries, plums, pineapples, apricots, flavoring agents including citrus flavors, such as extracts, essences or oils of lemon, lime, orange, tangerine, grapefruit, lime, kumquat and combinations thereof.
Non-limiting examples of proprietary flavoring agents include DohlerTMNatural flavor sweetness enhancer K14323 (Dohler)TM,Darmstadt,Germany)、SymriseTMNatural flavor masks 161453 and 164126 for sweeteners (Symrise)TM,Holzminden,Germany)、Natural AdvantageTM Bitter taste blockers 1,2,9 and 10(Natural Advantage)TMFreehold, New Jersey, U.S.A.) and SurramaskTM(Creative Research Management,Stockton,California,U.S.A.)。
In some embodiments, the amount of flavoring agent in the compositions of the present application should be effective to provide a final level of about 0.1ppm to about 5000 ppm.
III, minerals
Minerals include inorganic chemical elements required by living organisms. Minerals include a wide range of compositions (e.g., simple substances, simple salts, and complex silicates), and their crystal structures also vary widely. They may be naturally occurring in food and beverages, may be added as supplements, or may be consumed or dispensed separately through food or beverages.
Minerals can be classified as either large quantities of minerals in greater demand or trace minerals in lesser demand. The large amount of minerals generally requires greater than or equal to about 100mg per day, while the trace minerals generally require less than about 100mg per day.
In some embodiments of the present application, the mineral is selected from a plurality of minerals, trace minerals, or combinations thereof. Non-limiting examples of numerous minerals include calcium, chlorine, magnesium, phosphorus, potassium, sodium, and sulfur. Non-limiting examples of trace minerals include chromium, cobalt, copper, fluorine, iron, manganese, molybdenum, selenium, zinc, and iodine. Although iodine is suggested to be classified within trace minerals, it is required in greater amounts than other trace minerals and is often classified in the category of large amounts of minerals.
In some embodiments, the minerals are trace minerals believed to be essential for human nutrition, non-limiting examples of which include bismuth, boron, lithium, nickel, rubidium, silicon, strontium, tellurium, tin, titanium, tungsten, and vanadium.
The minerals used herein can be in any form known to those of ordinary skill in the art. In some embodiments, the mineral is in its ionic form, having a positive or negative charge. For example, sulfur and phosphorus are commonly found in nature in the form of sulfates, sulfides, and phosphates. In some embodiments, the mineral is present in its molecular form.
In some embodiments, the amount of mineral in the compositions of the present application should be effective to provide a level of mineral in the final product of from about 25ppm to about 25000 ppm.
IV, organic acid and inorganic acid
Suitable organic acid additives include any compound containing a-COOH moiety, for example, C2-C30 carboxylic acid, substituted hydroxy C2-C30 carboxylic acid, ethyl butyrate, substituted ethyl butyrate, benzoic acid, substituted benzoic acids (such as 2, 4-dihydroxybenzoic acid), substituted cinnamic acids, oxo acids, substituted hydroxybenzoic acids, anisic acid-substituted cyclohexyl carboxylic acids, tannic acid, aconitic acid, lactic acid, tartaric acid, citric acid, isocitric acid, gluconic acid, glucoheptonic acid, adipic acid, hydroxycitric acid, malic acid (which is a mixture of malic acid, fumaric acid, and tartaric acid), fumaric acid, maleic acid, succinic acid, chlorogenic acid, salicylic acid, creatine, caffeic acid, bile acid, acetic acid, ascorbic acid, alginic acid, isoascorbic acid, polyglutamic acid, gluconic acid-lactone, lactone, And alkali metal or alkaline earth metal salt derivatives thereof. In addition, the organic acid additive may also be of a levorotatory or dextrorotatory structure.
Examples of such organic acids may be optionally substituted with at least one group selected from: hydrogen, alkyl, alkenyl, alkynyl, halo, haloalkyl, carboxy, acyl, acyloxy, amino, carboxy derivative, alkylamino, dialkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfo, thiol, imine, sulfonyl, thiooxy, sulfinyl, sulfamoyl, alkoxycarbonyl, carbamoyl, phosphonyl, phosphinyl, phosphoryl, phosphino, thioester, thioether, anhydride, oximo, hydrazino, carbamoyl, phosphorous, or phosphonato. In some embodiments, the amount of organic acid additive in the compositions of the present application should be effective to provide a level of from about 10ppm to about 5000ppm in the final product.
Organic acids also include amino acids such as, for example, aspartic acid, arginine, glycine, glutamic acid, proline, threonine, theanine, cysteine, cystine, alanine, valine, tyrosine, leucine, arabinose, trans-4-hydroxyproline, isoleucine, asparagine, serine, lysine, histidine, ornithine, methionine, carnitine, aminobutyric acid (α -, β -, and/or-isomers), glutamine, hydroxyproline, taurine, norvaline, and sarcosine. The amino acids may be in a levorotatory or dextrorotatory configuration, and may be in the form of mono-, di-or tri-amino acids of the same or different nature. In addition, the amino acids may be alpha-, beta-, gamma-and/or-isomers as desired. In some embodiments, combinations of the above-described amino acids and their corresponding salts (e.g., their sodium, potassium, calcium, magnesium or other alkali or alkaline earth metal salts, or acid salts) are also suitable additives. The amino acids may be natural or synthetic. Amino acids may also be modified. Modified amino acids refer to any amino acid (e.g., N-alkyl amino acids, N-acyl, or N-methyl amino acids) or combinations thereof in which at least one atom is added, removed, or substituted. Non-limiting examples of modified amino acids include amino acid derivatives such as trimethylglycine, N-methyl-glycine, and N-methyl-alanine. Modified amino acids in the present application include both modified and unmodified amino acids.
In the present application, amino acids also include peptides and polypeptides (e.g., dipeptides, tripeptides, tetrapeptides, and pentapeptides), such as: glutathione and L-alanyl-L-glutamine. Suitable polyamino acid additives include poly-L-aspartic acid, poly-L-lysine (e.g., poly-L-a-lysine or poly-L-s-lysine), poly-L-ornithine (e.g., poly-L-a-ornithine or poly-L-s-ornithine), poly-L-arginine, other polymeric forms of amino acids, and salt forms thereof (e.g., calcium, potassium, sodium, or magnesium salts, such as L-glutamic acid monosodium salt). The polyamino acid additive may also be of a levorotatory or dextrorotatory structure. In addition, the polyamino acids may be alpha-, beta-, gamma-, and-isomers, as desired. In some embodiments, combinations of the above polyamino acids and their corresponding salts (e.g., their sodium, potassium, calcium, magnesium or other alkali or alkaline earth metal salts, or acid salts) are also suitable additives. The polyamino acids described herein may also include copolymers of different amino acids. The polyamino acids may be natural or synthetic. The polyamino acid may also be modified. Such that at least one atom thereof is added, removed, or substituted or combinations thereof (e.g., N-alkylpolyamino acids or N-acylpolyamino acids). Polyamino acids in the present application include modified and unmodified amino acids. For example, modified polyamino acids include, but are not limited to, polyamino acids of various Molecular Weights (MW) such as poly-L-a-lysine having a MW of 1500, 6000, 25200, 63000, 83000, or 300000.
In some embodiments, the amount of amino acids in the compositions of the present application should be effective to provide a level of from about 10ppm to about 50000ppm in the final product.
Suitable inorganic acid additives include, but are not limited to, phosphoric acid, phosphorous acid, polyphosphoric acid, hydrochloric acid, sulfuric acid, carbonic acid, sodium dihydrogen phosphate, and alkali or alkaline earth metal salts thereof (e.g., Mg/Ca salts of phytic acid).
In some embodiments, the amount of mineral acid in the compositions of the present application should be effective to provide a level of from about 25ppm to about 25000ppm in the final product.
V, polyol
As used herein, the term "polyol" refers to a molecule containing more than one hydroxyl group. The polyols may be diols, triols and tetrols containing 2, 3 and 4 hydroxyl groups respectively. The polyol may also contain more than 4 hydroxyl groups, for example, pentahydric, hexahydric, heptahydric, and the like, containing 5, 6, and 7 hydroxyl groups, respectively. In addition, the polyols may also be sugars, polyhydroxy or polyols in which the carbohydrate is in reduced form, the carbonyl group (aldehyde or ketone, reducing sugar) of which is reduced to a primary or secondary hydroxyl group.
In some embodiments, non-limiting examples of polyols include maltitol, mannitol, sorbitol, lactitol, xylitol, isomalt, propylene glycol, glycerol (glycerol), threitol, galactitol, sucralose, reduced isomaltooligosaccharides, reduced xylooligosaccharides, reduced gentiooligosaccharides, reduced maltose syrup, reduced glucose syrup, and sugar alcohols, or any other carbohydrate that can be reduced without negatively affecting taste.
In some embodiments, the amount of polyol in the compositions of the present application should be effective to provide a level of polyol in the final product of from about 100ppm to about 250000 ppm.
VI, nucleotide
Suitable nucleotide additives include, but are not limited to, inosine monophosphate ("IMP"), guanosine monophosphate ("GMP"), adenosine monophosphate ("AMP"), Cytosine Monophosphate (CMP), Uracil Monophosphate (UMP) i, inosine diphosphate, glycoside diphosphate, adenosine diphosphate, cytosine diphosphate, uracil diphosphate, inosine triphosphate, guanosine triphosphate, adenosine triphosphate, cytosine triphosphate, uracil triphosphate, alkali or alkaline earth metal salts thereof, and combinations thereof. Nucleotides described herein can also include nucleotide related derivatives, such as nucleotides or nucleic acid bases (e.g., guanine, cytosine, adenine, thymine, and uracil).
In some embodiments, the amount of nucleotides in the compositions of the present application should be effective to provide a level of from about 5ppm to about 1000ppm in the final product.
VII bitter taste Compound
Suitable bitter compound additives include, but are not limited to, caffeine, quinine, urea, bitter orange oil, naringin, quassia and salts thereof.
In some embodiments, the amount of bitter compounds in the compositions of the present application should be effective to provide a level of from about 25ppm to about 25000ppm in the final product.
VIII, astringent compounds
Suitable astringent compound additives include, but are not limited to, tannic acid, europium chloride (EuCl3), gadolinium chloride (GdCl3), terbium chloride (TbCl3), alum, tannic acid, and polyphenols (e.g., tea polyphenols).
In some embodiments, the amount of the astringent compound in the compositions herein should be effective to provide a level of from about 10ppm to about 5000ppm in the final product.
IX, proteins or protein hydrolysates
Suitable protein or protein hydrolysate additives include, but are not limited to, Bovine Serum Albumin (BSA), whey protein (including instant whey protein isolate in proportions or concentrations such as 90%, 34%, 50% > hydrolyzed whey protein and 80% > whey protein concentrate), soluble rice protein, soy protein, protein isolate, protein hydrolysates, reaction products of protein hydrolysates, glycoproteins and/or amino acid-containing proteoglycans (e.g., glycine, alanine, serine, threonine, asparagine, glutamine, arginine, valine, isoleucine, leucine, norvaline, methionine, proline, tyrosine, hydroxyproline, etc.), collagen (e.g., gelatin), partially hydrolyzed collagen (e.g., hydrolyzed fish collagen), and collagen hydrolysates (e.g., porcine collagen hydrolysate).
In some embodiments, the amount of protein or protein hydrolysate in the compositions of the present application should be effective to provide a level of protein or protein hydrolysate in the final product of from about 100ppm to about 50000 ppm.
X, surfactant
Suitable surfactant additives include, but are not limited to, polysorbate (e.g., polyoxyethylene sorbitan monooleate (tween 80), tween 20, tween 60), sodium dodecylbenzenesulfonate, dioctyl or dioctyl sodium sulfosuccinate, sodium dodecylsulfonate, cetylpyridinium chloride, cetylmethylammonium bromide, sodium cholate, methionyl, choline chloride, sodium glycocholate, sodium taurodeoxycholate, arginine laurate, sodium stearoyl lactylate, sodium taurocholate, lecithin, sucrose oleate, sucrose stearate, sucrose palmitate, sucrose laurate, and other emulsifiers and the like.
In some embodiments, the amount of surfactant in the compositions herein should be effective to provide a level of surfactant in the final product of from about 20ppm to about 20000 ppm.
XI, gums and waxes
Gums and mucilages represent a wide range of different branched structures. Guar gum is a galactomannan produced with the ground endosperm of guar seeds. Guar gum is commercially available (e.g., Benefiber manufactured by Novartis AG). Other gums such as gum arabic and pectin also have different structures. Other gums include xanthan gum, gellan gum, tara gum, flaxseed gum, and locust bean gum.
Waxes are esters of ethylene glycol and two fatty acids, generally hydrophobic liquids, and are insoluble in water.
In some embodiments, the amount of gum and wax in the compositions of the present application should be effective to provide a level of about 100ppm to about 100000ppm in the final product.
XII, antioxidant
As used herein, "antioxidant" refers to any substance that is capable of blocking, inhibiting or reducing oxidative damage to cells and biomolecules. Without wishing to be bound by theory, it is believed that antioxidants can hinder, inhibit, or reduce oxidative damage to cells and biomolecules by stabilizing free radicals before they can undergo damaging reactions. Also, antioxidants can prevent or delay the onset of some degenerative diseases.
Examples of antioxidants suitable for use in embodiments of the present application include, but are not limited to, vitamins, vitamin coenzymes, minerals, hormones, carotenoids, carotenoid terpenoids, non-carotenoid terpenoids, flavonoids, flavonoid polyphenols (e.g., bioflavonoids), flavonols, flavones, phenols, polyphenols, phenolic esters, polyphenolic esters, non-flavonoid phenolics, isothiocyanates, and combinations thereof. In some embodiments, the antioxidant is vitamin a, vitamin C, vitamin E, ubiquinone, the minerals selenium, manganese, melatonin, a-carotene, β -carotene, lycopene, lutein, zeaxanthin, cryptoxanthin, resveratrol, eugenol, quercetin, catechin, gossypol, phloretin, curcumin, ferulic acid, thymol, hydroxytyrosol, turmeric, thyme, olive oil, lipoic acid, glutathione, glutamine, oxalic acid, tocopherol-derived compounds, Butylated Hydroxytoluene (BHT), ethylenediaminetetraacetic acid (EDTA), tertiary butylhydroquinone, acetic acid, pectin, tocotrienols, tocopherol, coenzyme Q10, zeaxanthin, astaxanthin, canthaxanthin, saponin, limonoids, kaempferol, myricetin, isorhamnetin, proanthocyanidins, vitamin a, vitamin b, lycopene, vitamin C, vitamin E, vitamin d, lutein, vitamin E, vitamin d, vitamin b, vitamin C, vitamin E, lutein, Quercetin, rutin, luteolin, apigenin, naringenin, dermatan, naringenin, eriodictyol, flavan-3-ol (e.g., anthocyanidin), betalain, epicatechin and its gallic acid form, epigallocatechin and its gallic acid form (ECGC), theaflavin and its gallic acid form, thearubicin, isoflavone, phytoestrogen, genistein, daidzein, glycitein, anthocyanin, delphinidin, malvidin, pelargonidin, methylcyanin, petroselinic acid, ellagic acid, gallic acid,. salicylic acid, rosmarinic acid, cinnamic acid and its derivatives (e.g., ferulic acid), chlorogenic acid, chicoric acid, betatannins, ellagitannins, anthocyanins, beta-cyanins and other phytochromes, silymarins, citric acid, lignans, antinutrients,. bilirubin, uric acid, naringenin, genistein, genistin, catechin, quercetin, and other phytochemicals, R-a-lipoic acid, N-acetylcysteine, emblic leafflower fruit extract, apple peel extract (apple polyphenol), black tea extract in south africa, green tea extract in south africa, hawthorn extract, raspberry extract, Green Coffee Antioxidant (GCA), rosa laevigata enzyme extract 20%, grape seed extract (VinOseed), cocoa extract, hops extract, mangosteen fruit extract, mangosteen shell extract, cranberry extract, pomegranate shell extract, pomegranate seed extract, hawthorn extract, pomella pomegranate extract, cinnamon bark extract, grape skin extract, bilberry extract, pine bark extract, pycnogenol, elderberry berry extract, mulberry root extract, yacon (wolfberry) extract, blackberry extract, blueberry leaf extract, raspberry extract, bilberry extract, blueberry leaf extract, grape skin extract, bilberry extract, blueberry extract, pine bark extract, pinus extract, pycnidium fruit extract, cherokee extract, blueberry extract, Turmeric extract, immature bitter orange flavone, blackcurrant polyphenol, ginger, acai berry powder, green coffee bean extract, green tea extract and phytic acid, or combinations thereof. In an alternative embodiment, the antioxidant is a synthetic antioxidant such as butylhydroxytoluene or butylhydroxyanisole. Other antioxidant sources suitable for use in embodiments of the present application include, but are not limited to, fruits, vegetables, tea, cocoa, chocolate, vanilla, spice, rice, livestock organic meats, yeast, whole wheat, or cereals.
A particular antioxidant belonging to the class of phytonutrients is called polyphenol (also called "polyphenol crude extract"), a group of chemicals found in plants characterized by more than one phenol group in one molecule. Polyphenols may provide various health benefits including, for example, prevention of cancer, heart disease and chronic inflammation, and also improve mental and physical strength. Polyphenols suitable for use in embodiments of the present application include catechol, proanthocyanidins, procyanidins, anthocyanins, quercetin, rutin, resveratrol, isoflavones, curcumin, punicalagin, ellagitannin, hesperidin, naringin, citrus flavonoids, chlorogenic acid, other similar substances, and combinations thereof.
In some embodiments, the antioxidant is a catechol, such as epigallocatechin gallate (EGCG), and sources of catechol suitable for use in embodiments of the present application include, but are not limited to, green tea, white tea, black tea, oolong tea, chocolate, cocoa, red wine, grape seed, red grape skin, purple grape skin, red grape juice, purple grape juice, berries, pycnogenol, and red apple skin.
In some embodiments, the antioxidant is selected from proanthocyanidins, procyanidins, or a combination thereof. Sources of proanthocyanidins and procyanidins suitable for use in embodiments herein include, but are not limited to, red grapes, purple grapes, cocoa, chocolate, grape seeds, red wine, cocoa beans, cranberries, apple peels, plums, blueberries, blackcurrants, wild cherries, green tea, sorghum, cinnamon, barley, red kidney beans, flower beans, humulus, almonds, hazelnuts, pecans, pistachios, pycnogenol, and berries of various colors.
In a particular embodiment, the antioxidant is an anthocyanin. Sources of anthocyanins suitable for use in embodiments of the present application include, but are not limited to, cranberries, blueberries, bilberries, cranberries, raspberries, cherries, pomegranates, strawberries, elderberries, wild cherries, red grape skin, purple grape skin, grape seeds, red wine, blackcurrants, red gallons, cocoa, plums, apple peel, peaches, red pears, red cabbage, red onions, red oranges, and blackberries.
In some embodiments, the antioxidant is selected from the group consisting of quercetin, rutin, or combinations thereof. Sources of quercetin and rutin suitable for use in embodiments of the present application include, but are not limited to, red apple, onion, kale, vaccinium uliginosum, bilberry, aronia bittermus, cranberry, blackberry, blueberry, strawberry, raspberry, blackcurrant, green tea, black tea, plum, apricot, parsley, leek, broccoli, paprika, berry wine, and ginkgo biloba.
In some embodiments, the antioxidant is resveratrol, and sources of resveratrol suitable for use in embodiments herein include, but are not limited to, red grapes, peanuts, cranberries, blueberries, bilberries, mulberries, japanese teas, and red wine.
In a particular embodiment, the antioxidant is an isoflavone. Sources of isoflavones suitable for use in embodiments of the present application include, but are not limited to, soybeans, soy products, legumes, alfalfa sprouts, chickpeas, peanuts, and red clover.
In some embodiments, the antioxidant is curcumin. Sources of curcumin suitable for use in embodiments of the present application include, but are not limited to, turmeric and mustard.
In particular embodiments, the antioxidant is selected from punicalagin, ellagitannin, or combinations thereof. Sources of punicalagin and ellagitannins suitable for use in embodiments of the present application include, but are not limited to, pomegranate, raspberry, strawberry, walnut, and oak barrel-aged red wine.
In some embodiments, the antioxidant is a citrus flavonoid, such as hesperidin or naringin. Sources of citrus flavonoids such as hesperidin or naringin suitable for use in embodiments of the present application include, but are not limited to, orange, grapefruit, and citrus juice.
In a particular embodiment, the antioxidant is chlorogenic acid. Sources of chlorogenic acid suitable for use with embodiments of the present application include, but are not limited to, green coffee, ilex, red wine, grape seeds, red grape skin, purple grape skin, red grape juice, purple grape juice, apple juice, cranberry, pomegranate, blueberry, strawberry, sunflower, echinacea, pycnogenol, and apple peel.
In some embodiments, the amount of antioxidant in the compositions of the present application should be effective to provide a level of from about 100ppm to about 250000ppm in the final product.
XII, Polymer
Suitable polymeric additives include, but are not limited to, chitosan, pectin, mucilage, pectic acid, polyuronic acid, polygalacturonic acid, starch, food hydrocolloids, or crude extracts thereof (e.g., acacia senegal (Fibergum)TM) Acacia seyal gum, carrageenan), poly-L-lysine (e.g.: poly-L- α -lysine or poly-L-lysine), poly-L-ornithine (e.g.: Poly-L-alpha-ornithineAcid or poly-L-ornithine), polypropylene glycol, polyethylene glycol, poly (ethylene glycol methyl ether), polyarginine, polyaspartic acid, polyglutamic acid, polyethyleneimine, alginic acid, sodium alginate, propylene glycol alginate, and propylene glycol sodium alginate, sodium hexametaphosphate and salts thereof, and other cationic and anionic polymers.
In some embodiments, the amount of polymer in the compositions of the present application should be effective to provide a level of from about 10ppm to about 10000ppm in the final product.
XIV, fatty acid
By "fatty acid" herein is meant any straight chain monocarboxylic acid, including saturated fatty acids, unsaturated fatty acids, long chain fatty acids, medium chain fatty acids, short chain fatty acids, fatty acid precursors (including omega-9 fatty acid precursors), and esterified fatty acids. By "long chain polyunsaturated fatty acid" is meant herein any polyunsaturated carboxylic or organic acid with a long fatty chain. As used herein, "omega-3 fatty acid" refers to any polyunsaturated fatty acid having a first double bond as the third carbon-carbon bond from the methyl group at the end of its carbon chain. In particular embodiments, the omega-3 fatty acids may include long chain omega-3 fatty acids. As used herein, "omega-6 fatty acid" refers to any polyunsaturated fatty acid having a first double bond as the sixth carbon-carbon bond from the methyl group at the end of its carbon chain.
Omega-3 fatty acids suitable for use in embodiments of the present application may be produced, for example, from algae, fish, animals, plants, or combinations thereof. Examples of suitable omega-3 fatty acids include, but are not limited to, linolenic acid, -linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, stearidonic acid, eicosatetraenoic acid, and combinations thereof. In some embodiments, suitable omega-3 fatty acids may be provided in fish oils (e.g., herring oil, tuna oil, salmon oil, bonito oil, and cod oil), microalgae omega-3 oils, or combinations thereof. In particular embodiments, suitable omega-3 fatty acids can be produced from commercially available omega-3 fatty acid oils, such as: microalgae DHA Oil (from Martek, Columbia, MD), Omega pure (from Omega Protein, Houston, TX), Marinol C-38 (from Lipid Nutrition, Channahon, IL), Bonito Oil and MEG-3 (from Ocean Nutrition, Dartmouth, NS), Evogel (from Symrise, Holzminden, Germany), Marine Oil from tuna or salmon (from Arista Wilton, CT), Omega resource 2000 from Fish, Marine Oil and Marine Oil from cod (from Omega resource, RTP, NC).
Examples of suitable omega-6 fatty acids include, but are not limited to, linoleic acid, gamma-linolenic acid, dihomo-gamma-linolenic acid, eicosatetraenoic acid, eicosadienoic acid, docosadienoic acid, adrenal acid, menhaden acid, and combinations thereof.
Esterified fatty acids suitable for use in embodiments of the present application include, but are not limited to, monoglycerides comprising omega-3 and/or omega-6 fatty acids, diglycerides comprising omega-3 and/or omega-6 fatty acids, triglycerides comprising omega-3 and/or omega-6 fatty acids, and combinations thereof.
In some embodiments, the amount of fatty acid in the compositions of the present application should be effective to provide a level of from about 100ppm to about 100000ppm in the final product.
XV, vitamins
Vitamins are small amounts of organic compounds required by the human body to maintain normal functioning. The human body does not need to decompose other nutrients like carbohydrates and proteins when using vitamins. Thirteen vitamins have been identified, one or more of which may be used in the compositions of the present application. Suitable vitamins and their alternative chemical names in the following brackets include: vitamin a (rosin oil, retinal), vitamin D (calcitol, cholecalciferol, photosterols, ergocalciferol, dihydrotachysterol, 7-dehydrocholesterol), vitamin E (tocopherol, tocotrienol), vitamin K (phylloquinone, naphthoquinone), vitamin B1 (thiamine), vitamin B2 (riboflavin, vitamin G), vitamin B3 (niacin, anti-glossogyne, vitamin PP), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine, pyridoxal, pyridoxamine), vitamin B7 (biotin, vitamin H), vitamin B9 (folic acid, folate, folic acid analogues, vitamin M, pteroyl-L-glutamic acid), vitamin B12 (cobalt, cyanocobalamin), and vitamin C (ascorbic acid).
Other different compounds are also classified as vitamins by experts. These compounds may be referred to as pseudo-vitamins, which include, but are not limited to, compounds such as ubiquinone (coenzyme Q10), pangamine, dimethylglycine, tasripole, amygdalin, flavonoids, p-aminobenzoic acid, adenine, adenylic acid, and s-methyl methionine. The term vitamin as used herein includes pseudo vitamins.
In some embodiments, the vitamin is a fat soluble vitamin selected from vitamin A, D, E, K and combinations thereof. In other embodiments, the vitamin is a water soluble vitamin selected from the group consisting of vitamin Bl, vitamin B2, vitamin B3, vitamin B6, vitamin B12, folic acid, biotin, pantothenic acid, vitamin C, and combinations thereof.
In some embodiments, the amount of vitamin in the compositions of the present application should be effective to provide a level of from about 10ppm to about 10000ppm in the final product.
XVI, preservative
In some embodiments of the present application, the preservative is selected from the group consisting of a bactericide, an anti-ferment, or a combination thereof.
Non-limiting examples of bactericides include sulfites, propionates, benzoates, sorbates, nitrates, nitrites, bacteriocins such as nisin, salts, sugars, acetic acid, dimethyl dicarbonate (DMDC), ethanol and ozone.
Sulfites include, but are not limited to, sulfur dioxide, sodium bisulfite, and potassium bisulfite. Propionates include, but are not limited to, propionic acid, calcium propionate, and sodium propionate. Benzoate salts include, but are not limited to, sodium benzoate and benzoic acid. Sorbates include, but are not limited to, potassium sorbate, sodium sorbate, calcium sorbate, and sorbic acid. Nitrates and nitrites include, but are not limited to, sodium nitrate and sodium nitrite.
Non-limiting examples of antibiotics suitable for use in particular embodiments of the present application include ascorbic acid, citric acid, and metal chelators such as ethylenediaminetetraacetic acid (EDTA).
In some embodiments, the amount of preservative in the compositions of the present application should be effective to provide a level of from about 100ppm to about 5000ppm in the final product.
XVII, hydrating agent
The hydration product helps to replenish the body with fluid that is lost by excretion. For example, liquids that are discharged as sweat for regulating body temperature, liquids that are discharged as urine for excreting waste, liquids that are discharged as water vapor for exchanging air in the lungs. Fluid loss can also be caused by a number of external causes, non-limiting examples of which include physical movement, exposure to dry air, diarrhea, vomiting, high fever, tremors, bleeding, and hypotension. Conditions in which the disease causes fluid loss include diabetes, cholera, gastroenteritis, bacillary dysentery, and yellow fever. Conditions of malnutrition that cause fluid loss include excessive electrolyte loss, imbalance, and loss of body weight spread.
In some embodiments, the hydration product is a composition that helps the body replenish lost fluid during exercise. Thus, in some embodiments, the hydration product is an electrolyte, non-limiting examples of which include sodium, potassium, calcium, magnesium, chloride, phosphate, bicarbonate, and combinations thereof. Electrolytes suitable for use in some embodiments of the present application are also described in US patent US5681569, which is incorporated herein by reference. In some embodiments, the electrolyte is derived from its corresponding water-soluble salt. Non-limiting examples of salts suitable for use in some embodiments include chlorides, carbonates, sulfates, acetates, bicarbonates, citrates, phosphates, hydrogen phosphates, tartrates, sorbates, benzoates, or combinations thereof. In other embodiments, the electrolyte is provided by fruit juice, fruit extract, vegetable extract, tea or tea extract.
In some embodiments, the hydrating agent is a flavanol that provides cellular rehydration. Flavanols are a natural class of substances present in plants, generally containing a 2-phenylbenzopyranone backbone to which one or more chemical groups are attached. Non-limiting examples of flavanols suitable for use herein include catechin, epicatechin, betalain, epigallocatechin, epicatechin gallate, epicatechin 3-gallate, theaflavin 3-gallate, theaflavin 3 '-gallate, theaflavin 3, 3' gallate, thearubigin, or combinations thereof. Several common sources of flavanols include tea, fruits, vegetables, and flowers. In a preferred embodiment, the flavanols are extracted from green tea.
In some embodiments, to increase exercise endurance, the hydrating agent is a glycerol solution. Ingestion of glycerol solutions has proven to have many physiological benefits, such as dilating blood vessels, reducing heart rate, and reducing rectal temperature.
In some embodiments, the amount of hydrating agent in the compositions of the present application should be effective to provide a level of from about 100ppm to about 250000ppm in the final product.
2. Orally consumable composition comprising SG/GSG composition
Another aspect of the present invention relates to orally consumable compositions comprising the compositions of the present application. The compositions of the present application can be added to an orally consumable composition to produce a sweetened orally consumable composition or a flavored edible composition.
By "orally consumable composition" is meant herein a substance that comes into contact with the mouth of a human or animal, including substances that are ingested into the mouth and then expectorated and substances that are drunk, eaten, ingested or absorbed and which are safe for the human or animal when used in generally acceptable amounts.
Examples of orally consumable compositions include, but are not limited to, confections, condiments, chewable compositions, cereal compositions, tabletop sweeteners, beverages, drinks, pharmaceutical compositions, smoking compositions, and oral hygiene compositions. The edible product may be a confectionery or a non-confectionery.
The orally consumable composition may optionally include additives, sweeteners, functional ingredients, and combinations thereof as described herein. Any of the additives, sweeteners, and other ingredients previously described may be present in the orally consumable composition.
Palatable foods using the compositions of the present application are also suitable for processed agricultural, livestock or sea foods; processed meat products such as sausages and the like; bagged product, pickled product boiled in soy sauce, delicacies, snacks; soup; snacks, such as potato chips, cookies, etc.; crushed filler, leaves, stems, homogenized leaves, and animal food.
A. Candy
In some embodiments, the orally consumable composition containing the composition of the present application is a candy. As referred to herein, a "candy" may be a dessert, fruit, candy or the like. Confectioneries typically have a base composition component and a sweetener component. "base composition" means any composition that can be used as a food product and provides a substrate for carrying a sweetener. The compositions of the present application containing the composition may be used as a sweetener component. The confectionery may be in any food form, generally considered to be sugar-rich or generally sweet.
In some embodiments of the present application, the confectionery may be a baked product such as a pastry; desserts such as yogurt, jelly, drinking jelly, pudding, bavaria cream, milk jelly, cake, chocolate cake, mousse, etc., sweet foods eaten at tea break or meals eaten subsequently; freezing the food; cold desserts, such as ice cream-like substances such as ice cream, ice milk, milk ice, etc. (foods in which a sweetener and other various materials are added to milk, and mixtures thereof are stirred and frozen), and ice confections such as sherbet, dessert ice cream, etc. (foods in which other various types of materials are added to a sugar-containing liquid, and mixtures thereof are stirred and frozen); general candies such as baked or steamed candies such as baked cookies, crackers, bread filled with jam fillings, sesame crunchy candies, Argentina confections (alfajor), and the like; rice cakes and snacks; a desktop product; typical sucrose confections such as chewing gums (e.g., the composition includes substantially water insoluble ingredients, chewable gum bases such as gums or substitutes thereof, including jelutong (jetulalong), guttakay (guttakay) rubber or certain edible natural synthetic resins or waxes), hard candy, soft candy, mints, nougats, jellies, fondants, toffee, swiss milk tablets, licorice candies, chocolate, gelatin candies, marshmallows, almonds, psychoses, marshmallows, and the like; the flavoring agent includes fruity sauce, chocolate sauce, etc.; edible gel; creams include cream cheese, roux, raw butter, etc.; the jam includes strawberry jam, etc.; bread includes sweet bread and the like or other starch products, and combinations thereof.
Base compositions suitable for use in embodiments of the present application may include flour, yeast, water, salt, butter, eggs, milk powder, white spirits, gelatin, nuts, chocolate, citric acid, tartaric acid, fumaric acid, natural flavors, artificial flavors, colors, polyols, sorbitol, isomalt, maltitol, lactitol, malic acid, magnesium stearate, lecithin, hydrogenated glucose syrup, glycerol, natural or synthetic gums, starches, and the like, and combinations thereof. These ingredients are generally considered safe (GRAS) and/or approved by the U.S. Food and Drug Administration (FDA). In some embodiments of the present application, the base composition is present in the confectionery in an amount of about 0.1 wt% to about 99 wt%.
The base composition of the candy may optionally comprise other artificial or natural sweeteners, bulk sweeteners, or combinations thereof. Bulk sweeteners include caloric and non-caloric compounds. Non-limiting examples of bulk sweeteners include sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, high fructose corn syrup, fructose, galactose, corn syrup solids, tagatose, polyols (e.g., sorbitol, mannitol, xylitol, lactitol, erythritol, maltitol), hydrogenated starch hydrolysates, isomalt, trehalose, and mixtures thereof. In general, the bulk sweetener may be included in the confectionery product in a wide range of amounts, depending on the particular embodiment of the confectionery product and the desired sweetness level. Suitable amounts of bulk sweeteners can be readily determined by one of ordinary skill in the art.
B. Seasoning
In some embodiments, a savory food product comprising the composition of the present application or a sweetener composition comprising the composition is a condiment. The flavoring agent used in the present invention is a composition for enhancing or improving the flavor of a food or beverage. Non-limiting examples of condiments include tomato paste; mustard; barbecue sauce; butter; red pepper paste; sour and spicy sauce; cocktail sauce; curry; dipping sauce; fish paste; horseradish; chili sauce; jelly, jam, sweet jam, or pickled product; mayonnaise; peanut butter; a seasoning; a filled mayonnaise; salad dressing (e.g., oil and vinegar, kaiser, france, pasture, blue cheese, russia, qiandao juice, italian and balm juice), sarsa; sauerkraut; soy sauce; beefsteak sauce; syrup; sauces and chili sauce.
Condiment bases generally comprise a mixture of different ingredients, non-limiting examples of which include a vehicle (e.g., water and vinegar); spices or seasonings (e.g., salt, pepper, garlic, mustard, onion, chili pepper, turmeric, and combinations thereof); fruits, vegetables, or products thereof (e.g., tomatoes or tomato products (pastes, purees), juices, peel juices, and combinations thereof); oils or oil emulsions, especially vegetable oils; thickeners (e.g., xanthan gum, edible starch, other hydrocolloids, and combinations thereof); and emulsifying agent (such as egg yolk solid, protein, acacia, locust bean gum, guar gum, karaya gum, tragacanth gum, carrageenan, pectin, propylene glycol alginate, sodium carboxymethylcellulose, polysorbate, and their combination). The formulation of flavoring bases and methods for their preparation are well known to those of ordinary skill in the art.
Typically, the flavoring will also include caloric sweeteners such as sucrose, high fructose corn syrup, molasses, honey, or brown sugar. In exemplary embodiments of the condiments provided herein, the compositions of the present application or sweetener compositions containing the same are used to replace traditional caloric sweeteners. Accordingly, it is desirable for a flavor composition to include the composition of the present application or a sweetener composition containing the composition of the present application and a flavor base.
The flavoring composition may optionally include other natural and/or synthetic high-potency sweeteners, bulk sweeteners, pH adjusters (e.g., lactic acid, citric acid, phosphoric acid, hydrochloric acid, acetic acid, and combinations thereof), fillers, functional aids (e.g., pharmaceutical agents, nutrients, or ingredients in food or plants), flavorants, colorants, or combinations thereof.
C. Chewing compositions
In some embodiments, the savory food comprising the steviol compositions of the present application is a chewable composition. "chewing compositions" include chewing gum compositions, chewing tobacco, smokeless tobacco, snuff, chewing gum, and other compositions that are expectorated upon chewing.
Chewing gum compositions generally include a water soluble portion and a water insoluble chewing gum base. The water soluble portion generally comprises the composition of the present application or a sweetener composition containing the composition, and a portion of the flavoring agent is consumed during chewing, while a portion of the insoluble gum portion remains in the mouth. Insoluble gum bases generally determine whether such gums are considered chewing gum, bubble gum or functional chewing gum.
The insoluble gum base, which is generally present in the chewing gum composition in an amount of about 15% to about 35% by weight, generally comprises a combination of elastomers, softeners (plasticizers), emulsifiers, resins and fillers. These ingredients are generally considered food grade, are generally recognized as safe food (GRA), and/or are approved by the U.S. Food and Drug Administration (FDA).
Elastomers are the major component of the gum base, provide elasticity and adhesion to the gum, and may include one or more natural rubbers (e.g., smoked latex, or guayule); natural gums (e.g., jelutong, peliluo, seiko, balata, chocolate iron wire, caeke iron wire, rosindinha, chicle, and gutta percha); or synthetic elastomers (e.g., butadiene-styrene copolymers, isobutylene-isoprene copolymers, polybutadiene, polyisobutylene, vinyl polymer elastomers). In a particular embodiment, the elastomer is present in the gum base in an amount of about 3 wt% to about 50 wt%.
The resin serves to modify the hardness of the gum base and to help soften the elastomeric component of the gum base. Non-limiting examples of suitable resins include rosin esters, terpene resins (e.g., terpene resins derived from alpha-pinene, beta-pinene, and/or D-limonene), polyvinyl acetate, vinyl polymers, ethylene glycol diacetate, vinyl acetate, and vinyl laurate copolymers. Non-limiting examples of rosin esters include glycerol esters of partially hydrogenated rosins, glycerol esters of polymerized rosins, glycerol esters of partially dimerized rosins, glycerol esters of rosins, pentaerythritol esters of partially hydrogenated rosins, methyl esters of rosins, or methyl esters of partially hydrogenated rosins. In some embodiments, the resin is present in the gum base in an amount of about 5 wt% to about 75 wt%.
Softeners, also known as plasticizers, are used to modify the ease of chewing and/or mouth feel of the chewing gum composition. Generally, softeners include oils, greases, waxes, and emulsifiers. Non-limiting examples of oils and greases include tallow, hydrogenated or partially hydrogenated vegetable oils (such as soybean, rapeseed, cottonseed, sunflower, palm, coconut, corn, safflower, or palm kernel oils), cocoa butter, glycerol monostearate, glycerol triacetate, rosin esters of glycerin, lecithin, monoglycerides, diglycerides, acetylated triglycerides, monoglycerides, and free fatty acids. Non-limiting examples of waxes include polypropylene/polyethylene/Fischer-Tropsch wax, paraffin wax, microcrystalline wax, natural waxes (e.g., candle wood, beeswax, and carnauba wax). Microcrystalline waxes, especially those with high crystallinity and high melting points, may also serve as excipients or structural modifiers. In some embodiments, the softener is present in the gum base in an amount of about 0.5 wt% to about 25 wt%.
The emulsifier is used to form a homogeneous dispersion of insoluble and soluble phases of the chewing gum composition and has plasticizing properties. Suitable emulsifiers include Glycerol Monostearate (GMS), lecithin (phosphatidylcholine), Polyglycerol Polyricinoleate (PPGR), mono-and diglycerides of fatty acids, glycerol distearate, acetylated monoglycerides of tolxatin (tracetin), glycerol triacetate and magnesium stearate. In some embodiments, the emulsifier is present in the gum base in an amount of about 2 wt% to about 30 wt%.
The chewing gum composition may also include adjuvants or fillers in the gum base or soluble portion of the chewing gum composition. Suitable adjuvants and fillers include lecithin, inulin, polydextrose, calcium carbonate, magnesium silicate, ground lime, aluminum hydroxide, aluminum silicate, talc, clay, alumina, titanium dioxide and calcium phosphate. In some embodiments, lecithin may be used as an inert filler to reduce the viscosity of the chewing gum composition. In other embodiments, lactic acid copolymers, proteins (e.g., gluten and/or maize protein) and/or colla Corii Asini (guar) may be used to create gels that are more readily biodegradable. The amount of adjuvant or filler in the gum base is generally up to about 20% by weight. Other optional ingredients include colorants, brighteners, preservatives, and perfumes.
In some embodiments of the chewing gum composition, the gum base comprises about 5 wt% to about 95 wt%, preferably about 15 wt% to about 50 wt%, more preferably about 20 wt% to about 30 wt% of the chewing gum composition.
The soluble portion of the chewing gum composition may optionally include other artificial or natural sweeteners, bulk sweeteners, softeners, emulsifiers, flavoring agents, coloring agents, adjuvants, fillers, functional agents (e.g., pharmaceutical agents or nutrients), or combinations thereof. Examples of suitable softeners and emulsifiers are described above.
Bulk sweeteners include both caloric and non-caloric compounds. Non-limiting examples of bulk sweeteners include sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, high fructose corn syrup, levulose, galactose, corn syrup solids, tagatose, polyols (such as sorbitol, mannitol, xylitol, lactitol, erythritol, and maltitol), hydrogenated starch hydrolysates, isomalt, trehalose, and mixtures thereof. In some embodiments, the bulk sweetener is present in the chewing gum composition in an amount of about 1 wt% to about 75 wt%.
Flavoring agents may be used in the insoluble gum base or soluble portion of the chewing gum composition. Such flavoring agents may be natural or artificial flavors. In some embodiments, the flavoring agent comprises essential oils (such as oils derived from plants or fruits), peppermint oil, spearmint oil, other mint oils, clove oil, cinnamon oil, wintergreen, bay, thyme, cedar leaf, nutmeg, red bell pepper, sage, cardamom, and almond oils. In other embodiments, the flavoring agent comprises a plant extract or fruit essential oil (such as apple, banana, watermelon, pear, juicy peach, grape, strawberry, raspberry, cherry, prune, pineapple, apricot, and mixtures thereof). In other embodiments, the flavoring agent comprises a citrus flavor, such as an extract, essential oil, or oil of lemon, lime, orange, tangerine, grapefruit, mandarin orange, or kumquat.
In some embodiments, a chewing gum composition comprises a composition of the present application or a sweetener composition comprising the composition and a gum base.
D. Cereal compositions
In some embodiments, consumable products containing steviol compositions of the present application include grain compositions. The cereal composition is typically consumed as a staple or snack food. Non-limiting examples of grain compositions for use in certain embodiments include ready-to-eat grains and hot cereals. By ready-to-eat cereal is meant a cereal that is edible by the consumer without further processing (i.e. cooking). Examples of ready-to-eat cereals include breakfast cereals and snack foods. Breakfast cereals are typically processed to produce a flaked, puffed or extruded product. Breakfast cereals are generally eaten cold, often mixed with milk and/or fruit. Snack foods include, for example, energy bars, rice cakes, oatmeal, nutritional bars. The hot cereal is typically cooked, usually in milk or water, prior to eating. Non-limiting examples of hot cereals include grits, porridge, corn porridge, rice and oats.
The cereal composition generally includes at least one cereal component. As used herein, the term "cereal component" refers to materials such as whole or partial grains, whole or partial seeds, and whole or partial grasses. Non-limiting examples of cereal ingredients for use in some embodiments include maize, wheat, rice, barley (barley), bran (bran), bran endosperm (brannendoperm), bulgur (bulgur), milo (soghum), chestnut, oat, rye (rye), triticale (triticale), buckwheat, african millet (fonio), chenopodium quinoa (quinoa), beans, soybeans, amaranth, teff, spelt (spelt), and kaniwa (kaniwa).
In some embodiments, the grain composition comprises the composition of the present application or a sweetener composition comprising the composition of the present application and at least one cereal ingredient. The compositions of the present application or sweetener compositions containing the compositions of the present application may be added to the cereal composition in various ways. For example, as a coating (coating), frosting mix (frosting), sugar juice (glaze), or base mix (i.e., added as an ingredient to the cereal formula prior to preparation of the final cereal product).
Accordingly, in some embodiments, the compositions of the present application or sweetener compositions containing the compositions of the present application are added to the cereal composition as a base mixture. In one embodiment, the composition of the present application or sweetener composition containing the composition of the present application is blended with a hot cereal prior to cooking to provide a sweetened hot cereal product. In another embodiment, the composition of the present application or sweetener composition containing the composition of the present application is blended with a cereal base prior to the cereal being extruded.
In some embodiments, the composition of the present application or sweetener compositions containing the composition of the present application are added to the cereal composition as a coating, e.g., mixed with a food grade oil, and the mixture is then spread onto the cereal. In various embodiments, the compositions of the present application, or the sweetener compositions and food grade oils comprising the compositions of the present application, can be applied to the cereal separately, either prior to applying the oil or prior to applying the sweetener. Non-limiting examples of food grade oils for use in some embodiments include vegetable oils such as corn oil, soybean oil, cottonseed oil, peanut oil, coconut oil, rapeseed oil, olive oil, sesame oil, palm kernel oil, and mixtures thereof. In another embodiment, food grade fat may be used in place of oil, but prior to applying the fat to the cereal, the fat is melted.
In another embodiment, the composition of the present application or a sweetener composition comprising the composition of the present application is added to the cereal composition as a sugar juice. Non-limiting examples of juicing agents suitable for use with some embodiments include corn syrup, honey syrup and honey syrup solids, maple syrup and maple syrup solids, sucrose, isomaltose, polydextrose, polyols, hydrogenated starch hydrolysates, aqueous solutions thereof, and mixtures thereof. In another embodiment, the composition of the present application or sweetener composition containing the composition of the present application is mixed with a sugar juice agent and a food grade oil or fat to form a mixture, and the mixture is then applied to the cereal as a sugar juice. In another embodiment, gum systems, such as gum arabic, methyl cellulose carboxylate, or algin, may be added to the juice to provide structural support. In addition, the sugar juice may also include coloring agents and may also include flavoring agents.
In another embodiment, the composition of the present application or a sweetener composition comprising the composition of the present application is added to the cereal composition as a frosting mixture. In one embodiment, the composition of the present application or sweetener composition containing the composition of the present application is mixed with water and a sugar cream (frostinggent) and then applied to the cereal. Non-limiting examples of sugar creams suitable for use in some embodiments include maltodextrin, sucrose, starch, polyols, and mixtures thereof. The icing mixture may also include food grade oils, food grade fats, colorants, and/or flavors.
In general, the amount of the composition of the present application or sweetener composition containing the composition of the present application in the cereal composition varies widely depending on the particular type of cereal composition and its desired sweetness. One of ordinary skill in the art can readily determine the appropriate amount of sweetener to add to the cereal composition.
E. Baked food
In some embodiments, a savory food comprising the composition of the present application is a baked food. Baked goods as used herein include ready-to-eat food products and all ready-to-bake products, flours and mixtures that are prepared prior to baking. Non-limiting examples of baked goods include cakes, crackers, cookies, brownies, muffins, rolls, bagels, donuts, pastries, croissants, breads, bread products, and buns.
According to embodiments of the present application, preferred baked goods may be divided into three categories: bread-type doughs (e.g., white bread, various types of bread, soft bread, hard bread, bagels, pizza dough, and tortillas), sweet doughs (e.g., danis bread, croissants, biscuits, pastries, pie crusts, biscuits, and biscuits), and batters (e.g., cakes such as sponges, pounds, devil's, cheese cakes and layer cakes, donuts or other yeast cakes, brownies, and muffins). Doughs are usually flour based, whereas batters are more aqueous.
According to particular embodiments of the present application, baked goods typically include a combination of sweetener, water, and fat. Baked goods made according to particular embodiments of the present application also contain flour to make a dough or batter. The term "dough" as used herein is a mixture of flour and other ingredients that is sufficiently hard to knead or roll. The term "batter" as used herein includes flour, liquids, such as milk or water, and other ingredients, and is thin enough to pour or drip from a spoon. According to particular embodiments of the present application, the flour is desirably present in the baked good in an amount of about 15 wt% to about 60 wt% (dry basis), more desirably about 23 wt% to about 48 wt% (dry basis).
The type of flour may be selected according to the desired product. Typically, the flour comprises an edible non-toxic flour commonly used in baked goods. According to particular embodiments, the flour may be a bleached baked flour, a universal flour, or an unbleached flour. In other particular embodiments, flours treated in other ways may also be used. For example, in certain embodiments, the flour may be enriched with additional vitamins, minerals, or proteins. Non-limiting examples of flours suitable for use in particular embodiments of the present application include wheat, corn flour, whole grain, portions of whole grains (wheat, bran, and oat gruel), and combinations thereof, as well as starch or starchy materials that may also be used as flours in particular embodiments. Common food starches are typically derived from potato, corn, wheat, barley, oats, tapioca, arrow root, and sago. Modified and pregelatinized starches are also useful in certain embodiments of the present application.
The type of fat or oil used in certain embodiments of the present application may include any edible fat, oil, or combination thereof suitable for baking. Non-limiting examples of fats suitable for use in particular embodiments of the present application include vegetable oils, tallow, lard, sea oil, and combinations thereof. According to particular embodiments, the fat may be fractionated, partially hydrogenated, and/or fortified. In another particular embodiment, it is desirable that the fat comprises reduced, low-calorie or non-digestible fat, fat substitute or synthetic fat. In another embodiment, short chain fats or mixtures of hard and soft fats may also be used. In particular embodiments, the short chain fat is derived primarily from triglycerides from vegetable sources (e.g., cottonseed oil, soybean oil, peanut oil, linseed oil, sesame oil, palm kernel oil, rapeseed oil, safflower oil, coconut oil, corn oil, sunflower oil, and mixtures thereof). Synthetic or natural triglycerides of fatty acids with chain lengths of 8 to 24 carbon atoms may also be used in certain embodiments. According to particular embodiments of the present application, it is desirable that the fat is present in the baked product in an amount of from about 2 wt% to about 35 wt%, more desirably from about 3 wt% to about 29 wt% (on a dry basis).
According to certain embodiments of the present application, the baked good further comprises a sufficient amount of water to provide a desired consistency to enable proper shaping, processing and cutting of the baked good before or after cooking. The total moisture content of the baked good includes any water added directly to the baked good, as well as moisture in separately added ingredients (e.g., flour, typically containing about 12 wt% to 14 wt% moisture), which according to particular embodiments of the present application, is present in the baked good at levels up to about 25 wt%. Depending on the particular embodiment of the application, the baked good may also include a number of additional conventional ingredients, such as leavening agents, flavors, colorants, milk by-products, eggs, egg by-products, cocoa, vanilla or other flavorings, as well as inclusions such as nuts, raisins, cherries, apples, apricots, peaches, other fruits, citrus peels, preservatives, coconut, flavored potato chips such as chocolate chips, butter candy pieces, caramel pieces, and the like, and combinations thereof. In particular embodiments, the baked good may further comprise an emulsifier, such as lecithin and monoglycerides.
According to particular embodiments of the present application, the starter culture may comprise a chemical starter culture or a yeast starter culture. Non-limiting examples of chemical leavening agents suitable for use in particular embodiments of the present application include baking soda (e.g., sodium, potassium, or aluminum bicarbonate), baking acids (e.g., sodium aluminum phosphate, monocalcium phosphate, or dicalcium phosphate), and combinations thereof.
According to another specific embodiment of the present application, the cocoa may comprise natural chocolate or "juiced" chocolate, in the case of "juiced" chocolate, in which a substantial portion of the fat or cocoa butter has been extracted or removed by solvent extraction, pressing or other means. In an exemplary embodiment, it may be necessary to reduce the amount of fat in a baked product comprising chocolate due to the presence of additional fat in the cocoa butter. In certain embodiments, it may be desirable to add more chocolate than cocoa to provide equal amounts of flavor and color.
Baked goods typically also include caloric sweeteners such as sucrose, high fructose corn syrup, erythritol, molasses, honey, or brown sugar. In exemplary embodiments of the baked goods provided herein, the caloric sweetener is partially or fully replaced with the SG compositions of the present application or sweeteners comprising such compositions. Thus, in one embodiment, a baked good comprises an SG composition of the present application or a sweetener composition comprising the same in combination with fat, water, and optionally flour. In particular embodiments, the baked good can optionally include other natural and/or synthetic high-potency sweeteners and/or bulk sweeteners.
F. Tabletop sweetener compositions
In some embodiments, orally consumable compositions comprising the compositions of the present application are tabletop sweetener compositions. In some embodiments, the tabletop sweetener compositions can further comprise at least one filler, additive, anti-caking agent, functional ingredient, or combination thereof.
Suitable "bulking agents" include, but are not limited to, maltodextrin (10DE, 18DE, or 5DE), corn syrup solids (20 or 36DE), sucrose, fructose, glucose, invert sugar, sorbitol, xylose, ribulose, mannose, xylitol, mannitol, galactitol, erythritol, maltitol, lactitol, isomalt, maltose, sugar, lactose, inulin, glycerol, propylene glycol, polyols, polydextrose, fructooligosaccharides, cellulose and cellulose derivatives, and the like, and mixtures thereof. In addition, according to other embodiments of the present application, granulated sugar (sucrose) or other caloric sweeteners such as crystalline fructose, other carbohydrates or sugar alcohols can provide good content uniformity without significant caloric increase and therefore can be used as bulking agents.
The phrases "anti-caking agent" and "flow agent" are used herein to denote any composition that contributes to content uniformity and uniform solubility. In some embodiments, non-limiting examples of anti-caking agents include creams of tartaric acid, calcium silicate, silicon dioxide, microcrystalline cellulose (Avicel, FMC BioPolymer, philiadelphia, Pennsylvania), and tricalcium phosphate. In one embodiment, the anti-caking agent is present in the tabletop sweetener composition in an amount from about 0.001% to about 3% by weight.
The tabletop sweetener compositions can be packaged in any form known in the art. Non-limiting forms include, but are not limited to, powders, granules, tablets, sachets, spheres, cubes, solids, and liquids.
In one embodiment, the tabletop sweetener composition is a single serving (portion control) package comprising a dry blend. Dry-mixed formulations may generally comprise powders or granules. Although the tabletop sweetener composition may be in any size package, an illustrative, non-limiting example of a conventional portion control tabletop sweetener package is about 2.5 inches by 1.5 inches, capable of holding about 1 gram of the sweetener composition having a sweetness equivalent to 2 teaspoons of particulate sugar (about 8 grams). The amount of a composition of the present application or a sweetener composition comprising a composition of the present application in a dry blended tabletop sweetener formulation may vary. In some embodiments, the compositions herein may be present in dry blended tabletop sweetener formulations in an amount from about 1% to about 10% by weight.
Embodiments of the solid tabletop sweetener include cubes and flakes. A non-limiting example of a conventional cube is a size comparable to a standard cube of granulated sugar, about 2.2 x 2.2 cubic centimeters, and weighs about 8 grams. In one embodiment, the solid tabletop sweetener is formulated in the form of a tablet or any other form known to those skilled in the art.
Tabletop sweetener compositions can also be presented in liquid form, wherein a composition of the present application or sweetener composition comprising the composition is combined with a liquid carrier. Non-limiting examples of carrier agents suitable for liquid tabletop sweeteners include water, polyols, glyceryl or water-dissolved citric acid groups, and mixtures thereof. The sweetness comparable to any form of tabletop sweetener composition described herein or known in the art may be varied in order to achieve the desired sweetness profile. For example, the sweetness of a tabletop sweetener composition may be comparable to the sweetness of standard sugar. In another embodiment, the tabletop sweetener composition may have a sweetness that is up to 100 times that of standard sugar. In another embodiment, the tabletop sweetener composition may have a sweetness that is up to 90 times, 80 times, 70 times, 60 times, 50 times, 40 times, 30 times, 20 times, 10 times, 9 times, 8 times, 7 times, 6 times, 5 times, 4 times, 3 times, 2 times that of standard sugar.
G. Beverage and drink
In some embodiments, the beverage or drink comprises the composition of the present application or a sweetener composition containing the composition. The beverage may be sweetened or unsweetened. The compositions of the present application or sweetener compositions containing the same may be added to beverages to sweeten the beverages or to enhance their original sweetness or flavor profile.
As used herein, a "drink" is a ready-to-drink beverage, beverage concentrate, beverage syrup, or powdered beverage. Suitable ready-to-drink beverages include carbonated beverages and non-carbonated beverages. Carbonated beverages include, but are not limited to, frozen carbonated beverages, fortified sparkling beverages, colas, fruit-flavored beverages (e.g., lemon-lime, orange, grape, strawberry, and pineapple), ginger sparkling waters, soft drinks, and root beer. Non-carbonated beverages include, but are not limited to, fruit juices, fruit flavored juices, fruit juice beverages, nectar beverages, vegetable juices, vegetable sauces, sports drinks, energy drinks, fortified water drinks, enhanced water drinks with vitamins (e.g., water with natural or synthetic flavors), coconut water, tea-type beverages (e.g., black tea, green tea, black tea, oolong tea), coffee, cocoa drinks containing milk components (e.g., milk drinks, coffee containing milk components, milk coffee, milk tea, fruit milk drinks), and drinks containing grain extracts and smoothies.
Beverage concentrates and beverage syrups are prepared from an initial liquid base (e.g., water) and the desired beverage ingredients. A full strength beverage is then prepared by adding more water. Powdered beverages are prepared by dry blending all the beverage ingredients without a liquid base. A full strength beverage is then prepared by adding a full volume of water.
The beverage comprises a matrix, i.e., a base component, in which the ingredients comprising the composition of the present application are dissolved. In one embodiment, the beverage comprises water as a base as a beverage quality, for example: deionized water, distilled water, reverse osmosis water, carbon treated water, purified water, desalted water and combinations thereof may be used. Other suitable substrates include, but are not limited to, phosphoric acid, phosphate buffer, citric acid, citrate buffer, and carbon-treated water.
In some embodiments, the beverage comprises a composition of the present application. In some embodiments, the beverage comprises the sweetener composition of the present application.
The following strength beverages may be provided with the compositions of the present application or the sweetener compositions of the present application.
In some embodiments, the total concentration of SG in the beverage is from about 50ppm to about 900ppm, for example: about 50ppm to about 600ppm, about 50ppm to about 500ppm, about 50ppm to about 400ppm, about 50ppm to about 300ppm, about 50ppm to about 200ppm, about 100ppm to about 600ppm, about 100ppm to about 500ppm, about 100ppm to about 400ppm, about 100ppm to about 300ppm, about 100ppm to about 200ppm, about 200ppm to about 600ppm, about 200ppm to about 500ppm, about 200ppm to about 400ppm, about 200ppm to about 300ppm, about 300ppm to about 600ppm, about 300ppm to about 500ppm, about 300ppm to about 400ppm, about 400ppm to about 600ppm, about 400ppm to about 500ppm, about 500ppm to about 600 ppm.
H. Pharmaceutical composition
The term "pharmaceutical composition" includes solids, liquids and gases, and is an ingestible material of pharmaceutical value, such as cough syrups, cough drops, medicinal sprays, vitamins, and chewable tablets.
I. Oral hygiene composition
The term "oral hygiene composition" includes mouthwashes, mouthrinses, toothpastes, tooth polishes, mouth sprays, mouth fresheners.
J. Smoking composition
The term "smoking composition" in this application includes cigarettes, pipes and cigars, as well as all forms of tobacco, such as shredded filler, leaf, stem, dried, cured homogenized leaf, reconstituted binder, reconstituted tobacco in sheet, granule or other form of tobacco dust, fines or other source. "smoking compositions" also include tobacco substitutes made with non-tobacco treatments, such as the representative tobacco substitutes described in U.S. patents US3529602, 3703177, and 4079742, which are incorporated herein by reference.
Process for producing SG/GSG composition
In another aspect, the present application relates to a method of producing the SG/GSG compositions of the present application.
In some embodiments, the compositions of the present application are prepared by enzymatically glycosylating a starting material to obtain a GSG product.
In certain embodiments, the GSG for use herein is prepared by the steps of: i) dissolving a glucose donor material in water to form a dissolved glucose donor material; ii) adding a raw material SG composition to the dissolved glucose donor material to obtain a mixture; iii) adding an effective amount of an enzyme to the reaction mixture to form a reaction mixture, wherein the enzyme facilitates the transfer of glucose from the glucose donor molecule to SG added to the raw SG composition in the mixture; incubating the reaction mixture at the desired temperature for a predetermined reaction time to glycosylate the SG of the SG composition with the glucose moiety present in the glucose donor material; in some further embodiments, after a predetermined ratio of GSG and residual SG is achieved, the mixture may be heated to a temperature high enough and for a time long enough to inactivate the enzyme. In some embodiments, the enzyme is removed by filtration, rather than inactivation. In other embodiments, the enzyme is removed by filtration after inactivation. In some embodiments, the resulting solution of GSG, residual SG, and dextrin is decolorized. In certain embodiments, the resulting solution of GSG, residual SG, and dextrin is dried. In some embodiments, the drying is spray drying. In some embodiments, step (i) comprises the following sub-steps: (a) mixing a glucose donor material in a defined amount of water to form a suspension, (b) adding a defined amount of glycosylase to the suspension, (c) incubating the suspension at a reaction temperature for a reaction time to form a liquefied glucose donor material. The enzyme reaction temperature is 20-100 deg.C, 40-80 deg.C, 50-70 deg.C, 55-65 deg.C, or about 60 deg.C. The reaction time may be about 0.5 hours to about 24 hours, and generally about 12 hours to about 24 hours.
In some embodiments, the glucose donor molecule is a dextrin. In a preferred embodiment, the dextrin is a cyclodextrin, a maltodextrin or a amylodextrin. In certain preferred embodiments, the raw material SG composition is a stevia extract.
Enzymes that hydrolyze starch and/or glycosylation include, but are not limited to, cyclodextrin glycosyltransferase (cgtase), alpha-amylase, pullulanase, beta-amylase, saccharifying enzyme, isoamylase, maltogenic amylase, and pullulanase. In some embodiments, the water is Reverse Osmosis (RO) purified water.
In some embodiments, the amount of SG in the raw SG composition is about 10 to 99 wt%. In some embodiments, the liquefied glucose donor molecule is liquefied dextrin, and the weight ratio of SG composition to dextrin when added to the starting SG composition is from 1:99 to 99: 1.
In some embodiments, the culturing time is from 0.1 to 24 hours, from 0.1 to 12 hours, from 0.1 to 6 hours, from 0.1 to 4 hours, from 0.1 to 3 hours, from 0.1 to 2, from 0.1 to 1 hour, from 0.1 to 0.5 hours, from 0.5 to 24 hours, from 0.5 to 12 hours, from 0.5 to 6 hours, from 0.5 to 4 hours, from 0.5 to 3 hours, from 0.5 to 2, from 0.5 to 1 hour, from 1 to 24 hours, from 1 to 12 hours, from 1 to 6 hours, from 1 to 4 hours, from 1 to 3 hours, from 2 to 24 hours, from 2 to 12 hours, from 2 to 6 hours, from 2 to 4 hours, from 2 to 3 hours, from 3 to 24 hours, from 3 to 12 hours, from 3 to 6 hours, from 3 to 4 hours, from 4 to 24 hours, 4-12 hours, 4-6 hours, 6-24 hours, 6-12 hours or 12-24 hours, the culture temperature is 4-80 ℃, 10-80 ℃, 15-80 ℃, 20-80 ℃, 30-80 ℃, 40-80 ℃, 50-80 ℃, 60-80 ℃, 70-80 ℃, 4-80 ℃, 10-80 ℃, 15-80 ℃, 20-80 ℃, 30-80 ℃, 40-80 ℃, 50-80 ℃, 60-80 ℃, 70-80 ℃, 50-70 ℃ or 55-65 ℃.
In an exemplary embodiment, the GSG used in the present application is prepared as follows: i) dissolving dextrin in water; ii) adding stevia extract to the liquefied dextrin, the total SG content in the stevia extract being 70% -99% or 60% -99%, to obtain a mixture, wherein the weight ratio of dextrin to stevia extract is preferably 20:80-80:20 or 40:60-60: 40; iii) adding GGT enzyme to the mixture, incubating at 60 ℃ for a desired length of reaction time, and glycosylating SG with glucose molecules from dextrin; IV) after the desired ratio of GSG to residual SG content has been achieved, the reaction mixture is heated at 90-100 ℃ for 30 minutes to inactivate the GGT enzyme, and the enzyme is then removed by filtration; v) decoloring and spray drying to prepare a solution of GSG, residual SG and dextrin. In a more preferred embodiment, the dextrin is tapioca dextrin and the water is Reverse Osmosis (RO) -purified water.
In other exemplary embodiments, the method for forming the hydrolysate-containing composition of the present application comprises the steps of: (1) mixing GSG and SG with water; (2) heating the mixture and stirring until the mixture is completely dissolved to obtain a clear solution; (3) the solution was further stirred at this temperature and then cooled to room temperature. Step (4) may comprise crystallizing or spray drying the solution of step (2) and then heating the mixture to 40-100 deg.C, 50-90 deg.C, or even 60-70 deg.C.
The sweetness of the hydrolysate-containing composition of the present application can be adjusted by adding any of the above additives. For example, β -1, 4-galactosyl can be substituted on GSG using β -1, 4-galactosyltransferase in reactions known in the art.
Methods of use of SG/GSG compositions
In another aspect, the invention relates to a method of using the SG/GSG compositions of the present application as a sweetener, co-sweetener, or flavoring agent.
In some embodiments, the method is a method of improving the sweetness of an orally consumable composition. The method comprises the step of adding an effective amount of a composition of the present application to an orally consumable composition. In some embodiments, the method further comprises the step of mixing the composition of the present application with a liquid carrier to form a solution. Preferred carriers include water, ethanol, other alkyl alcohols used in food processing or mixtures thereof. The resulting solution is contacted with the orally consumable composition and the carrier is then evaporated or otherwise removed from the orally consumable composition or the composition of the present application is deposited in the orally consumable composition. This process is particularly useful for adding the compositions of the present application to tea leaves, herbal leaves and other sweeteners, particularly granular sucrose.
According to another embodiment, a liquid filtration material suitable for use in an orally consumable composition is prepared with the composition of the present application. As used herein, "liquid filter" refers to a porous or semi-porous filter material used to prepare orally consumable compositions such as tea bags, coffee filters, or filter discs. By "filter disc" is meant a porous or semi-porous inert substance added to an orally consumable composition, intended as a vehicle for adding a flavour or sweetener composition to the orally consumable composition. A liquid filter comprising a filter material and a composition of the present application is generally prepared by mixing the composition of the present application with a carrier to form a mixture of the composition of the present application and the carrier; contacting a composition carrier mixture of the present application with a filter material; the carrier is removed from the filter material, thereby depositing a residue of the composition of the present application on the filter material.
The compositions of the present application can be used as a sweetener, a co-sweetener, or as a flavor in confectioneries, and snacks selected from the group consisting of dairy-based, cereal-based, baked, vegetable-based, fruit-based, root/tuber/stem-based, nut-based, gum-based, other vegetable-based, egg-based, meat-based, seafood-based, other animal-based, algae-based, processed (e.g., coated), preserved (e.g., portion ready-to-eat meals), and synthetic (e.g., gel) products. The confectionery, sweetmeats, desserts and snacks may be in the form of ready-to-eat, ready-to-cook, ready-to-mix, raw materials or ingredients.
The compositions of the present application may be used as sweeteners, co-sweeteners, or as flavoring agents in both prescription and over-the-counter pharmaceuticals, analytical, diagnostic kits, and treatment regimens. The treatment regimen is selected from the group consisting of weight management, nutritional supplementation, vitamins, infant diets, diabetic diets, athlete's diet, senior diet, low carbohydrate diet, low fat diet, low protein diet, high carbohydrate diet, high fat diet, high protein diet, low calorie diet, non-caloric diet, oral hygiene products (e.g., toothpaste, mouthwash, dental floss, toothbrush, tools, etc.), personal care products (e.g., soap, shampoo, rinse, lotion, balm, ointment, salve, paper, perfume, lipstick, other cosmetics), professional dental products (e.g., liquids, chews, inhalants, injections, salves, resins, lotions, pads, floss, tools), medical, veterinary and surgical products (e.g., liquids, chews, inhalants, injections, ointments, resins, lotions, pads, floss, implements), and drug mix fillers, syrups, capsules, gels, and coated products.
The compositions of the present application may be used as flavorants in consumer packaging materials and containers selected from the group consisting of plastic films, thermosetting and thermoplastic resins, glues, aluminum foil, paper, bottles, boxes, inks, coatings, adhesives, packaging coating products.
The compositions of the present application may be used as flavorants on commercial products selected from the group consisting of: sweeteners, co-sweeteners, coated sweetener sticks, frozen dessert sticks, spoons (for human and veterinary use), dental appliances, pre-sweetened disposable tableware and utensils, sachets, dried flowers, edible dried flowers, artificial flowers, edible artificial flowers, garments, edible garments, massage oils and edible massage oils.
In some embodiments, the compositions of the present application are used as sweeteners in effective amounts with improved solubility and/or sensory profile.
In some embodiments, the compositions of the present application are used as co-sweeteners in effective amounts, having improved solubility and/or sensory profile.
In other embodiments, the compositions of the present application are used as co-flavoring agents in effective amounts.
The term "isosweet" is used herein to indicate that the sweetness of the present composition is comparable to that of sugar.
For use as a co-sweetener, the compositions of the present application (e.g., vapor, ethanol, or alkanol aerosolized products deposited onto the co-sweetener) may be coated or impregnated with other solid sweeteners such as granulated or powdered sugar and synthetic sweeteners in a manner known in the sweetener art; as a separate powder mixed with a solid sweetener; co-crystallizing with other solid sweeteners; or suspended or dissolved in liquid sweeteners such as corn syrup and honey. The ethanol purge and drying stages in industrial embodiments can generally be configured using commercial spray dryers to produce product particle sizes suitable for the intended use.
In some embodiments, the compositions of the present application are used as flavoring agents to enhance or improve the flavor of consumables. In some embodiments, the improved or enhanced flavor characteristics of the compositions of the present invention, when used in effective amounts, are sweet, fruity, floral, herbal, spicy, aromatic, pungent, "nut-like" (e.g., almonds, walnuts), "spicy" (e.g., cinnamon, clove, nutmeg, fennel, and wintergreen), "non-citrus fruit flavors" (e.g., strawberry, cherry, apple, grape, raisin, tomato, currant, and blackberry), "citrus flavors" (e.g., orange, lemon, lime, and grapefruit), and other useful flavors, including coffee, cocoa, mint, spearmint, vanilla, and maple.
In some embodiments, the compositions of the present application sweeten, modify, or enhance the taste, flavor, and/or texture of orally consumable compositions in an effective amount.
The term "effective amount" refers to an amount that produces sensory perception. Excessive use of the compositions of the present application can produce undesirable flavor changes or enhancements, as can be the inability to add too much sugar to a food or beverage. The amount of the composition of the present application may vary within wide limits depending on the desired organoleptic effect to be achieved in order to achieve the desired effect of the orally consumable composition and the properties of the starting composition.
The compositions of the present application may be added to an orally consumable composition by mixing the composition of the present application with the orally consumable composition or mixing the composition of the present application with the ingredients of the orally consumable composition.
5. Detailed description of the preferred embodiments
The following paragraphs numbered consecutively from 1 to 94 provide various aspects of the present application. In one embodiment of paragraph 1, the present application provides:
1. a composition comprising one or more Glycosylated Steviol Glycosides (GSG) and one or more Steviol Glycosides (SG).
2. The composition according to paragraph 1, which comprises one or more SG, the total content of SG in the composition being from 0.1 to 99.5% by weight.
3. The composition of paragraph 1, wherein the one or more SG are selected from table a or table B.
4. The composition of paragraph 1, wherein the one or more SGs comprise 25-35 wt% Reb-a, 0.4-4 wt% Reb-B, 5-15 wt% Reb-C, 1-10 wt% Reb-D, 2-5 wt% Reb-F, 1-5 wt% Reb-K, and 20-40 wt% stevioside.
5. The composition of paragraph 3 or 4, wherein the one or more SG include one or more compounds selected from the group consisting of 1-5 wt% rubusoside, 1-3 wt% dulcoside A, 0.01-3 wt% steviolbioside, 0.2-1.5 wt% dulcoside B, 00.01-2 wt% Reb-O, 0.01-2 wt% Reb-S, 0.01-1.2 wt% Reb-T, 0.01-0.8 wt% Reb-R, 0.01-0.7 wt% Reb-J, 0.01-0.7 wt% Reb-W, 0.01-0.7 wt% Reb-V, 0.01-0.6 wt% Reb-V2, 0.01-0.5 wt% Reb-G, 0.01-0.5 wt% Reb-H, 0.01-0.5 wt% Reb-K2, 0.01-0.5 wt% Reb-5 wt% Reb-G, 0.01-0.5 wt% Reb-5 wt% Reb-H, 0.5 wt% Reb-3-5 wt% K630.5 wt% Reb-5U # 9, 0.5-5U # 9-5, 0.01-0.5 wt% Rel SG #5, 0.01-0.4 wt% Reb-M, 0.01-0.4 wt% Reb-N, 0.01-0.4 wt% Reb-E, 0.01-0.4 wt% Reb-F1, 0.01-0.4 wt% Reb-Y, and combinations thereof.
6. The composition of any of paragraphs 3-5, wherein the one or more SG include at least 20, at least 21, at least 22, at least 23, or at least 24 selections from 1-5 wt% rubusoside, 1-3 wt% dulcoside A, 0.01-3 wt% steviolbioside, 0.2-1.5 wt% dulcoside B, 00.01-2 wt% Reb-O, 0.01-2 wt% Reb-S, 0.01-1.2 wt% Reb-T, 0.01-0.8 wt% Reb-R, 0.01-0.7 wt% Reb-J, 0.01-0.7 wt% Reb-W, 0.01-0.7 wt% Reb-V, 0.01-0.6 wt% Reb-V2, 0.01-0.5 wt% Reb-G, 0.01-0.5 wt% Reb-V6356, 0.01-0.5 wt% Reb-G, 0.01-0.5 wt% Reb-0.5 wt% H-0.01-0.5 wt% Reb-3-0.3 wt% Reb-3U-2, 0.01-0.5% Reb-I, 0.01-0.5% Rel SG #4, 0.01-0.5% Rel SG #5, 0.01-0.4% Reb-M, 0.01-0.4% Reb-N, 0.01-0.4% Reb-E, 0.01-0.4% Reb-F1, and 0.01-0.4% Reb-Y.
7. The composition of paragraph 1, wherein the one or more SG comprise 45-55 wt% Reb-a, 20-40 wt% stevioside, 2-6 wt% Reb-C, 0.5-3 wt% Reb-B, and 0.5-3 wt% Reb-D.
8. The composition of paragraph 7, wherein the one or more SG further comprises one or more ingredients selected from the group consisting of 0.1-3 wt% related SG # 5, 0.05-1.5 wt% Reb-R1, 0.0.05-1.5 wt% Reb-K2, 0.05-1.5 wt% Reb-E, 0.01-1 wt% dulcoside a, 0.01-1 wt% dulcoside B, 0.01-1 wt% rubusoside, 0.01-1 wt% steviolbioside, 0.01-1 wt% isosteviolbioside, 0.01-1 wt% stevioside-B, 0.01-1 wt% related SG # 3, 0.01-1 wt% related SG # 2, 0.01-1 wt% Reb-G, 0.01-1 wt% Reb-F, and 0.01-1 wt% Reb-W.
9. The composition of paragraph 7, wherein the one or more SG further comprises at least 12, at least 13, at least 14, or at least 15 ingredients selected from the group consisting of 0.1-3 wt% related SG # 5, 0.05-1.5 wt% Reb-R1, 0.0.05-1.5 wt% Reb-K2, 0.05-1.5 wt% Reb-E, 0.01-1 wt% dulcoside a, 0.01-1 wt% dulcoside B, 0.01-1 wt% rubusoside, 0.01-1 wt% steviolbioside, 0.01-1 wt% isoalcohol bioside, 0.01-1 wt% stevioside-B, 0.01-1 wt% related SG # 3, 0.01-1 wt% related SG # 2, 0.01-1 wt% Reb-G, 0.01-1 wt% B-F, and 0.01-1 wt% Reb-1W.
10. The composition of paragraph 1, wherein the one or more SG comprise 35-45 wt% Reb-a, 10-25 wt% stevioside, 4-12 wt% Reb-B, 4-12 wt% dulcoside a, 0.5-4 wt% Reb-C, and 0.1-4 wt% Reb-O.
11. The composition of paragraph 8, wherein the one or more SG further comprises one or more ingredients selected from the group consisting of 0.3-3 wt% rubusoside, 0.1-3 wt% Reb-D, 0.1-3 wt% Reb-G, 0.1-3 wt% Reb-I, 0.1-3 wt% stevioside B, 0.1-3 wt% related SG # 3, 0.05-1.5 wt% Reb-E, 0.05-2 wt% Reb-R, 0.05-1 wt% dulcoside B, 0.01-1 wt% Reb-N, 0.01-1 wt% Reb-Y, 0.01-1 wt% steviol bisoside, 0.01-1 wt% dulcoside B, and combinations thereof.
12. The composition of paragraph 8, wherein the one or more SGs further comprise at least 10, at least 11, at least 12, or at least 13 of an ingredient selected from the group consisting of 0.3-3 wt% rubusoside, 0.1-3 wt% Reb-D, 0.1-3 wt% Reb-G, 0.1-3 wt% Reb-I, 0.1-3 wt% stevioside B, 0.1-3 wt% related SG # 3, 0.05-1.5 wt% Reb-E, 0.05-2 wt% Reb-R, 0.05-1 wt% dulcoside B, 0.01-1 wt% Reb-N, 0.01-1 wt% Reb-Y, 0.01-1 wt% steviol bisoside, and 0.01-1 wt% dulcoside B.
13. A composition according to paragraph 1, which comprises one or more GSGs, the total content of GSGs in the composition being from 0.1 to 99.5 wt%.
14. The composition of paragraph 13, wherein the one or more GSGs are selected from table B.
15. A composition according to paragraph 13 or 14, comprising a plurality of GSGs and a plurality of SGs, wherein the total amount of the plurality of GSGs comprises from 10 to 80 wt% of the composition and the total amount of the plurality of SGs comprises from 10 to 40 wt% of the composition.
16. The composition according to paragraph 15, which comprises 10-30 wt% SG, 50-70 wt% GSG and 60-90 wt% total glycosides.
17. The composition of any of paragraphs 13-15, further comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.2-5 wt% GSG-3G-7, and 1-6 wt% GSG-3G-8;
(b) One or more SG-4G group components selected from the group consisting of 5-15 wt% GSG-4G-1, 1-2 wt% GSG-4G-2, 0.5-2.5 wt% GSG-4G-3, and 2-10 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.1-0.5 wt% GSG-5G-1, 0.05-0.5 wt% GSG-5G-2, 0.5-3 wt% GSG-5G-3, 0.05-0.5 wt% GSG-5G-4, and 0.2-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.5-5.5 wt% GSG-3G1R-33a and 2-6 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-5 wt% GSG-4G1R4, and 0.5-10 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.2-2 wt% GSG-6G1R-1b and 0.3-2.5 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-8 wt% GSG-3G1X-4 and 0.5-3 wt% GSG-3G 1X-5;
(j) one or more SG-4GX group components selected from the group consisting of 0.5-3 wt% GSG-4G1X-1, 0.5-3 wt% GSG-4G1X-2, 1-6 wt% GSG-4G1X-3, and 0.2-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
Wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
18. The composition of paragraph 17, further comprising at least 5, 6, 7, or 8 unreacted steviol glycosides selected from the group consisting of 1-8 wt% Reb-A, 0.1-1.5 wt% Reb-B, 0.05-3 wt% Reb-C, 0.05-1 wt% Reb-D, 0.05-0.3 wt% Reb-F, 0.05-0.25 wt% Reb-K, 0.05-0.5 wt% rubusoside, and 0.05-3 wt% stevioside.
19. A composition according to any of paragraphs 13-15, comprising:
(a) one or more SG-3G group components selected from the group consisting of 2-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-2 wt% GSG-3G-4, 0.2-3 wt% GSG-3G-7, and 1-4 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.3-1.5 wt% GSG-4G-2, 0.5-1.5 wt% GSG-4G-3, and 2.5-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.4 wt% GSG-5G-2, 0.75-2 wt% GSG-5G-3, 0.05-0.3 wt% GSG-5G-4, and 0.4-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more GSG-3G1R-3 group components selected from the group consisting of 0.2-3 wt% GSG-3G1R-3a and 1.5-5 wt% GSG-3G1R-3 b;
(f) One or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.05-0.75 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.5-6.5 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.2-2 wt% GSG-6G1R-1b and 0.3-2.5 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4GX group components selected from the group consisting of 0.5-2 wt% GSG-4G1X-1, 0.5-2 wt% GSG-4G1X-2, 1.5-5 wt% GSG-4G1X-3, and 0.2-1.5 wt% GSG-4G 1X-4; and
(k)1-2.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
20. The composition of paragraph 19, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 1.5-12.5 wt% Reb-a, 0.2-1.5 wt% Reb-B, 0.5-4 wt% Reb-C, 0.3-1 wt% Reb-D, 0.1-2.5 wt% Reb-F, 0.05-2.5 wt% rubusoside, and 1.5-6.5 wt% stevioside.
21. A composition according to any of paragraphs 13-15, comprising:
(a) One or more SG-3G group components selected from the group consisting of 3-6 wt% GSG-3G-2, 1.5-3.5 wt% GSG-3G-3, 1-3 wt% GSG-3G-4, 2-5 wt% GSG-3G-7, and 2-5 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 6-10 wt% GSG-4G-1, 0.5-1.5 wt% GSG-4G-2, 1-3 wt% SG-4G3, and 3-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.3 wt% GSG-5G-2, 1-2 wt% GSG-5G-3, 0.08-0.2 wt% GSG-5G-4, and 1.5-4.5 wt% GSG-5G-5;
(d)0.5-1.5wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 2-5 wt% GSG-3G1R-3a and 2-4 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.2-0.6 wt% GSG-4G1R3, 1.5-4 wt% GSG-4G1R4, and 3-10 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.5-1.5 wt% GSG-6G1R-1a,0.5-1.5 wt% GSG-6G1R-1b, and 0.5-2 wt% GSG-6G 1R-2;
(i) a component having SG-3G-1X group selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) A component consisting of SG-4GX group selected from the group consisting of 0.3-1.5 wt% GSG-4G1X-1, 1-3.5 wt% GSG-4G1X-2, 1.5-4 wt% GSG-4G1X-3, and 0.5-2 wt% GSG-4G 1X-4; and
(k)1.5-3wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
22. The composition of paragraph 21, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of 0.5-2.5 wt% Reb-a, 0.2-1 wt% Reb-B, 0.2-0.8 wt% Reb-C, 0.2-0.6 wt% Reb-D, 0.05-0.25 wt% Reb-F, 0.05-0.6 wt% rubusoside, and 0.05-2 wt% stevioside.
23. A composition according to any of paragraphs 13-15, comprising:
(a) one or more SG-3G group components selected from the group consisting of 5-15 wt% GSG-3G-2, 1-6 wt% GSG-3G-3, 0.5-3.5 wt% GSG-3G-4, 0.5-3.5 wt% GSG-3G-7, and 1.5-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 10-18 wt% GSG-4G-1, 0.5-3.5 wt% GSG-4G-2, 0.5-3.5 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.15-1.5 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.5-3.5 wt% GSG-5G-3, 0.05-0.35 wt% GSG-5G-4, and 0.1-1.5 wt% GSG-5G-5;
(d)0.3-2.5wt%GSG-6G-3;
(e) One or more SG-3G1R group components selected from the group consisting of 0.5-2 wt% GSG-3G1R-3a and 3-5 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.25-2.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.3-3 wt% GSG-4G1R 6;
(g)1.5-7.5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-2 wt% GSG-6G1R-1a,0.1-2 wt% GSG-6G1R-1b, and 0.1-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) one or more SG-4G1X group components selected from the group consisting of 0.5-5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1.5-6 wt% GSG-4G1X-3, and 0.5-2.5 wt% GSG-4G 1X-4; and
(k)0.5-4.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
24. The composition of paragraph 23, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 1-6 wt% Reb-a, 0.2-2 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.05-2 wt% Reb-F, 0.05-1 wt% rubusoside, and 0.05-3.5 wt% stevioside.
25. The composition of paragraph 23, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 3-10 wt% Reb-a, 0.05-2 wt% Reb-C, 0.05-2 wt% Reb-D, 0.05-1.5 wt% Reb-G, 0.05-0.5 wt% Reb-O, 0.05-0.5 wt% rubusoside, and 0.05-4 wt% stevioside.
26. Any one of the compositions 13-15 according to paragraph 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-5 wt% GSG-3G-2, 1-5 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-4 wt% GSG-3G-7, and 2-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.2-3 wt% GSG-4G-2, 0.2-3 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1.5 wt% GSG-5G-1, 0.05-1.5 wt% GSG-5G-2, 0.1-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.5-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 1-3 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R-2, 0.05-1 wt% GSG-4G1R-3, 1-3 wt% GSG-4G1R-4, and 5-10 wt% GSG-4G 1R-6;
(g)2-6wt%GSG-5G-1R4;
(h) One or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1a,0.1-1 wt% GSG6G1R-1b, and 0.2-2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4G1X group components selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1-3 wt% GSG-4G1X-3, and 0.3-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
27. The composition of paragraph 26, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 6-12 wt% Reb-a, 0.1-1.5 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.8-3 wt% Reb-F, 0.5-2.5 wt% rubusoside, and 2-6 wt% stevioside.
28. A composition according to any of paragraphs 13-15, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-4 wt% GSG-3G-2, 1-4 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-3 wt% GSG-3G-7, and 0.5-3.5 wt% GSG-3G-8;
(b) One or more SG-4G group components selected from the group consisting of 3-8 wt% GSG-4G-1, 0.1-2 wt% GSG-4G-2, 0.1-2 wt% SG-4G3, and 1-4 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.3-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.1-2 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 0.2-2 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-3 wt% GSG-4G1R4, and 1-3 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.05-1 wt% GSG-6G1R-1a,0.05-1 wt% GSG-6G1R-1b and 0.1-1.2 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) one or more SG-4G1X group components selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 0.5-2.5 wt% GSG-4G1X-3, and 023-2 wt% GSG-4G 1X-4; and
(k)1-3wt%GSG-5G1X-1,
Wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
29. The composition of paragraph 28, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides selected from the group consisting of 15-25 wt% Reb-a, 0.05-1 wt% Reb-B, 1-3 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.8-3 wt% Reb-F, 0.3-2 wt% rubusoside, and 6-12 wt% stevioside.
30. The composition of any one of paragraphs 1-29, further comprising thaumatin.
31. The composition of any of paragraphs 1-29, further comprising a dextrin.
32. The composition of paragraph 30, wherein the dextrin is a cyclodextrin.
33. The composition of any of paragraphs 1-29, further comprising a salt.
non-SG sweeteners
34. The composition of any of paragraphs 1-33, further comprising one or more non-SG sweeteners.
35. The composition of paragraph 34, wherein the one or more non-SG sweeteners comprise a non-steviol sugar or a non-steviol caramel.
36. The composition of paragraph 34 or 35, wherein the non-SG sweetener comprises one or more sweeteners selected from: cyclamate and salts thereof, sucralose, aspartame, saccharin and salts thereof, xylitol, acesulfame-K, neotame, N- [3- (3-hydroxy-4-methoxyphenyl) propyl ] -alpha-aspartyl ] -L-phenylalanine 1-methyl ester (ANS9801), glycyrrhizin, thaumatin, monellin, and combinations thereof.
37. The composition of any of paragraphs 34-35, wherein the non-SG sweetener comprises one or more carbohydrate sweeteners selected from the group consisting of sucrose, glyceraldehyde, dihydroxyacetone, erythrose, threose, erythrulose, arabinose, lyxose, ribose, xylose, ribulose, xylulose, allose, altrose, galactose, glucose, gulose, idose, mannose, talose, fructose, psicose, sorbose, tagatose, mannoheptulose, sedoheptulose, octulose, fucose, rhamnose, arabinose, terrose, sialose, and combinations thereof.
38. The composition of paragraph 34, wherein the non-steviol sugars comprise more than one carbohydrate sweetener and more than one non-carbohydrate sweetener.
39. The composition of paragraph 34, wherein the non-SG sweetener comprises one or more protein sweeteners.
40. The composition of paragraph 39, wherein the one or more protein sweeteners comprises thaumatin.
Salt (salt)
41. The composition of any of paragraphs 1-40, further comprising one or more salts.
42. The composition of paragraph 41, wherein the one or more salts comprise NaCl and/or KCl.
43. The composition of paragraph 41, the salt comprising one or more SG salts.
44. The composition of paragraph 43, wherein the one or more salts of SG include salts of STB.
45. The composition of paragraph 43, wherein the one or more salts of SG include the sodium salt of RB.
Consumer product
46. An orally consumable composition comprising an SG composition of any one of paragraphs 1 to 45.
47. The orally consumable composition of paragraph 46, wherein the orally consumable composition is a sweetener.
48. The orally consumable composition of paragraph 46, wherein the orally consumable composition is a flavoring agent.
Production method
49. A method of preparing a GSG composition comprising the steps of: (a) dissolving a glucose donor material in water to form a dissolved glucose donor material; (b) adding a SG composition to the dissolved glucose donor material to obtain a reaction mixture; (c) adding an effective amount of an enzyme to the reaction mixture, wherein the enzyme facilitates the transfer of glucose from the glucose donor molecule to SG added to the SG composition in the mixture; (d) incubating at the desired temperature for a predetermined reaction time to glycosylate the SG of the SG composition with the glucose moiety present in the glucose donor material; (e) inactivating the enzyme; (f) removing the enzyme from the reaction mixture; and (g) drying the resulting solution of GSG, residual SG and dextrin.
50. The method of paragraph 48, wherein the glucose donor material is dextrin.
51. The method of paragraph 50, wherein the dextrin is tapioca dextrin.
52. The method of paragraph 50, wherein the dextrin is a cyclodextrin.
53. The method of paragraph 50, wherein the dextrin is maltodextrin.
54. The method of preparing a GSG composition of any of paragraphs 49-53, wherein the water is reverse osmosis purified water.
55. The method of preparing a GSG composition of any one of paragraphs 49-54, wherein the SG composition is a stevia extract.
56. The method of preparing a GSG composition of any of paragraphs 49-55, wherein the total content of SG in the SG composition is 1% to 99%, or 10% to 90%, or 15% to 60%.
57. The method of making a GSG composition of any of paragraphs 49-56, wherein the weight ratio of the glucose donor molecule to the SG composition is 10:90-90:10, 20:80-80:20, 30:70-70:30, or 40:60-60: 40.
58. The method of preparing a GSG composition of any of paragraphs 49-57, wherein the enzyme is a cgtase.
59. The method of preparing a GSG composition of any of paragraphs 49-58, wherein the inactivation of the enzyme comprises heating the reaction mixture at a temperature of 90 ℃ or greater for a time period of 10 minutes or greater.
60. The method of preparing a GSG composition of any of paragraphs 49-59, further comprising decolorizing the reaction mixture after step v).
61. The method of preparing a GSG composition of any of paragraphs 49-60, wherein the drying is spray drying.
Application method
62. A method of increasing the sweetness of an orally consumable composition comprising the step of adding an effective amount of one or more SG and/or one or more GSGs of any one of paragraphs 1-48 to the orally consumable composition.
63. A method of increasing the taste or flavor of an orally consumable composition comprising the step of adding an effective amount of one or more SG and/or one or more GSG of any one of paragraphs 1-48 to the orally consumable composition.
64. The composition of any of the above paragraphs, wherein the one or more SG comprise at least one SG selected from the group consisting of: related SG # 1, SG-4, isosteviolbioside, related SG # 3, rebaudioside R1, stevioside F, SG-Unk1, dulcoside B, SG-3, isorebaudioside B, isosteviolbioside, rebaudioside KA, SG-13, stevioside B, rebaudioside R, SG-Unk2, SG-Unk3, rebaudioside F3, rebaudioside F2, rebaudioside C2, stevioside E2, SG-10, rebaudioside L1, SG-2, rebaudioside A3, isorebaudioside A2, rebaudioside A2, rebaudioside E, rebaudioside H1, related SG # 2, related SG # 5, rebaudioside U2, rebaudioside T, rebaudioside W2, rebaudioside W3, rebaudioside W68612, SG # 9-K8653, SG-828653, rebaudioside K8653, rebaudioside K5, rebaudioside K-82 3, rebaudioside A, rebaudioside D-4, rebaudioside D, rebaudioside A, rebaudioside D-K-5, rebaudioside D-4, rebaudioside A, rebaudioside D-I, rebaudioside E-D-, SG-Unk6, rebaudioside Q2, rebaudioside Q3, rebaudioside I2, rebaudioside T1, related SG # 4, rebaudioside V2, rebaudioside Y, 15 α -OH-rebaudioside M, rebaudioside O2, and combinations thereof.
65. The composition of any of the preceding paragraphs, wherein one or more SG are present in the composition and are selected from the group consisting of: RA20, RA40, RA50, RA60, RA80, RA90, RA95, RA97, RA98, RA99, RA99.5, RB8, RB10, RB15, RC15, RD6, and combinations thereof.
66. The composition of any of the above paragraphs, wherein one or more SG's correspond to at least one SG group selected from SG-1G, SG-2G, SG-3G, SG-4G, SG-5G, SG-6G, SG-1G1R, SG-2G1R, SG-3G1R, SG-4G1R, SG-5G1R, SG-6G1R, SG-1G1X, SG-2G1X, SG-3G1X, SG-4G1X, SG-5G1X, and combinations thereof.
67. The composition of any of the above paragraphs, wherein the one or more SGs comprise at least one SG having a molecular weight of less than or equal to 965 daltons, or, the one or more SGs comprise at least one SG having a molecular weight of less than or equal to 804 daltons, or, the one or more SGs comprise at least one SG having a molecular weight of greater than 965 daltons, or, the one or more SGs comprise at least one SG having a molecular weight of greater than or equal to 1127 daltons, or, the one or more SGs comprise at least one SG having a molecular weight of greater than or equal to 1259 daltons.
68. The composition of any of the preceding paragraphs, wherein the one or more GSGs are further glycosylated with one or more SGs in table a.
69. The composition of paragraph 68, wherein the one or more GSGs are one or more SG further glycosylation products selected from the group consisting of: related SG # 1, SG-4, isosteviolbioside, related SG # 3, rebaudioside R1, stevioside F, SG-Unk1, dulcoside B, SG-3, isorebaudioside B, isosteviolbioside, rebaudioside KA, SG-13, stevioside B, rebaudioside R, SG-Unk2, SG-Unk3, rebaudioside F3, rebaudioside F2, rebaudioside C2, stevioside E2, SG-10, rebaudioside L1, SG-2, rebaudioside A3, isorebaudioside A2, rebaudioside A2, rebaudioside E, rebaudioside H1, related SG # 2, related SG # 5, rebaudioside U2, rebaudioside T, rebaudioside W2, rebaudioside W3, rebaudioside W68612, SG # 9-K8653, SG-828653, rebaudioside K8653, rebaudioside K5, rebaudioside K-82 3, rebaudioside A, rebaudioside D-4, rebaudioside D, rebaudioside A, rebaudioside D-K-5, rebaudioside D-4, rebaudioside A, rebaudioside D-I, rebaudioside E-D-, SG-Unk6, rebaudioside Q2, rebaudioside Q3, rebaudioside I2, rebaudioside T1, related SG # 4, rebaudioside V2, rebaudioside Y, 15 α -OH-rebaudioside M, rebaudioside O2, and combinations thereof.
70. The composition of paragraph 68, wherein the one or more GSGs comprise at least one GSG selected from the group consisting of GSG-1G-1, GSG-1G-2, GSG-1G-3, GSG-1G-4, GSG-1G-5, GSG-2G-1, GSG-2G-2, GSG-2G-3, GSG-2G-4, GSG-3G-1, GSG-3G-2, GSG-3G-3, GSG-4G-1, GSG-4G-2, GSG-5G-1, and combinations thereof.
71. The composition of paragraph 68, wherein the one or more GSGs comprise at least one GSG selected from the group consisting of GSG-3G-2, GSG-3G-3, GSG-3G-4, GSG-3G-7, GSG-3G-8, GSG-4G-1, GSG-4G-2, GSG-4G-3, GSG-4G-7, GSG-5G-1, GSG-5G-2, GSG-5G-3, GSG-5G-4, GSG-5G-5, GSG-6G-3, and combinations thereof.
72. The composition of paragraphs 68-69, the one or more GSGs comprising one or more rhamnose moieties, one or more deoxyhexose moieties, or a combination thereof.
73. The composition of paragraph 72, wherein the one or more GSGs are selected from the group consisting of: GSG-1G1R-1, GSG-1G1R-2, GSG-2G1R-1, GSG-1G1R-3, GSG-2G1R-2, GSG-3G1R-1, GSG-1G1R-4, GSG-2G1R-3, GSG-3G1R-2, GSG-4G-1R-1, GSG-1G1R-5-1, GSG-2G1R-4, GSG-3G1R-3a, GSG-3G1R-3b, GSG-4G1R-2, GSG-5G1R-1 and combinations thereof.
74. The composition of paragraph 72, wherein said one or more GSGs are selected from the group consisting of: GSG-3G1R-3a, GSG-3G1R-3b, GSG-4G1R-2, GSG-4G1R-3, GSG-4G1R-4, GSG-4G1R-6, GSG-5G1R-4, GSG-6G1R-1a, GSG-6G1R-1b, GSG-6G1R-2 and combinations thereof.
75. The composition of paragraphs 68-69, wherein the one or more GSGs comprise one or more xylose moieties, arabinose moieties or a combination thereof.
76. The composition of paragraph 75, wherein said one or more GSGs are selected from the group consisting of: GSG-1G1X-1, GSG-1G1X-2, GSG-1G1X-3, GSG-1G1X-4, GSG-2G1X-1, GSG-2G1X-2, GSG-2G1X-3, GSG-3G1X-1, GSG-3G1X-2, GSG-4G1X-1 and combinations thereof.
77. The composition of paragraph 75, wherein said one or more GSGs are selected from the group consisting of: GSG-3G1X-4, GSG-3G1X-5, GSG-4G1X-1, GSG-4G1X-2, GSG-4G1X-3, GSG-4G1X-4 and combinations thereof.
78. The composition of any one of paragraphs 68-77 above, wherein at least one of the one or more GSGs has a molecular weight of less than or equal to 1128 daltons, or at least one of the one or more GSGs has a molecular weight of less than or equal to 966 daltons, or at least one of the one or more GSGs has a molecular weight of less than or equal to 804 daltons, or at least one of the one or more GSGs has a molecular weight of greater than 1128 daltons, or at least one of the one or more GSGs has a molecular weight of greater than or equal to 1260 daltons, or at least one of the one or more GSGs has a molecular weight of greater than or equal to 1422 daltons, or at least one of the one or more GSGs has a molecular weight of greater than or equal to 6 daltons, or 174at least one of the one or more GSGs has a molecular weight of greater than or equal to 1922 daltons.
79. The composition of any of the above paragraphs, wherein the one or more GSGs comprise 50-70 wt% of the composition, or wherein the one or more GSGs comprise 55-65 wt% of the composition, or wherein the one or more SG comprises less than 25 wt% of the composition.
80. An orally consumable composition comprising a GSG composition of any of the above paragraphs.
81. An oral consumer product composition comprising the SG composition of any one of the above paragraphs and the GSG composition of any one of the above paragraphs.
82. The method of preparing a GSG composition of any one of the preceding paragraphs, wherein the weight ratio of glucose donor molecule to SG is from 10:90 to 90:10, from 20:80 to 80:20, from 30:70 to 70:30, or from 40:60 to 60: 40.
83. An orally consumable composition comprising the GSG composition of any one of the above paragraphs, wherein the concentration of SG composition in the orally consumable composition is from about 50ppm to about 900 ppm.
84. The composition of any preceding paragraph, wherein the non-steviol sugar or non-steviol caramel comprises from 0.001% to about 25% by weight of the composition.
85. The composition of any preceding paragraph, wherein the thaumatin comprises 0.01 to 10 wt% of the composition.
86. The composition of any preceding paragraph, wherein SG is RA 20.
87. The composition of any preceding paragraph, wherein the GSG is GSG-RA 20.
88. A composition of any of the preceding paragraphs, further comprising 0.1-2 wt% stev-bios, 0.05-1 wt% Reb-G, 0.5-2 wt% Reb-E, 0.2-2 wt% Reb-M, 0.1-2 wt% dulcoside A, 0.3-2 wt% dulcoside B, 0.2-1 wt% Reb-S, 0.05-0.5 wt% Reb-O, and 0.2-1.5 wt% Reb-R.
89. The composition of any preceding paragraph, further comprising an unreacted steviol glycoside selected from: 0.2-0.5 wt% stev-bios, 0.05-0.5 wt% Reb-G, 0.5-1.5 wt% Reb-E, 0.2-1 wt% Reb-M, 0.2-1 wt% dulcoside A, 0.5-1.5 wt% dulcoside B, 0.2-1 wt% Reb-S, 0.05-0.1 wt% Reb-O and 0.2-1 wt% Reb-R.
90. The composition of any preceding paragraph, further comprising an unreacted steviol glycoside selected from: 0.1-2 wt% stev-bios, 0.2-1 wt% Reb-G, 0.5-2 wt% Reb-E, 0.1-0.5 wt% Reb-M, 0.1-0.5 wt% dulcoside A, 1-2 wt% dulcoside B, 0.5-3 wt% Reb-S, 0.1-0.5 wt% Reb-O and 0.1-1 wt% Reb-R.
91. The composition of any one of the preceding paragraphs, wherein GSG-6G1R-1 comprises 0.2-0.8 wt% GSG-6G1R-1a and 0.3-1.7 wt% GSG-6G1R-1 b.
92. The composition of any preceding paragraph, further comprising an unreacted steviol glycoside selected from: 0.1-0.5 wt% stev-bios, 0.2-1 wt% Reb-G, 0.5-2 wt% Reb-E, 0.05-0.5 wt% Reb-M, 0.1-2 wt% dulcoside A, 0.5-2 wt% dulcoside B, 0.1-1 wt% Reb-S, 0.1-0.5 wt% Reb-O and 0.2-1.5 wt% Reb-R.
93. A composition of any of the preceding paragraphs, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-10 wt% GSG-3G-2, 1-6 wt% GSG-3G-3, 0.5-3.5 wt% GSG-3G-4, 0.2-5 wt% GSG-3G-7, and 0.5-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 3-15 wt% GSG-4G-1, 0.1-3.5 wt% GSG-4G-2, 0.1-3.5 wt% SG-4G-3, and 1-10 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1.5 wt% GSG-5G-1, 0.05-1.5 wt% GSG-5G-2, 0.1-3.5 wt% GSG-5G-3, 0.01-0.5 wt% GSG-5G-4, and 0.1-4 wt% GSG-5G-5;
(d)0.1-2.5wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.2-5.5 wt% GSG-3G1R-3a and 1-6 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-5 wt% GSG-4G1R4, and 0.3-10 wt% GSG-4G1R 6;
(g)1.5-7.5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.05-2.5 wt% GSG-6G1R-1a,0.0-2 wt% GSG-6G1R-1b and 0.1-3 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 1-8 wt% GSG-3G1X-4 and 0.5-3 wt% GSG-3G 1X-5;
(j) At least one SG-4G1X group component selected from the group consisting of 0.2-5 wt% GSG-4G1X-1, 0.5-3 wt% GSG-4G1X-2, 0.5-6 wt% GSG-4G1X-3, and 0.2-2.5 wt% GSG-4G 1X-4; and
(k)0.5-4.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
94. The composition of any preceding paragraph, further comprising at least 5, 6, 7, or 8 unreacted steviol glycosides, an ingredient selected from the group consisting of 1-15 wt% Reb-A, 0.05-3 wt% Reb-B, 0.05-4 wt% Reb-C, 0.05-1.5 wt% Reb-D, 0.05-3 wt% Reb-F, 0.05-2.5 wt% rubusoside, and 0.05-12 wt% stevioside.
While multiple embodiments are disclosed, other embodiments of the invention will be apparent to those of ordinary skill in the art from the following detailed description. As will be realized, the invention is capable of modifications in various obvious aspects, all without departing from the spirit and scope of the present invention. The detailed description is, therefore, to be regarded as illustrative in nature and not as restrictive. Further aspects and embodiments of the present application will be further described with reference to the following non-limiting examples. It will be apparent to those skilled in the art that many changes can be made in the embodiments described without departing from the scope of the application. Accordingly, the scope of the invention should not be limited to the embodiments described herein, which are limited only by the embodiments described in the claims and the equivalents of those embodiments. All percentages are by weight unless otherwise indicated.
Examples
Analysis of compositions comprising SG and/or GSG
TABLE 1
The following examples use GSG-RA20, GSG-RA30, GSG-RA40, GSG-RA50, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90, GSG-RA95, GSG- (RA50+ RC5), GSG- (RA30+ RC15), GSG- (RA40+ RB 8). GSG-RA20, GSG-RA30, GSG-RA40, GSG-RA50, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90 and GSG-RA95 use RA having ST as a raw material. Therefore, it is presumed that GSG-RA20, GSG-RA30, GSG-RA40, GSG-RA50, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90 and GSG-RA95 contain ST, ST-G1, ST-G2, ST-G3, ST-G4, ST-G5, RA, RA-G1, RA-G2, RA-G3, RA-G4 and RA-G5 as main components.
GSG-RA50 can be prepared by the following method: :
120g of cassava dextrin was dissolved in 2L of water; adding 100g of stevia extract (RA 53.1%, total SG 80.6%) to liquefied dextrin to obtain a mixture; the ratio of dextrin to stevia extract is 55: 45, a first step of; adding 5ml of CGTase to the mixture and incubating at 60 ℃ for 48 hours to glycosylate steviol glycoside having glucose molecules derived from tapioca dextrin;
after the desired ratio of GSG to residual steviol glycoside content is reached, the reaction mixture is heated to 95 ℃ for 30min to inactivate the CGTase, then filtered to remove the CGTase;
Decolorizing and spray drying the resulting solution of GSG, residual steviol glycosides and dextrin. Thus, a yield of 230g of GSG-RA50 was obtained as a white powder.
GSG-RA95, GSG-RA60, GSG-RA70, GSG-RA80, GSG-RA90, GSG-RA20, GSG- (RA50+ RC5), GSG- (RA30+ RC15) and GSG- (RA40+ RB8) can be prepared by the same method as GSG-RA50, respectively.
Evaluation of taste profile:
1. the components were mixed and then dissolved in aqueous citric acid (ph3.8) with ultrasound at room temperature and left to stand for 30 min.
2. Panel evaluation: group of 6 persons
3. The method comprises the following steps: for sweetness evaluation of each sample, the samples were tested in pairs using several sucrose solutions with a certain sweetness. The sweetness of each sample was compared to the sweetness of the sucrose solutions and the sweetness was evaluated and recorded based on whether the sweetness of the sample was similar to or judged between specific sucrose solutions. The results reported are the average of the results provided by the panel. For the evaluation of taste profile, samples were tested and scored from 0 to 5 according to increasing sugar-like, bitter, aftertaste and twisted taste profile. The results reported are the average of the results provided by the panel.
Example 1: the taste profile of the GSG-RA50 and RA97 compositions was evaluated with the aim of finding the best ratio with a preferred synergistic taste effect.
Conditions are as follows: the samples were tested in an aqueous solution with a citric acid pH of 3.8. The control was RA97 at 350ppm, corresponding to 8% SE.
Table 2: sample (I)
Table 3: results
The concentration of the solution depends on the desired sweetness. In a specific embodiment, the sweetness is set at 8%, but the sweetness may be lower or higher, depending on the desired application. Thus, the concentration may also be lower or higher, depending on the desired application.
And (4) conclusion: GSG-RA50 improved the taste profile of RA 97. Increasing the concentration of GSG-RA50 in the composition increases the sugar-like (i.e. feeling and taste similar to sucrose). However, the sweetness of the composition decreases at higher GSG-RA50 ratios.
Samples with a solids content of 350ppm (1, 2-1, 3-1, 4-1, 5-1, 6-1) were selected and tested further as in FIGS. 1-4. As can be seen from fig. 1-4, the GSG-RA50/RA97 blend between 100/250 and 150/200 achieves the best synergistic effect at 350ppm total solids, with the same sweetness as 350 ppma, while achieving the best taste profile.
Samples with about 8% SE (1, 2-2, 3-3, 4-1, 5-2, 6-3) were selected and tested further. In these samples with high and low RA97 concentrations, it was necessary to increase GSG-RA50 to achieve the desired sweetness. At lower concentrations of RA97, the same sweetness of 100% RA97 is not obtained even with a large amount of GSG-RA 50. Thus, using GSG-RA50 to maintain 8% SE with a decrease in RA97 concentration, the concentration of total solids was increased until the concentration of RA97 reached 200ppm, indicating a synergistic effect at this concentration. At low RA7 concentrations, the addition of GSG-RA50 cannot compensate for the reduced sweetness of the same amount of RA97, i.e. an additional amount of GSG-RA50 should be added. This trend was not reversed until RA97 reached 200 ppm.
Example 2: taste profiles of GSG-RA95 and RA97 compositions were evaluated to identify the optimal ratio with optimized synergistic taste effects.
Conditions are as follows: the samples were tested in an aqueous solution with a citric acid pH of 3.8. The control was RA97 at 350ppm, corresponding to 8% SE.
Table 4: sample (I)
| Sample numbering | RA97 | GSG- | Total GSG | |
| 1 | 350ppm | - | ||
| 2-1 | 300ppm | 50ppm | 12.94% | |
| 2-2 | 300ppm | 100ppm | 22.65% | |
| 2-3 | 300ppm | 150ppm | 30.20% | |
| 3-1 | 250ppm | 100ppm | 25.89% | |
| 3-2 | 250ppm | 150ppm | 33.98% | |
| 3-3 | 250ppm | 200ppm | 40.27% | |
| 4-1 | 200ppm | 150ppm | 38.83% | |
| 4-2 | 200ppm | 200ppm | 45.30% | |
| 4-3 | 200ppm | 250ppm | 50.33% | |
| 5-1 | 150ppm | 200ppm | 51.77% | |
| 5-2 | 150ppm | 250ppm | 56.63% | |
| 5-3 | 150ppm | 300ppm | 60.40% | |
| 6-1 | 100ppm | 250ppm | 64.71% | |
| 6-2 | 100ppm | 300ppm | 67.95% | |
| 6-3 | 100ppm | 350ppm | 70.47% |
Table 5: results
It was concluded that GSG-RA95 improved the taste profile of RA 7. As the ratio of GSG-RA95 increases, the overall taste profile of the composition becomes more sugar-like (i.e., sugar-like). However, the sweetness of the composition is reduced at a high proportion of GSG-RA 95.
Samples with a solids content of 350ppm (1, 2-1, 3-1, 4-1, 5-1, 6-1) were selected and further examined in FIGS. 5-8. As can be seen from figures 5-8, GSG-RA95/RA97 proportioned between 100/250 and 150/200 achieved the best synergistic effect of 350ppm total solids, had the same sweetness as 350ppm RA97, and achieved the best taste profile.
Samples with about 8% SE (1, 2-2, 3-3, 4-1, 5-2, 6-3) were selected and tested further. In these samples of high and low RA97 concentrations, it was necessary to increase GSG-RA95 to achieve the desired sweetness. At lower RA7 concentrations, the same sweetness of 100% RA97 cannot be achieved even with large amounts of GSG-RA 95. Thus, using GSG-RA95 with a reduced concentration of RA97, to maintain the reduced 8% SE, the concentration of total solids was increased until the concentration of RA97 reached 250ppm, and the effect was maintained until the concentration of RA97 reached 200ppm, indicating a synergistic effect at these concentrations.
Example 3: the taste profile of the GSG-RA50, GSG-RA95 and RA97 compositions was evaluated with the aim of finding the best ratio with an optimized synergistic taste effect.
Conditions are as follows: the samples were tested in an aqueous solution with a citric acid pH of 3.8. The control was RA97 at 350ppm, corresponding to 8% SE.
Table 6: sample (I)
| Sample numbering | RA97 | GSG-RA50 | GSG- | Total GSG | |
| 1 | 350 | - | - | ||
| 2 | 200 | 25 | 175 | 45.22% | |
| 3 | 200 | 50 | 150 | 45.14% | |
| 4 | 200 | 75 | 125 | 45.07% | |
| 5 | 200 | 100 | 100 | 44.99% | |
| 6 | 200 | 125 | 75 | 44.91% | |
| 7 | 200 | 150 | 50 | 44.83% | |
| 8 | 200 | 175 | 25 | 44.75% |
Table 7: results
And (4) conclusion: at all ratios, the blend of GSG-RA50 and GSG-RA95 improved the taste profile of RA 97. The improvement was more pronounced at ratios of 50/150 and 75/125 of GSG-RA50/GSG-RA95, where the taste profile was more sugar-like.
Example 4: the taste profile of GSG-RA95 and steviol glycosides comprising RD (RA/RD) compositions was evaluated to find the optimal ratio of the preferred synergistic taste effect.
Raw materials: RA/RD (RA 93.96%, RD 4.54%)
TABLE 8 samples
Table 9 results
And (4) conclusion: GSG-RA95 improves bitterness and aftertaste with a wide effective range of RA/RD. Compared with RA97, RA/RD has wider synergistic range with GSG-RA 95.
Example 5: the taste profile of GSG-RA50 and steviol glycosides comprising RD (RA/RD) compositions was evaluated to find the optimal ratio of the preferred synergistic taste effect.
Raw materials: RA/RD (RA 93.96%, RD 4.54%)
TABLE 10 samples
| Sample numbering | (RA/RD) | GSG- | Total GSG | |
| 1 | 350ppm | - | ||
| 2-1 | 200ppm | 150ppm | 38.29% | |
| 2-2 | 200ppm | 200ppm | 44.68% | |
| 2-3 | 200ppm | 250ppm | 49.64% | |
| 3-1 | 150ppm | 200ppm | 51.06% | |
| 3-2 | 150ppm | 250ppm | 55.84% | |
| 3-3 | 150ppm | 300ppm | 59.57% |
Table 11 results
GSG-RA50 improves the bitterness and aftertaste of RA/RD. As for the synergistic effect of sweetness, GSG-RA50 is not as good as GSG-RA95 because of the narrow synergistic range of GSG-RA 50.
Example 6: effect of GSG-RA50 on the taste profile of steviol glycosides.
GSG-RA50 was mixed with various SGs at a ratio of 1:1 and the taste profile of the mixture in water (500ppm) was tested.
TABLE 12 RA50
As shown in table 13, GSG-RA50 improved the taste profile of RA 50.
TABLE 13 RA95
GSG-RA50 improved the bitter and metallic aftertaste of RA95, but did not significantly alter sweetness.
TABLE 14 RA97
GSG-RA50 improved the bitter and metallic aftertaste of RA97, but did not significantly alter sweetness.
TABLE 15 RA98
GSG-RA50 improved the bitter and metallic aftertaste of RA98, but did not significantly alter sweetness.
TABLE 16 RA99.5
GSG-RA50 improved the bitter and metallic aftertaste of RA99.5, but did not significantly alter sweetness.
TABLE 17 RA/RD
GSG-RA50 has no effect on the taste profile of RA/RD, but GSG-RA50 is cheaper than RD, thus reducing costs.
TABLE 18 control samples
Example 7: sweetness of the combination of GSG-RA50 and RA 97.
The sweetness of the GSG-RA50 and RA97 compositions at different concentrations was determined from the sweetness profile (fig. 9), and the combined sweetness of each of the GSG-RA50 and RA97 compositions was calculated and compared to the test values in table 19.
Watch 19
And (4) conclusion: the sweetness of the GSG-RA50 and RA97 compositions benefits from a synergistic effect that first appears when the concentration of GSG-RA50 reaches 100 ppm.
Example 8: the sweetness of the 350ppm GSG-RA50 and RA97 composition is shown in table 20.
Calculated SE (ppm sucrose) per ppm of GSG-RA 50-calculated SE/GSG-RA50 concentration of GSG-RA 50. The sweetness per ppm of GSG-RA50 measured (ppm sucrose) ═ concentration of GSG-RA50 (SE measured SE-calculated RA 97).
And (4) conclusion: at 350ppm solids, increasing the content of GSG-RA50 resulted in a measured sweetness value higher than the calculated value (figure 10). Although the optimal range is 100-150ppm, a positive synergistic sweetness effect is found when GSG-RA50>100 ppm.
Example 9: the sweetness of the 400ppm GSG-RA50 and RA97 composition is shown in table 21.
TABLE 21
Calculated SE (ppm sucrose) per ppm of GSG-RA 50-calculated SE/GSG-RA50 concentration of GSG-RA 50. The sweetness per ppm of GSG-RA50 measured (ppm sucrose) ═ concentration of GSG-RA50 (SE measured SE-calculated RA 97).
And (4) conclusion: at 400ppm solids, the level of GSG-RA50 was increased so that the sweetness measurement was higher than the calculated value (figure 11). When GSG-RA50>100ppm, a positive synergistic sweetness effect was found.
Example 10: the sweetness of the combination of GSG-RA50 and RA97 at 450ppm is shown in table 22.
TABLE 22
Calculated SE (ppm sucrose) per ppm of GSG-RA 50-calculated SE/GSG-RA50 concentration of GSG-RA 50. The sweetness per ppm of GSG-RA50 measured (ppm sucrose) ═ concentration of GSG-RA50 (SE measured SE-calculated RA 97).
And (4) conclusion: at 450ppm solids, increasing the content of GSG-RA50 resulted in a measured sweetness value higher than the calculated value (figure 12). Although the optimal range is 200-250ppm, a positive synergistic sweetness effect is found when GSG-RA50>150 ppm.
Example 11: sweetness of the combination of GSG-RA95 and RA 97.
The sweetness of the GSG-RA95 and RA (97% pure RA) compositions at different concentrations was determined from the sweetness profile (fig. 13), and the combined sweetness of each of the compositions of GSG-RA95 and RA97 was calculated and compared to the test values in table 23.
TABLE 23
And (4) conclusion: the sweetness of the GSG-RA95 and RA97 compositions benefits from a synergistic effect that first appears when the concentration of GSG-RA95 reaches 100 ppm.
Example 12: the sweetness of the 350ppm GSG-RA95 and RA97 composition is shown in table 24.
Watch 24
Calculated SE (ppm sucrose) per ppm of GSG-RA 95-calculated SE/GSG-RA95 concentration of GSG-RA 95. The sweetness per ppm of GSG-RA95 measured (ppm sucrose) ═ concentration of GSG-RA50 (SE measured SE-calculated RA 97).
And (4) conclusion: at 350ppm solids, increasing the content of GSG-RA95 resulted in a measured sweetness value higher than the calculated value (figure 14). When GSG-RA95 is >100ppm, a positive synergistic sweetness effect is found, with the optimal range being 100-150 ppm.
Example 13: the sweetness of the 400ppm GSG-RA95 and RA97 composition is shown in table 25.
TABLE 25
Calculated SE (ppm sucrose) per ppm of GSG-RA 95-calculated SE/GSG-RA95 concentration of GSG-RA 95. The sweetness per ppm of GSG-RA95 measured (ppm sucrose) ═ concentration of GSG-RA95 (SE measured SE-calculated RA 97).
And (4) conclusion: at 400ppm solids, increasing the content of GSG-RA95 resulted in a measured sweetness value higher than the calculated value (figure 15). When GSG-RA95>150ppm, a positive synergistic sweetness effect was found and the optimized range was 150-200 ppm.
Example 14: the sweetness of the 450ppm GSG-RA95 and RA97 composition is shown in table 26.
Watch 26
Calculated SE (ppm sucrose) per ppm of GSG-RA 95-calculated SE/GSG-RA95 concentration of GSG-RA 95. The sweetness per ppm of GSG-RA95 measured (ppm sucrose) ═ concentration of GSG-RA95 (SE measured SE-calculated RA 97).
And (4) conclusion: at 450ppm solids, increasing the content of GSG-RA95 resulted in a measured sweetness value higher than the calculated value (figure 16). When GSG-RA95>200ppm, a positive synergistic sweetness effect was found, with the optimal range being 200-250 ppm.
Example 15: a combination of steviol glycosides and GSG-RA 50.
Watch 27
For the compositions of RA and GSG-RA50, the solubility may be improved by the treatment according to the invention. For the combination of RA, RC, or RD and GSG-RA50, solubility is improved by treatment according to the invention only at higher GSG-RA50 to SG ratios.
Example 16: HPLC-MS experiment
HPLC-System: agilent 1100 (quad pump, autosampler, column oven, UV/VIS-detector, coupled with Agilent EIS MS (G1956A) at 350 deg.C, 12L/min N2, lysis voltage: 150, positive scan mode.
Mobile phase: acetonitrile/0.01% acetic acid 95/5(0min) to 80/20(20min) (linear gradient) was maintained for an additional 20min and returned to source conditions.
A chromatographic column: Supelcosil-LC-NH2, 250X 4.6mm, 5 μm
Flow rate: 1mL/min
Temperature: 35 deg.C
Sample introduction volume: 0.015mL
GSG-RA50 (FIG. 17) was characterized by HPLC-MS, with the ratios of GSGS as shown in Table 28.
Watch 28
GSG-RA95 (FIG. 18) was characterized by HPLC-MS, with the ratios of GSGS as shown in Table 29.
Watch 29
GSG-RA95 (FIG. 19) was characterized by HPLC-MS, with the ratios of GSG as shown in Table 30.
Example 17 HPLC-MS experiment
HPLC-System: agilent 1100/1200
Mobile phase:
| Time of day | Solvent A | Solvent B | Flow rate of flow | Pressure of |
| 0.00 | 72.2 | 27.8 | 1.000 | 300 |
| 8.00 | 55.6 | 44.4 | 1.000 | 300 |
| 12.00 | 55.6 | 44.4 | 1.000 | 300 |
| 18.00 | 62.2 | 37.8 | 1.000 | 300 |
| 20.00 | 72.2 | 27.8 | 1.000 | 300 |
0.01M ammonium acetate, 0.1% acetic acid and 0.01% trimethylamine, saturated with dichloromethane
Solvent B90% acetonitrile/10% water with 0.1% acetic acid and 0.01% trimethylamine and 0.1% dichloromethane
Sample introduction volume of 30.00 mu l
Detector including diode array detector and UV
Wavelength: 210nm
Temperature setting: at 45 ℃. Flow rate: 1mL/min
MS: agilent G1956A
Ionization mode: API-ES
Scanning parameters
Gas temperature: 300 ℃ of 350 ℃ at maximum
Drying gas: 11.0l/min maximum 13.0l/min
Atomization pressure (Neb Pres) 29psig and maximum 60psig
Fourth-stage temperature: 0 ℃ max 0 DEG C
VCap (Positive electrode) 3000V
VCap (negative electrode) 4000V
GSG-RA20 (fig. 20) was characterized by HPLC-MS, with the ratio of GSG as shown in table 31.
Watch 31
GSG-RA40 (FIG. 21) was characterized by HPLC-MS, with the ratios of GSG as shown in Table 32.
Watch 32
GSG-RA85 (FIG. 22) was characterized by HPLC-MS, with the ratios of GSG as shown in Table 33A.
TABLE 33A
GSG-RA90 (FIG. 23) was characterized by HPLC-MS, with the ratios of GSG as shown in Table 33B.
TABLE 33B
Example 18: synergistic effects of GSG-RA50 and RA97
Sweetness profiles were plotted for the GSG-RA50 and RA97 compositions (fig. 24), taking a taste profile of the sample at 200ppm total solids as shown in table 34.
Watch 34
Calculated sweetness per ppm of GSG-RA50 (ppm sugar) ═ calculated SE/GSG-RA50 concentration of GSG-RA 50. The sweetness per ppm of GSG-RA50 measured (ppm sucrose) ═ concentration of GSG-RA50 (SE measured SE-calculated RA 97).
And (4) conclusion: as shown in fig. 25, at 200ppm solids, increasing the content of GSG-RA50 resulted in a higher measured sweetness value than the calculated value. When GSG-RA50>50ppm, a positive synergistic sweetness effect was found.
Samples with a total solids content of 350ppm are shown in Table 35. Samples 2-1 and 2-2 both had higher concentrations of glucose and salts than samples 1-1 and 1-2, and the difference between these samples was large. For samples 3-1 and 3-2, the concentration of RB in the product was high, reducing the overall sweetness. The difference between the samples was not large.
Watch 35
And (4) conclusion: as shown in fig. 26, at 350ppm solids, increasing the content of GSG-RA50 resulted in a higher measured sweetness value than the calculated value. When GSG-RA50 is 100ppm or more, a positive synergistic sweetness effect is found, and the optimum range is 100-150 ppm.
Samples with a total solids content of 400ppm are shown in Table 36.
Watch 36
And (4) conclusion: as shown in fig. 27, at 400ppm solids, increasing the content of GSG-RA50 resulted in a higher measured sweetness value than the calculated value. When GSG-RA50 is greater than or equal to 100ppm, a positive synergistic sweetness effect is found.
Samples with a total solids content of 450ppm are shown in Table 37.
Watch 37
And (4) conclusion: as shown in fig. 28, at 450ppm solids, increasing the content of GSG-RA50 resulted in a higher measured sweetness value than the calculated value. When GSG-RA50 is 150ppm or more, a positive synergistic sweetness effect is found.
Samples with a total solids content of 500ppm are shown in Table 38.
Watch 38
And (4) conclusion: as shown in fig. 29, at 500ppm solids, increasing the content of GSG-RA50 resulted in a higher measured sweetness value than the calculated value. When GSG-RA50 is greater than or equal to 200ppm, a positive synergistic sweetness effect is found.
Example 19: synergistic effects of GSG-RA60 and RA97
Sweetness profiles were plotted for the GSG-RA60 and RA97 compositions (fig. 30), taking a taste profile for the sample at 350ppm total solids as shown in table 39.
Watch 39
Calculated sweetness per ppm of GSG-RA60 (ppm sugar) ═ calculated SE/GSG-RA60 concentration of GSG-RA 60. The sweetness per ppm of GSG-RA60 measured (ppm sucrose) ═ concentration of GSG-RA60 (SE measured SE-calculated RA 97).
And (4) conclusion: as shown in figure 31, increasing the level of GSG-RA60 resulted in a sustained increase in sweetness measurements at 350ppm solids. When the concentration of GSG-RA60 was greater than 150ppm, the measured value of sweetness was higher than the calculated value. A positive synergistic sweetness effect was found when the concentration of GSG-RA60 was 150-300 ppm.
Example 20: synergistic effects of GSG-RA70 and RA97
Sweetness profiles were plotted for the GSG-RA70 and RA97 compositions (fig. 32), taking a taste profile for the sample at 350ppm total solids as shown in table 40.
Calculated sweetness per ppm of GSG-RA70 (ppm sugar) ═ calculated SE/GSG-RA70 concentration of GSG-RA 70. The sweetness per ppm of GSG-RA70 measured (ppm sucrose) ═ concentration of GSG-RA70 (SE measured SE-calculated RA 97).
And (4) conclusion: as shown in figure 33, increasing the level of GSG-RA70 resulted in a sustained increase in sweetness measurements at 350ppm solids. When the concentration of GSG-RA70 was greater than 150ppm, the sweetness value measured was higher than the calculated value. A positive synergistic sweetness effect was found when the concentration of GSG-RA70 was 150-200 ppm.
Example 21: synergistic effects of GSG-RA80 and RA97
Sweetness profiles were plotted for the GSG-RA80 and RA97 compositions (fig. 34), taking a taste profile for the sample at 350ppm total solids as shown in table 41.
Table 41
At a total solids content of 350ppm, synergistic effects were found in the range of 200-250ppm RA97 and 100-150ppm GSG-RA 80.
The sweetness at each concentration of GSG-RA80 or RA97 was read out from the sweetness profile and the combined sweetness of each composition of GSG-RA80 and RA97 was calculated and compared to the measured values, as shown in table 42.
Watch 42
Calculated sweetness per ppm of GSG-RA80 (ppm sucrose) ═ calculated SE/GSG-RA80 concentration of GSG-RA 80. The sweetness per ppm of GSG-RA80 measured (ppm sucrose) ═ concentration of GSG-RA80 (SE measured SE-calculated RA 97).
And (4) conclusion: as shown in figure 35, increasing the level of GSG-RA80 resulted in a sustained increase in sweetness measurements at 350ppm solids. When the concentration of GSG-RA80 was greater than 100ppm, the measured value of sweetness was higher than the calculated value. When the concentration of GSG-RA80 is greater than 100ppm, a positive synergistic sweetness effect is found.
Example 22: synergistic effects of GSG-RA90 and RA97
Sweetness profiles were plotted for the GSG-RA90 and RA97 compositions (fig. 36), taking a taste profile for the sample at 350ppm total solids as shown in table 43.
Watch 43
Calculated sweetness per ppm of GSG-RA90 (ppm sugar) ═ calculated SE/GSG-RA90 concentration of GSG-RA 90. The sweetness per ppm of GSG-RA90 measured (ppm sucrose) ═ concentration of GSG-RA90 (SE measured SE-calculated RA 97).
And (4) conclusion: as shown in figure 37, increasing the level of GSG-RA90 resulted in a sustained increase in sweetness measurements at 350ppm solids. When the concentration of GSG-RA90 was greater than 150ppm, the measured value of sweetness was higher than the calculated value. A positive synergistic sweetness effect was found when the concentration of GSG-RA90 was 150-200 ppm.
Example 23: synergistic effects of GSG-RA95 and RA97
Sweetness profiles were plotted for the GSG-RA95 and RA97 compositions (fig. 38), taking a taste profile of the sample at 200ppm total solids as shown in table 44.
Watch 44
Calculated sweetness per ppm of GSG-RA95 (ppm sugar) ═ calculated SE/GSG-RA95 concentration of GSG-RA 95. The sweetness per ppm of GSG-RA95 measured (ppm sugar) ═ concentration of GSG-RA95 (SE measured SE-calculated RA 97).
And (4) conclusion: as shown in fig. 39, at 200ppm solids, increasing the content of GSG-RA95 resulted in a higher measured sweetness value than the calculated value. When GSG-RA95>100ppm, a positive synergistic sweetness effect was found.
Samples with a total solids content of 350ppm are shown in Table 45.
TABLE 45
And (4) conclusion: as shown in fig. 40, at 350ppm solids, increasing the content of GSG-RA95 resulted in a higher measured sweetness value than the calculated value. A positive synergistic sweetness effect was found when GSG-RA95>150ppm, especially >200 ppm.
Samples with a total solids content of 400ppm are shown in Table 46.
TABLE 46
And (4) conclusion: as shown in fig. 41, at 400ppm solids, increasing the content of GSG-RA95 resulted in a higher measured sweetness value than the calculated value. When GSG-RA95>150ppm, a positive synergistic sweetness effect was found, with the optimal range being 150-200 ppm.
Samples with a total solids content of 450ppm are shown in Table 47.
Watch 47
And (4) conclusion: as shown in fig. 42, at 450ppm solids, increasing the content of GSG-RA50 resulted in a higher measured sweetness value than the calculated value. When GSG-RA50>200ppm, a positive synergistic sweetness effect was found, with the optimal range being about 250 ppm.
Samples with a total solids content of 500ppm are shown in Table 48.
Watch 48
And (4) conclusion: as shown in fig. 43, at 500ppm solids, increasing the content of GSG-RA95 resulted in a higher measured sweetness value than the calculated value. When GSG-RA95>200ppm, a positive synergistic sweetness effect was found.
Example 24: taste profiles of RA50/RC5 and GSG-RC5 were evaluated to find the taste improving effect of glycosylation on RA50/RC 5.
Conditions are as follows: the samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
watch 49
| RA50/RC5 | GSG-(RA50+RC5) |
| 500ppm | - |
| - | 1000ppm |
The concentration of GSG- (RA50+ RC5) is twice that of RA50/RC5, so that the sweetness is similar.
TABLE 50 results
Glycosylation can significantly improve the taste profile of RA50/RC 5.
Example 25: taste profiles of RA30/RC15 and GSG- (RA50+ RC5) were evaluated to find the taste improving effect of glycosylation on RA30/RC 15.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
Watch 51
| RA30/RC15 | GSG-(RA30+RC15) |
| 500ppm | - |
| - | 1000ppm |
The concentration of GSG- (RA30+ RC15) is twice that of RA30/RC15, so that the sweetness is similar.
Table 52 results
Glycosylation can significantly improve the taste profile of RA30/RC 15.
Example 26: taste profiles of RA40/RB8 and GSG- (RA40+ RB8) were evaluated to find a taste-improving effect of glycosylation on RA40/RB 8.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
watch 53
| RA40/RB8 | GSG-(RA40+RB8) |
| 500ppm | - |
| - | 1000ppm |
The concentration of GSG- (RA40+ RB8) is twice that of RA40/RB8, so that the sweetness is similar.
Table 54: results
Glycosylation can significantly improve the taste profile of RA40/RB 8.
Example 27: the taste profile of GSG- (RA50+ RC5) and RA97 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA97, corresponding to 8.3% SE.
The samples were as follows:
watch 55
| RA97 | GSG-(RA50+RC5) |
| 400ppm | - |
| 300ppm | 100ppm |
| 250ppm | 150ppm |
| 200ppm | 200ppm |
| 150ppm | 250ppm |
| 100ppm | 300ppm |
The sweetness profiles of GSG- (RA50+ RC5) and RA97 are shown in fig. 44.
The taste profile of the RA97/GSG- (RA50+ RC5) composition is shown in Table 56:
watch 56
GSG- (RA50+ RC5) improves the taste of RA97, especially at a ratio of 3:1 to 1: 1.
Watch 57
Calculated sweetness per ppm of GSG- (RA50+ RC5) (ppm sugar) ═ calculated concentration of SE/GSG-RC5 of GSG- (RA50+ RC 5).
The sweetness (ppm sugars) per ppm of GSG- (RA50+ RC5) measured (SE of measured SE-calculated RA 97)/concentration of GSG- (RA50+ RC 5).
The data are shown in FIG. 45.
It can be seen that: at 400ppm total solids, the sweetness measurements were higher than calculated with increasing GSG- (RA50+ RC5) content. Although the optimal range is 150-200ppm, significant synergy is found when GSG- (RA50+ RC5) >150 ppm.
Example 28: the taste profile of GSG- (RA30+ RC15) and RA97 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA97, corresponding to 8.3% SE.
The samples were as follows:
watch 58
The sweetness profiles of GSG- (RA30+ RC15) and RA97 are shown in figure 46.
The taste profile of the RA97/GSG- (RA30+ RC15) composition is shown in Table 59:
watch 59
GSG- (RA30+ RC15) improves the taste of RA 97.
As for the synergistic effect, it can be seen from table 60.
Calculated sweetness per ppm of GSG- (RA30+ RC15) (ppm sugar) ═ calculated concentration of SE/GSG- (RA30+ RC15) of GSG- (RA30+ RC 15).
The sweetness (ppm sugars) per ppm of GSG- (RA30+ RC15) measured (SE of measured SE-calculated RA 97)/concentration of GSG- (RA30+ RC 15).
The data are shown in FIG. 47.
It can be seen that: at 400ppm total solids, the sweetness measurements were higher than calculated as the content of GSG- (RA30+ RC15) increased. Although the optimal range is 100-150ppm, significant synergy is found when GSG- (RA30+ RC15) >100 ppm.
Example 29: the taste profile of GSG- (RA40+ RB8) and RA97 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA97, corresponding to 8.3% SE.
The samples were as follows:
watch 61
| RA97 | GSG-(RA40+RB8) |
| 400ppm | - |
| 300ppm | 100ppm |
| 250ppm | 150ppm |
| 200ppm | 200ppm |
| 150ppm | 250ppm |
| 100ppm | 300ppm |
The sweetness profiles of GSG- (RA40+ RB8) and RA97 are shown in fig. 48.
The taste profile of the RA97/GSG- (RA40+ RB8) composition is shown in Table 62:
watch 62
GSG- (RA40+ RB8) improves the taste of RA 97.
As for the synergistic effect, it can be seen from table 63.
Table 63
Calculated sweetness per ppm of GSG- (RA40+ RB8) (ppm sugar) ═ calculated SE/GSG- (RA40+ RB8) concentration of GSG- (RA40+ RB 8).
The sweetness (ppm sugars) per ppm of GSG- (RA40+ RB8) measured (SE of measured SE-calculated RA 97)/concentration of GSG- (RA40+ RB 8).
The data are shown in FIG. 49.
It can be seen that: at 400ppm total solids, the sweetness measurements were higher than calculated as the content of GSG- (RA40+ RB8) increased. Although the optimal range is 200-300ppm, significant synergy is found when GSG- (RA40+ RB8) >150 ppm.
Example 30: taste profiles of GSG-RA20 and RA/RB/RD compositions were evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA/RB/RD, corresponding to 8.3% SE.
The samples were as follows:
table 64
| RA/RB/RD compositions | GSG-RA20 |
| 400ppm | - |
| 300ppm | 100ppm |
| 250ppm | 150ppm |
| 200ppm | 200ppm |
| 150ppm | 250ppm |
| 100ppm | 300ppm |
The sweetness profile of the GSG-RA20 and RA/RB/RD combination is shown in FIG. 50.
The taste profile of the RA/RB/RD/GSG-RA20 compositions is shown in Table 65.
Table 65
As for the synergistic effect, it can be seen from table 66.
TABLE 66
Calculated sweetness per ppm of GSG-RA20 (ppm sugar) ═ calculated SE/GSG-RA20 concentration of GSG-RA 20.
The sweetness per ppm of GSG-RA20 measured (ppm sugar) is (SE of measured SE-calculated RA-B-D)/concentration of GSG-RA 20.
The data are shown in FIG. 51.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA20 content increased. Although the optimal range is 150-200ppm, significant synergy is found when GSG-RA20>100 ppm.
Example 31: the taste profile of the GSG-RA95 and RA75/RB15 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA75/RB15, corresponding to 7.0% SE.
The samples were as follows:
watch 67
| RA75/RB15 | GSG-RA95 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.65% |
| 250ppm | 150ppm | 33.98% |
| 200ppm | 200ppm | 45.30% |
| 150ppm | 250ppm | 56.63% |
| 100ppm | 300ppm | 67.95% |
The sweetness profiles of GSG-RA95 and RA75/RB15 are shown in FIG. 52.
Taste profiles of the RA75/RB15/GSG-RA95 compositions are shown in Table 68.
Table 68
Although the taste of RA75/RB15 was good enough by itself, GSG-RA95 improved the taste of RA75/RB 15.
As for the synergistic effect, it can be seen from table 69.
Watch 69
Calculated sweetness per ppm of GSG-RA95 (ppm sugar) ═ calculated SE/GSG-RA95 concentration of GSG-RA 95.
The sweetness (ppm sugar) per ppm of GSG-RA95 measured (SE-calculated RA75/RB15 measured)/concentration of GSG-RA 95.
The data are shown in FIG. 53.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA95 content increased. Although the optimal range is 150-200ppm, significant synergy is found when GSG-RA95>150 ppm.
Example 32: taste profiles of GSG-RA95 and RA/RD compositions were evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA/RD, corresponding to 6.5% SE.
The samples were as follows:
Watch 70
| RA/RD | GSG-RA95 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.65% |
| 250ppm | 150ppm | 33.98% |
| 200ppm | 200ppm | 45.30% |
| 150ppm | 250ppm | 56.63% |
| 100ppm | 300ppm | 67.95% |
The sweetness profiles of GSG-RA95 and RA/RD are shown in FIG. 54.
The taste profile of the RA/RD/GSG-RA95 compositions is shown in Table 71.
Watch 71
GSG-RA95 improves the taste of RA/RD by reducing bitterness and entanglement.
As for the synergistic effect, it can be seen from table 72.
Watch 72
Calculated sweetness per ppm of GSG-RA95 (ppm sugar) ═ calculated SE/GSG-RA95 concentration of GSG-RA 95.
The sweetness per ppm of GSG-RA95 measured (ppm sugar) is (SE of measured SE-calculated RA/RD)/concentration of GSG-RA 95.
The data are shown in FIG. 55.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA95 content increased. Although the optimal range is 100-250ppm, significant synergy was found when GSG-RA95>100 ppm.
Example 33: the taste profile of the GSG-RA95 and RA80/RB10/RD6 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA80/RB10/RD6, corresponding to 8.3% SE.
The samples were as follows:
TABLE 73
| RA80/RB10/RD6 | GSG-RA95 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.65% |
| 250ppm | 150ppm | 33.98% |
| 200ppm | 200ppm | 45.30% |
| 150ppm | 250ppm | 56.63% |
| 100ppm | 300ppm | 67.95% |
The sweetness profiles of GSG-RA95 and RA80/RB10/RD6 are shown in FIG. 56.
Taste profiles of the RA80/RB10/RD6/GSG-RA95 compositions are shown in Table 74.
Table 74
As for the synergistic effect, it can be seen from table 75.
TABLE 75
Calculated sweetness per ppm of GSG-RA95 (ppm sugar) ═ calculated SE/GSG-RA95 concentration of GSG-RA 95.
The sweetness (ppm sugar) per ppm of GSG-RA95 measured (SE-calculated concentration of RA80/RB10/RD6 measured)/concentration of GSG-RA 95.
The data are shown in FIG. 57.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA95 content increased. Although the optimum range is 200-250ppm, a significant synergistic effect was found when GSG-RA95>150 ppm.
Example 34: the taste profile of the GSG-RA80 and RA75/RB15 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA75/RB15, corresponding to 7.0% SE.
The samples were as follows:
watch 76
| RA75/RB15 | GSG-RA80 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.25% |
| 250ppm | 150ppm | 33.38% |
| 200ppm | 200ppm | 44.50% |
| 150ppm | 250ppm | 55.63% |
| 100ppm | 300ppm | 66.75% |
The sweetness profiles of GSG-RA80 and RA75/RB15 are shown in FIG. 58.
Taste profile of the RA75/RB15/GSG-RA80 composition is shown in Table 77.
Watch 77
As for the synergistic effect, it can be seen from table 78.
Watch 78
Calculated sweetness per ppm of GSG-RA80 (ppm sugar) ═ calculated SE/GSG-RA80 concentration of GSG-RA 80.
The sweetness (ppm sugar) per ppm of GSG-RA80 measured (SE-calculated RA75/RB15 measured)/concentration of GSG-RA 80.
The data are shown in FIG. 59.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA80 content increased. Although the optimal range is 150-250ppm, significant synergy is found when GSG-RA80>150 ppm.
Example 35: taste profiles of GSG-RA80 and RA/RD compositions were evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA/RD, corresponding to 6.5% SE.
The samples were as follows:
TABLE 79
| RA/RD | GSG-RA80 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.25% |
| 250ppm | 150ppm | 33.38% |
| 200ppm | 200ppm | 44.50% |
| 150ppm | 250ppm | 55.63% |
| 100ppm | 300ppm | 66.75% |
The sweetness profiles of GSG-RA80 and RA/RD are shown in FIG. 60.
The taste profile of the RA/RD/GSG-RA80 composition is shown in Table 80.
GSG-RA80 improves the taste of RA/RD by reducing bitterness and entanglement.
As for the synergistic effect, it can be seen from table 81.
Watch 81
Calculated sweetness per ppm of GSG-RA80 (ppm sugar) ═ calculated SE/GSG-RA80 concentration of GSG-RA 80.
The sweetness per ppm of GSG-RA80 measured (ppm sugar) is (SE of measured SE-calculated RA/RD)/concentration of GSG-RA 80.
The data are shown in FIG. 61.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA80 content increased. Although the optimal range is 100-150ppm, significant synergy was found when GSG-RA80 was 100-200 ppm.
Example 36: the taste profile of the GSG-RA80 and RA80/RB10/RD6 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA80/RB10/RD6, corresponding to 8.3% SE.
The samples were as follows:
table 82
| RA80/RB10/RD6 | GSG-RA80 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.25% |
| 250ppm | 150ppm | 33.38% |
| 200ppm | 200ppm | 44.50% |
| 150ppm | 250ppm | 55.63% |
| 100ppm | 300ppm | 66.75% |
The sweetness profiles of GSG-RA80 and RA80/RB10/RD6 are shown in FIG. 62.
Taste profiles of the RA80/RB10/RD6/GSG-RA80 compositions are shown in Table 83.
Watch 83
As for the synergistic effect, it can be seen from table 84.
Watch 84
Calculated sweetness per ppm of GSG-RA80 (ppm sugar) ═ calculated SE/GSG-RA80 concentration of GSG-RA 80.
The sweetness (ppm sugar) per ppm of GSG-RA80 measured (SE-calculated concentration of RA80/RB10/RD6 measured)/concentration of GSG-RA 80.
The data are shown in FIG. 63.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA80 content increased. Although the optimal range is 250-300ppm, significant synergy is found when GSG-RA80>150 ppm.
Example 37: the taste profile of the GSG-RA50 and RA75/RB15 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA75/RB15, corresponding to 7.0% SE.
The samples were as follows:
watch 85
| RA75/RB15 | GSG-RA50 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.34% |
| 250ppm | 150ppm | 33.51% |
| 200ppm | 200ppm | 44.68% |
| 150ppm | 250ppm | 55.84% |
| 100ppm | 300ppm | 67.01% |
The sweetness profiles of GSG-RA50 and RA75/RB15 are shown in FIG. 64.
Taste profile of the RA75/RB15/GSG-RA50 compositions is shown in Table 86.
Watch 86
As for the synergistic effect, it can be seen from table 87.
Watch 87
Calculated sweetness per ppm of GSG-RA50 (ppm sugar) ═ calculated SE/GSG-RA50 concentration of GSG-RA 50.
The sweetness (ppm sugar) per ppm of GSG-RA50 measured (SE-calculated RA75/RB15 measured)/concentration of GSG-RA 50.
The data are shown in FIG. 65.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA50 content increased. Although the optimal range is 100-200ppm, significant synergy is found when GSG-RA50>100 ppm.
Example 38: taste profiles of GSG-RA50 and RA/RD compositions were evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA/RD, corresponding to 6.5% SE.
The samples were as follows:
watch 88
| RA/RD | GSG-RA50 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.34% |
| 250ppm | 150ppm | 33.51% |
| 200ppm | 200ppm | 44.68% |
| 150ppm | 250ppm | 55.84% |
| 100ppm | 300ppm | 67.01% |
The sweetness profiles of GSG-RA50 and RA/RD are shown in FIG. 66.
The taste profile of the RA/RD/GSG-RA50 composition is shown in Table 89.
GSG-RA50 improves the taste of RA/RD by reducing bitterness and entanglement.
As for the synergistic effect, it can be seen from table 90.
Watch 90
Calculated sweetness per ppm of GSG-RA50 (ppm sugar) ═ calculated SE/GSG-RA50 concentration of GSG-RA 50.
The sweetness per ppm of GSG-RA50 measured (ppm sugar) is (SE of measured SE-calculated RA/RD)/concentration of GSG-RA 50.
The data are shown in FIG. 67.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA50 content increased. Although the optimal range is 100-200ppm, significant synergy is found when GSG-RA50>100 ppm.
Example 39: the taste profile of the GSG-RA50 and RA80/RB10/RD6 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA80/RB10/RD6, corresponding to 8.3% SE.
The samples were as follows:
watch 91
| RA80/RB10/RD6 | GSG-RA50 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 22.34% |
| 250ppm | 150ppm | 33.51% |
| 200ppm | 200ppm | 44.68% |
| 150ppm | 250ppm | 55.84% |
| 100ppm | 300ppm | 67.01% |
The sweetness profile of the GSG-RA50 and RA80/RB10/RD6 compositions is shown in FIG. 68.
Taste profiles of the RA80/RB10/RD6/GSG-RA50 compositions are shown in Table 92.
As for the synergistic effect, it can be seen from table 93.
Watch 93
Calculated sweetness per ppm of GSG-RA50 (ppm sugar) ═ calculated SE/GSG-RA50 concentration of GSG-RA 50.
The sweetness (ppm sugar) per ppm of GSG-RA50 measured (SE-calculated concentration of RA80/RB10/RD6 measured)/concentration of GSG-RA 50.
The data are shown in FIG. 69.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA50 content increased. Although the optimal range is 150-200ppm, significant synergy is found when GSG-RA50>150 ppm.
Example 40: the taste profile of the GSG-RA40 and RA75/RB15 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA75/RB15, corresponding to 7.0% SE.
The samples were as follows:
table 94
| RA75/RB15 | GSG-RA40 |
| 400ppm | - |
| 300ppm | 100ppm |
| 250ppm | 150ppm |
| 200ppm | 200ppm |
| 150ppm | 250ppm |
| 100ppm | 300ppm |
The sweetness profiles of GSG-RA40 and RA75/RB15 are shown in FIG. 70.
The taste profile of the RA75/RB15/GSG-RA40 composition is shown in Table 95.
Watch 95
As for the synergistic effect, it can be seen from table 96.
Watch 96
Calculated sweetness per ppm of GSG-RA40 (ppm sugar) ═ calculated SE/GSG-RA40 concentration of GSG-RA 40.
The sweetness (ppm sugar) per ppm of GSG-RA40 measured (SE-calculated RA75/RB15 measured)/concentration of GSG-RA 40.
The data are shown in FIG. 71.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA40 content increased. Although the optimal range is 150-200ppm, significant synergy is found when GSG-RA40>150 ppm.
Example 41: taste profiles of GSG-RA40 and RA/RD compositions were evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA/RD, corresponding to 6.5% SE.
The samples were as follows:
watch 97
| RA/RD | GSG-RA40 |
| 400ppm | - |
| 300ppm | 100ppm |
| 250ppm | 150ppm |
| 200ppm | 200ppm |
| 150ppm | 250ppm |
| 100ppm | 300ppm |
The sweetness profiles of GSG-RA40 and RA/RD are shown in FIG. 72.
The taste profile of the RA/RD/GSG-RA40 compositions is shown in Table 98.
Watch 98
As for the synergistic effect, it can be seen from table 99.
TABLE 99
Calculated sweetness per ppm of GSG-RA40 (ppm sugar) ═ calculated SE/GSG-RA40 concentration of GSG-RA 40.
The sweetness per ppm of GSG-RA40 measured (ppm sugar) is (SE of measured SE-calculated RA/RD)/concentration of GSG-RA 40.
The data are shown in FIG. 73.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA40 content increased. Although the optimal range is 150-250ppm, significant synergy is found when GSG-RA40>150 ppm.
Example 42: the taste profile of the GSG-RA40 and RA80/RB10/RD6 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA80/RB10/RD6, corresponding to 8.3% SE.
The samples were as follows:
watch 100
| RA80/RB10/RD6 | GSG-RA40 |
| 400ppm | - |
| 300ppm | 100ppm |
| 250ppm | 150ppm |
| 200ppm | 200ppm |
| 150ppm | 250ppm |
| 100ppm | 300ppm |
The sweetness profiles of GSG-RA40 and RA80/RB10/RD6 are shown in FIG. 74.
Taste profiles of the RA80/RB10/RD6/GSG-RA40 compositions are shown in Table 101.
Watch 101
As for the synergistic effect, it can be seen from table 102.
Watch 102
Calculated sweetness per ppm of GSG-RA40 (ppm sugar) ═ calculated SE/GSG-RA40 concentration of GSG-RA 40.
The sweetness (ppm sugar) per ppm of GSG-RA40 measured (SE-calculated concentration of RA80/RB10/RD6 measured)/concentration of GSG-RA 40.
The data are shown in FIG. 75.
It can be seen that: at 400ppm total solids, the sweetness measured was higher than the calculated value with increasing GSG-RA40 content. Although the optimal range is 150-250ppm, significant synergy is found when GSG-RA40>150 ppm.
Example 43: the taste profile of the GSG-RA20 and RA75/RB15 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA75/RB15, corresponding to 7.0% SE.
The samples used were as follows:
watch 103
| RA75/RB15 | GSG-RA20 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 18.56% |
| 250ppm | 150ppm | 27.84% |
| 200ppm | 200ppm | 37.13% |
| 150ppm | 250ppm | 46.41% |
| 100ppm | 300ppm | 55.69% |
The sweetness profiles of GSG-RA20 and RA75/RB15 are shown in FIG. 76.
The taste profile of the RA75/RB15/GSG-RA20 composition is shown in Table 104.
Table 104
As for the synergistic effect, it can be seen from table 105.
Watch 105
Calculated sweetness per ppm of GSG-RA20 (ppm sugar) ═ calculated SE/GSG-RA20 concentration of GSG-RA 20.
The sweetness (ppm sugar) per ppm of GSG-RA20 measured (SE-calculated RA75/RB15 measured)/concentration of GSG-RA 20.
The data are shown in FIG. 77.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA20 content increased. Although the optimal range is 100-200ppm, significant synergy is found when GSG-RA20>100 ppm.
Example 44: taste profiles of GSG-RA20 and RA/RD compositions were evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA/RD, corresponding to 6.5% SE.
The samples were as follows:
table 106
| RA/RD | GSG-RA20 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 18.56% |
| 250ppm | 150ppm | 27.84% |
| 200ppm | 200ppm | 37.13% |
| 150ppm | 250ppm | 46.41% |
| 100ppm | 300ppm | 55.69% |
The sweetness profiles of GSG-RA20 and RA/RD are shown in FIG. 78.
The taste profile of the RA/RD/GSG-RA20 composition is shown in Table 107.
Table 107
As for the synergistic effect, it can be seen from table 108.
Table 108
Calculated sweetness per ppm of GSG-RA20 (ppm sugar) ═ calculated SE/GSG-RA20 concentration of GSG-RA 20.
The sweetness per ppm of GSG-RA20 measured (ppm sugar) is (SE of measured SE-calculated RA/RD)/concentration of GSG-RA 20.
The data are shown in FIG. 79.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA20 content increased. Although the optimal range is 150-250ppm, significant synergy is found when GSG-RA20>150 ppm.
Example 45: the taste profile of the GSG-RA20 and RA80/RB10/RD6 compositions was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The control sample was 400ppm RA80/RB10/RD6, corresponding to 8.3% SE.
The samples were as follows:
watch 109
| RA80/RB10/RD6 | GSG-RA20 | Total GSG |
| 400ppm | - | |
| 300ppm | 100ppm | 18.56% |
| 250ppm | 150ppm | 27.84% |
| 200ppm | 200ppm | 37.13% |
| 150ppm | 250ppm | 46.41% |
| 100ppm | 300ppm | 55.69% |
The sweetness profiles of GSG-RA20 and RA80/RB10/RD6 are shown in FIG. 80.
Taste profiles of the RA80/RB10/RD6/GSG-RA20 compositions are shown in Table 110.
Watch 110
As for the synergistic effect, it can be seen from table 111.
Watch 111
Calculated sweetness per ppm of GSG-RA20 (ppm sugar) ═ calculated SE/GSG-RA20 concentration of GSG-RA 20.
The sweetness (ppm sugar) per ppm of GSG-RA20 measured (SE-calculated concentration of RA80/RB10/RD6 measured)/concentration of GSG-RA 20.
The data are shown in FIG. 81.
It can be seen that: at 400ppm total solids, the sweetness measurement was higher than calculated as the GSG-RA20 content increased. Although the optimum range is 200-300ppm, significant synergy is found when GSG-RA20>150 ppm.
Example 46: the taste profile of the combination of GSG-RA20, RA97 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
watch 112
| RA97 | GSG-RA20 | Candy | Total GSG |
| 250ppm | 100ppm | 3% | 21.21% |
| 200ppm | 150ppm | 3% | 31.82% |
| 150ppm | 200ppm | 3% | 42.43% |
Taste profiles of RA97/GSG-RA20/GSG-RA 20/sugar compositions are shown in Table 113.
Watch 113
As for the synergistic effect, it can be seen from table 114.
Watch 114
Calculated sweetness per ppm of GSG-RA20 plus RA97 (ppm sugar) — calculated SE/GSG-RA20 plus RA97 concentration of GSG-RA20 plus RA 97.
Sweetness (ppm sugar) measured per ppm of GSG-RA20 plus RA97 (SE-sugar concentration measured for GSG-RA20 plus RA 97)/concentration of GSG-RA20 plus RA 97.
It can be seen that: at 350ppm total GSG-RA20 plus RA97, the sweetness measured was higher than calculated when mixed with 3% sugar. The GSG-RA20 plus RA97 combination had a significant synergistic effect on the sweetness of sugar.
Example 47: the taste profile of the combination of GSG-RA20, RA75/RB15 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
watch 115
| RA75/RB15 | GSG-RA20 | Candy | Total GSG |
| 300ppm | 100ppm | 3% | 18.56% |
| 200ppm | 200ppm | 3% | 37.13% |
| 100ppm | 300ppm | 3% | 55.69% |
The taste profile of the RA75/RB15/GSG-RA 20/sugar composition is shown in Table 116.
Watch 116
As for the evidence of the synergistic effect, it can be seen from table 117.
Table 117
Calculated sweetness per ppm of GSG-RA20 plus RA75/RB15 (ppm sugars) ═ calculated concentration of SE/GSG-RA20 plus RA75/RB15 of GSG-RA20 plus RA75/RB 15.
Sweetness (ppm sugars) measured per ppm of GSG-RA20 plus RA75/RB15 (SE-sugar concentration measured for GSG-RA20 plus RA75/RB 15)/concentration of GSG-RA20 plus RA75/RB 15.
It can be seen that: the sweetness measured at 400ppm total GSG-RA20 plus RA75/RB15 levels when combined with 3% sugar is higher than calculated. The GSG-RA20 plus RA75/RB15 combination has a significant synergistic effect on the sweetness of sugars.
Example 48: the taste profile of the combination of GSG-RA20, RA80/RB10/RD6 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
Watch 118
Taste profiles of RA80/RB10/RD6/GSG-RA 20/sugar compositions are shown in Table 119.
Watch 119
As for the evidence of synergy, it can be seen from table 120.
Watch 120
Calculated sweetness per ppm of GSG-RA20 plus RA80/RB10/RD6 (ppm sugars) — calculated concentration of SE/GSG-RA20 plus RA80/RB10/RD6 of GSG-RA20 plus RA80/RB10/RD 6.
Sweetness (ppm sugars) per ppm of GSG-RA20 plus RA80/RB10/RD6 measured (SE-sugar concentration of GSG-RA20 plus RA80/RB10/RD 6)/concentration of GSG-RA20 plus RA80/RB10/RD 6.
It can be seen that: the sweetness measured was higher than calculated at 400ppm total GSG-RA20 plus RA80/RB10/RD6 levels when combined with 3% sugar. The GSG-RA20 plus RA80/RB10/RD6 combination has a significant synergistic effect on the sweetness of sugar.
Example 49: the taste profile of the combination of GSG-RA50, RA97 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
table 121
| RA97 | GSG-RA50 | Candy | Total GSG |
| 250ppm | 100ppm | 3% | 25.53% |
| 200ppm | 150ppm | 3% | 38.29% |
| 150ppm | 200ppm | 3% | 51.06% |
Taste profile of RA97/GSG-RA 50/sugar composition is shown in Table 122.
Watch 122
As for the evidence of the synergistic effect, it can be seen from table 123.
Table 123
Calculated sweetness per ppm of GSG-RA50 plus RA97 (ppm sugar) — calculated SE/GSG-RA50 plus RA97 concentration of GSG-RA50 plus RA 97.
Sweetness (ppm sugar) measured per ppm of GSG-RA50 plus RA97 (SE-sugar concentration measured for GSG-RA50 plus RA 97)/concentration of GSG-RA50 plus RA 97.
It can be seen that: the sweetness measured was higher than calculated at 350ppm total GSG-RA50 plus RA97 level when combined with 3% sugar. The GSG-RA50 plus RA97 combination had a significant synergistic effect on the sweetness of sugar.
Example 50: the taste profile of the combination of GSG-RA50, RA75/RB15 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
table 124
| RA75/RB15 | GSG-RA50 | Candy | Total GSG |
| 300ppm | 100ppm | 3% | 25.53% |
| 200ppm | 200ppm | 3% | 38.29% |
| 100ppm | 300ppm | 3% | 51.06% |
The taste profile of the RA75/RB15/GSG-RA 50/sugar compositions is shown in Table 125.
Watch 125
As for the evidence of synergy, this can be seen in table 126.
Table 126
Calculated sweetness per ppm of GSG-RA50 plus RA75/RB15 (ppm sugars) ═ calculated concentration of SE/GSG-RA50 plus RA75/RB15 of GSG-RA50 plus RA75/RB 15.
Sweetness (ppm sugars) measured per ppm of GSG-RA50 plus RA75/RB15 (SE-sugar concentration measured for GSG-RA50 plus RA75/RB 15)/concentration of GSG-RA50 plus RA75/RB 15.
It can be seen that: the sweetness measured at 400ppm total GSG-RA50 plus RA75/RB15 levels when combined with 3% sugar is higher than calculated. The GSG-RA50 plus RA75/RB15 combination has a significant synergistic effect on the sweetness of sugars.
Example 51: the taste profile of the combination of GSG-RA50, RA80/RB10/RD6 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
watch 127
Taste profiles of RA80/RB10/RD6/GSG-RA 50/sugar compositions are shown in Table 128.
Table 128
As for the evidence of synergistic effect, it can be seen from table 129.
TABLE 129
Calculated sweetness per ppm of GSG-RA50 plus RA80/RB10/RD6 (ppm sugars) — calculated concentration of SE/GSG-RA20 plus RA80/RB10/RD6 of GSG-RA50 plus RA80/RB10/RD 6.
Sweetness (ppm sugars) per ppm of GSG-RA50 plus RA80/RB10/RD6 measured (SE-sugar concentration of GSG-RA50 plus RA80/RB10/RD 6)/concentration of GSG-RA50 plus RA80/RB10/RD 6.
It can be seen that: the sweetness measured was higher than calculated at 400ppm total GSG-RA50 plus RA80/RB10/RD6 levels when combined with 3% sugar. The GSG-RA50 plus RA80/RB10/RD6 combination has a significant synergistic effect on the sweetness of sugar.
Example 52: the taste profile of the combination of GSG-RA95, RA97 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
Watch 130
| RA97 | GSG-RA95 | Candy | Total GSG |
| 250ppm | 100ppm | 3% | 25.89% |
| 200ppm | 150ppm | 3% | 38.83% |
| 150ppm | 200ppm | 3% | 51.77% |
Taste profile of RA97/GSG-RA 95/sugar composition is shown in table 131.
Watch 131
As for the evidence of synergy, it can be seen from table 132.
Watch 132
Calculated sweetness per ppm of GSG-RA95 plus RA97 (ppm sugar) — calculated SE/GSG-RA95 plus RA97 concentration of GSG-RA95 plus RA 97.
Sweetness (ppm sugar) measured per ppm of GSG-RA95 plus RA97 (SE-sugar concentration measured for GSG-RA95 plus RA 97)/concentration of GSG-RA95 plus RA 97.
It can be seen that: the sweetness measured was higher than calculated at 350ppm total GSG-RA95 plus RA97 level when combined with 3% sugar. The GSG-RA95 plus RA97 combination had a significant synergistic effect on the sweetness of sugar.
Example 53: the taste profile of the combination of GSG-RA95, RA75/RB15 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
table 133
| RA75/RB15 | GSG-RA95 | Candy | Total GSG |
| 300ppm | 100ppm | 3% | 22.65% |
| 200ppm | 200ppm | 3% | 45.3% |
| 100ppm | 300ppm | 3% | 67.95% |
Taste profile of RA75/RB15/GSG-RA 95/sugar compositions is shown in Table 134.
Table 134
As for the evidence of synergy, it can be seen from table 135.
Watch 135
Calculated sweetness per ppm of GSG-RA95 plus RA75/RB15 (ppm sugars) ═ calculated concentration of SE/GSG-RA95 plus RA75/RB15 of GSG-RA95 plus RA75/RB 15.
Sweetness (ppm sugars) measured per ppm of GSG-RA95 plus RA75/RB15 (SE-sugar concentration measured for GSG-RA95 plus RA75/RB 15)/concentration of GSG-RA95 plus RA75/RB 15.
It can be seen that: the sweetness measured at 400ppm total GSG-RA95 plus RA75/RB15 levels when combined with 3% sugar is higher than calculated. The GSG-RA95 plus RA75/RB15 combination has a significant synergistic effect on the sweetness of sugars.
Example 54: the taste profile of the combination of GSG-RA95, RA80/RB10/RD6 and sugar was evaluated to find the optimal ratio with the best synergistic taste effect.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
table 136
Taste profiles of RA80/RB10/RD6/GSG-RA 95/sugar compositions are shown in Table 137.
Watch 137
As for the evidence of synergy, it can be seen from table 138.
Watch 138
Calculated sweetness per ppm of GSG-RA95 plus RA80/RB10/RD6 (ppm sugars) — calculated concentration of SE/GSG-RA95 plus RA80/RB10/RD6 of GSG-RA95 plus RA80/RB10/RD 6.
Sweetness (ppm sugars) per ppm of GSG-RA95 plus RA80/RB10/RD6 measured (SE-sugar concentration of GSG-RA95 plus RA80/RB10/RD 6)/concentration of GSG-RA95 plus RA80/RB10/RD 6.
It can be seen that the sweetness measured at 400ppm total GSG-RA95 plus RA80/RB10/RD6 levels when combined with 3% sugar is higher than calculated. The GSG-RA95 plus RA80/RB10/RD6 combination has a significant synergistic effect on the sweetness of sugar.
Example 55: taste profiles of compositions of GSG-RA20, RA97 and salt were evaluated for taste improvement.
The samples were tested in aqueous citric acid at pH 3.8.
The samples were as follows:
table 139
| RA97 | GSG-RA95 | Salt (NaCl) | Total GSG |
| 200ppm | 200ppm | - | 45.30% |
| 200ppm | 200ppm | 100ppm | 45.30% |
| 200ppm | 200ppm | 200ppm | 45.30% |
The taste profile of the RA97/GSG-RA 20/salt composition is shown in Table 140.
Watch 140
It can be seen that: at a level of 400ppm total GSG-RA20 plus RA97, when mixed with salt, the sweetness was not increased, but the taste profile was improved by reducing aftertaste and tangling.
Example 56:
GSG-RA20 is mixed with RA, RB, RD or ST at a weight ratio of 1:1 to obtain a mixture, and a certain amount of solvent such as water, ethanol/water mixture is added to the mixture, heated to a certain temperature until the mixture is completely dissolved, and incubated for one hour. The solution was treated by spray drying to obtain a composition comprising GSG and SG. The solubility of the compositions, in contrast to the solubility of RA, RB, RD or ST alone, is shown in table 141.
Table 141
| Water (W) | GSG-RA20 | RA | RB | RD | SS | Time of settling |
| 10ml | 1g | 2h | ||||
| 10ml | 1g | 1g | >14d | |||
| 10ml | 0.05g | Insoluble matter | ||||
| 10ml | 0.05g | 0.05g | 14d | |||
| 10ml | 0.25g | Insoluble matter | ||||
| 10ml | 0.25g | 0.25g | 2d | |||
| 10ml | 0.01g | Insoluble matter | ||||
| 10ml | 0.01g | 0.01g | 1d | |||
| 10ml | 0.01g | Insoluble matter | ||||
| 10ml | 0.01g | 0.01g | >14d |
As shown in table 141, GSG-RA20 can improve the solubility of SG.
Example 57:
GSG-RA20 was mixed with RA, RB, RD or ST at a weight ratio of 1:1 to give a mixture, and then the obtained mixture was mixed with γ -cyclodextrin at a weight ratio of 1: 1. To the resulting mixture is added a quantity of solvent, e.g. water, an ethanol/water mixture, heated to a temperature until the mixture is completely dissolved, and incubated for one hour. The solution is treated by spray drying to obtain a composition comprising GSG, SG and γ -cyclodextrin. The solubility of the compositions, in contrast to the solubility of compositions comprising GSG and SG, is shown in table 142.
Watch 142
It can be concluded that gamma-cyclodextrin can further improve the solubility of compositions containing GSG and SG.
Example 58 preparation of GSG flavor composition No.1 of the invention
The compositions of the present application were prepared as follows. Tapioca dextrin (35g) was dissolved in 2L of water and 100g of stevia extract (RA 24.05%; total steviol glycoside 73.38%, based on 9 steviol glycosides, rebaudioside a, stevioside, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, dulcoside a, rubusoside, steviolbioside) was added to the liquefied dextrin to obtain a mixture in which the ratio of dextrin to stevia extract was 26: 74. 5ml of cyclodextrin glycosyltransferase (CGTase) enzyme was added to the mixture and incubated at 60 ℃ for 24 hours to allow SGs glycosylation of the glucose molecules derived from tapioca dextrin. After the desired ratio of GSG and residual SG content was achieved, the reaction mixture was heated to 95 ℃ for 30 minutes to inactivate the cgtase, which was then removed by filtration. The obtained GSG, the remaining SG and dextrin solution were decolorized and spray dried to obtain 130g of white powder as composition 1. The residual SG (based on 9 SGs), residual dextrin and total GSG contents were 20.98%, 15.04% and 63.98%, respectively. The composition of the product is shown in table 143.
Example 59 preparation of GSG flavor composition No.2 of the invention
The compositions of the present application were prepared as follows. Tapioca dextrin (50g) was dissolved in 2L water, and 100g of stevia extract (RA 23.13%; total steviol glycosides is 63.20%, based on 9 steviol glycosides, rebaudioside a, steviol glycosides, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, dulcoside a, rubusoside, steviolbioside) was added to the liquefied dextrin to obtain a mixture where the ratio of dextrin to stevia extract was 33: 67. 5ml of CGTase was added to the mixture and incubated at 60 ℃ for 24 hours to allow the glucose molecules to derive glycosylated SG from tapioca dextrin. After the desired ratio of GSG and residual SG content was achieved, the reaction mixture was heated to 95 ℃ for 30 minutes to inactivate the cgtase, which was then removed by filtration. The resulting GSG, remaining SG and dextrin solution were decolorized and spray dried, yielding 145g of white powder as composition 2. The residual SG (based on 9 SGs) was found to be 19.62%, 17.36% and 61.35% for residual dextrin and total GSG, respectively. The composition of the product is shown in table 143.
Example 60 preparation of GSG flavor composition No.3 of the present invention
The compositions of the present application were prepared as follows. Tapioca dextrin (60g) was dissolved in 2L of water, and 100g of stevia extract (RA 24.05%; total steviol glycosides 73.38%, based on 9 steviol glycosides, rebaudioside a, steviol glycosides, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, dulcoside a, rubusoside, steviolbioside) was added to the liquefied dextrin to obtain a mixture in which the ratio of dextrin to stevia extract was 37.5: 62.5. 5ml of CGTase was added to the mixture and incubated at 60 ℃ for 24 hours to allow the glucose molecules to derive glycosylated SG from tapioca dextrin. After the desired ratio of GSG and residual SG content was achieved, the reaction mixture was heated to 95 ℃ for 30 minutes to inactivate the cgtase, which was then removed by filtration. The resulting GSG, residual SGs and dextrin solutions were decolorized and spray dried to yield 155g of a white powder as composition 3, the remaining SG (based on 9 SG), residual dextrin and total GSG content were 17.26%, 19.31% and 63.43%, respectively. The composition of the product is shown in table 143.
Watch 143
The steviol glycoside refers to 9 steviol glycoside, rebaudioside A, stevioside, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, dulcoside A, rubusoside and steviolbioside.
Stevia extracts of examples 58, 59 and 60 were obtained from Sweet Green Fields (Sweet Green Fields). The content of each component in the stevia extract and the content of each unreacted SG are listed as follows:
EXAMPLE 61. preparation of GSG control sample
GSG control samples were prepared as follows. Tapioca dextrin (100g) was dissolved in 2L water, and 100g of stevia extract (RA 52%; based on 9 steviol glycosides, rebaudioside a, stevioside, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside F, dulcoside a, rubusoside, steviolbioside, total steviol glycosides 95.5%) was added to the liquefied dextrin to obtain a mixture where the ratio of dextrin to stevia extract was 50: 50. 5ml of CGTase was added to the mixture and incubated at 60 ℃ for 24 hours to glycosylate SGs of the glucose moiety present in the tapioca dextrin. After the desired ratio of GSG and residual SG content was achieved, the reaction mixture was heated to 95 ℃ for 30 minutes to inactivate the cgtase, which was then removed by filtration. The resulting GSG solution, the remaining SG and dextrin were decolorized and spray dried to obtain 192g of white powder as a control composition. The residual SG, residual dextrin and total glycosylated SG contents were found to be 9.15%, 19.5% and 71.35%, respectively. The control sample met the FEMA GRAS 4728 specification.
Example 62 evaluation of sweetness threshold of GSG flavor composition No.1
Watch 144
To evaluate the sweetness threshold of GSG flavor composition No.1, each person from the 9-person test panel was required to classify the solution samples according to sweetness level and remove the non-sweet solution samples. The criteria for a "non-sweet" sample is that one considers the solution to be non-sweet.
The test results are shown in Table 145.
Watch 145
In table 145, the shaded portion refers to the solution sample that is considered "sweet". In table 146, the data in table 145 are used to determine the percentage of a particular solution sample that the panelist believes to be "sweet" or "non-sweet".
Watch 146
By plotting the percentage of people who considered the sample as "sweet" or "sweet" relative to the sample concentration, it was determined that at a concentration of 160ppm, the 50% panel did not evaluate the sample as sweet (fig. 83). Furthermore, at a concentration of 105ppm, the panel that determined 75% did not evaluate the sample as sweet. These results indicate that the average normal usage level/average maximum usage level can be set between about 100-150 ppm.
Example 63 evaluation of sweetness thresholds for compositions 2 and 3
The sweetness threshold of GSG flavor compositions nos. 2 and 3 (prepared as in examples 59 and 60, respectively) was determined according to the method of example 62. The results of this analysis are consistent with the following conclusions: the average normal use level of compositions 1-3 can be set between about 100 and 150 ppm.
Example 64 evaluation of GSG-synergistic taste Effect of compositions 1-3 of the present invention with respect to sugar
To evaluate the synergistic taste effect of the compositions 1-3 of the present invention, 4 solutions were prepared. Three solutions containing 150ppm of composition 1 (example 58), composition 2 (example 59) and composition 3 (example 60) were prepared, and a GSG-control sample solution containing 175ppm (average maximum usage FEMA No.4728) was prepared. These 4 solutions were evaluated by a panel of 8 people to determine the relative level of sweetness. Six of eight considered the GSG-control solution to be sweeter, while two others considered GSG flavor composition 1 to be sweeter. This indicates that 150ppm of GSG flavor composition 1 can be considered as the average maximum usage level.
The eight panel further evaluated the effect of sugar reduction by tasting six samples described in table 147. The panel determined that the sweetness of the 6 samples was very similar.
Table 147
And (6) concluding. The GSG flavor compositions of the invention exhibit lower usage levels than the GSG control samples compared to the GSG control samples. For example, 150ppm of GSG flavor composition 1 may replace 3% of the sugar, while 100ppm of GSG flavor composition 1 may replace 2% of the sugar. However, the GSG control sample was unable to replace 3% of the sugars at its average maximum usage (175ppm), but only 2% of the sugars. In other words, 100ppm of GSG flavor composition No.1 can provide the same sugar reduction as 175ppm of GSG-control. Given the lower level of use of the same sugar reduction effect, the cost of using GSG flavor composition 1 was about 30% lower than the cost of the GSG-control.
Example 65 evaluation of taste profiles of GSG fragrance compositions 1-3
The taste profile of 5 solution samples was evaluated. As shown in Table 148, the samples included GSG flavor composition Nos. 1-3, GSG-control, and RA50/SG95 samples available from Sweet Green Fields. These samples were dissolved in an aqueous citric acid solution (pH3.8) at room temperature with ultrasonic waves and allowed to stand for further 30 minutes.
Watch 148
A panel of 4 people tasted each sample and scored 0-5 points according to sweetness, sugar-like, bitter, aftertaste and twisted taste profile. Results are reported as the average of the results provided by the panel and are listed in table 148.
Watch 149
And (6) concluding. The results in Table 149 show that glycosylation can significantly improve the taste profile of stevia extract. However, as the degree of glycosylation increases, sweetness decreases, while metallic aftertaste increases. Overall, the GSG flavor compositions of the invention taste cleaner and sweeter than the GSG-control.
Example 66 evaluation of taste improvement by GSG flavor composition 1
The two samples described in table 150 were dissolved in deionized water with ultrasound at room temperature and allowed to stand for a further 30 minutes.
Watch 150
The taste profiles from 0-5 points for each sample were evaluated by a panel of 4 persons comparing and describing the taste of the two samples in table 150, and based on the enhanced sweetness, texture, bitterness, aftertaste and twisted taste profiles. Results are reported in table 151 as the average of the results provided by the panel.
Table 151
The results in Table 151 show that composition No.1 of the present invention can be used to reduce the use of sugar. At a Sugar Equivalent (SE) of 10%, the composition No.1 of the present invention can reduce the amount of sugar used by 50%, can maintain the mouthfeel of sugar, and can provide even stronger mouthfeel. In addition, it can provide a pleasant herbal taste.
EXAMPLE 67 method for determining distribution and content of unreacted and reacted products
Fig. 82 shows an analysis method for evaluating the distribution and concentration of reaction products obtained by glycosylation of SG raw materials.
Materials reference standards for steviol glycosides (Reb A, Reb B, Reb C, Reb D, Reb E, Reb F, Reb G, Reb I, Reb M, Reb N, Reb O, Isoreb A, IsoST) were obtained from Chromadex (LGC Germany). Solvents and reagents (HPLC grade) were obtained from vwr (vienna) or Sigma-aldrich (vienna). Davisil Grade 633 (high purity Grade silica colloid, pore size)200-425 mesh particle size) was obtained from Sigma-Aldrich (Vienna).
Preparation of samplesAll samples were separated via a glass column (100x 5mm) packed with Davisil Grade 633. The column was purified using ethyl acetate/acetic acid/H2And O is 8/3/2 (v/v/v). 100mg of the sample was dissolved in 2ml of water and loaded in a column, followed by extraction with ethyl acetate/acetic acid/H 2O8/3/2 (v/v/v) rinse at a flow rate of 2 ml/min. The first 6ml of effluent was discarded and the lower 30ml of effluent containing unreacted steviol glycosides was collected. About 36-70ml of the enzymatically reacted steviol glycoside effluent was collected.
After 3 samples were separated, the combined eluates were evaporated to dryness and reconstituted with 20mL acetonitrile/water 9/1(v/v), which corresponds to a sample concentration of 150mg of sample/10 mL.
The method can separate steviol glycoside standard and steviol glycoside obtained by enzyme reaction. The effluent had > 97% steviol glycosides and > 95% enzymatically reacted steviol glycosides, with less than 3% carryover between fractions. The combined evaporated samples were used for further analysis.
HPLC methodThe HPLC system consists of an Agilent 1100 system (autosampler, triple gradient pump, column oven, VWD-UV detector, DAD-UV/VIS detector) connected in-line with an Agilent mass spectrometer (ESI-MS quadrupole G1956A VL). For HPLC analysis, 150mg of the corresponding sample was dissolved in acetonitrile (1 ml) and filled to 10 ml with H2O.
The samples were separated on a Phenomenex Synergi Hydro-RP (150X 3 mm) at a rate of 0.8ml/min and then eluted with a Macherey Nagel Nuclear 100-7C18(250X 4.6 mm) gradient at 45 ℃. Mobile phase a consisted of 0.01 molar ammonium acetate buffer (pH of itself) with 0.1% acetic acid, 0.05% trimethylamine and 0.001% dichloromethane. Mobile phase B consisted of 0.01 molar ammonium acetate buffer (pH of itself) with 0.1% acetic acid, 0.05% trimethylamine and 0.001% dichloromethane and acetonitrile (1/9 v/v). The gradient started at 22% B, increased linearly to 45% B in 20 minutes, and was maintained in this case for 15 minutes. The injection amount was set to 10. mu.L.
The detectors were set to 210nm (VWD), 205 and 254nm (DAD for spectra collection between 200 and 600 nm), ESI negative ion mode m/z 300 and 1500, Fragmentor 200, Gain 2(MS, 300 ℃, 12 liters/min nitrogen, nebulizer set to 50psig, capillary voltage 4500V). Detection at 205 and 210nm was used to quantify the chromatograms and mass spectra were used to determine molar mass and structural information of individual peaks. Detection at 254nm was used to identify the non-steviol glycoside peaks.
The samples were quantified for the reference compound by external standards, and in the absence of an authoritative reference standard, the peak areas were quantified relative to the reference standard with the most similar mass, and the molar mass difference was corrected. The maximum calibration range for the reference standard is 0.1-50 mg/10 ml (dissolved in acetonitrile/water-9/1 (V/V)).
Identification and quantification:the steviol glycosides and enzymatically reacted steviol glycosides were identified by comparing the retention times of authoritative reference standards and/or evaluating the resulting mass spectra, including interpretation of fragmentation patterns and doubly charged ions triggered by the presence of dichloromethane.
The steviol glycosides were quantified relative to external standards. Quantification is performed relative to the reference standard with the most similar molar mass, without an authoritative reference standard.
Example 68 distribution and percentage (wt/wt) of GSG (reacted SG) and unreacted SG produced with steviol feedstock
The SG feedstock of 12 sample lots was glycosylated as described in example 61 and the distribution and percentage (wt/wt) of the specific unreacted SG and reacted SG (i.e., GSG) in these sample lots was determined as described in example 67.
Table 152 shows the results of the analysis of sample lots 20171101, 20171102, 20171103, and 20171104. In table 149 and the tables that follow, the SG groups define a basic structure. For example, in Table 152, "SG-4G" refers to a steviol glycoside having 4 additional glucose units added. The SG group consisted of unreacted SG and reacted GSG. In the SG-group, the reacted GSG is formed from more than one parent SG(s). Thus, in the case of SG-4G groups, GSGs formed by Reb-A, Reb-E, Reb-A2 or Reb-H1 are obtained. In the table below, "mg/10 ml" corresponds to the original results of the test; "% (m/m)" was calculated as mg/10ml divided by the weight of the sample dissolved in 10 ml.
Watch 152
Table 152 shows
Table 153 summarizes descriptive statistics corresponding to the sample lots 20171101, 20171102, 20171103, and 20171104 (n-4) tested.
Watch 153
Table 154 describes the distribution and percentage (wt/wt) of specific unreacted SG and reacted SG (i.e., GSG) after glycosylation of the starting material in sample lots 3017153,3017276,3017308,3017195 and 3017215:
watch 154
Watch 154 (continuation)
Table 155 provides a summary of the descriptive statistics corresponding to sample lot numbers 3017153,3017276,3017308,3017195 and 3017215 (n-5).
Table 155
Watch 155 (continue)
Table 156 describes the distribution and percentage (wt/wt) of specific unreacted SG and reacted SG (i.e., GSG) after glycosylation of the sample lot numbers 23201701, 23201702, 23201703 starting material.
Table 156
Watch 156 (continuation)
Table 157 summarizes descriptive statistics corresponding to the sample lots 23201701, 23201702, and 23201703 (n-3) tested.
Watch 157
Watch 157 (continue)
Table 158 provides the summary data (wt%) of unreacted, reacted, and total steviol glycosides obtained from the 12 sample batches above, including the percentages of residual RD and glycosylated RM.
Watch 158
Watch 159
Table 159 summarizes the descriptive statistics corresponding to all of the 12 sample lots tested above, whereby the mean, median, minimum (min) and maximum (max) values quoted are expressed in% m/m.
159 (continue)
The raw materials used to prepare GSG were as follows:
The amounts of each component of lots 20160118 and 20160106 were the same as those of examples 58 and 59. The content of each component of the other batches was determined by HPLC-MS and the results were as follows:
steviol glycoside in sample SCJ20171009 (sample weight 149.7mg/10ml)
Steviol glycosides in sample SCJ20171008 (sample weight 150.5mg10 ml)
Steviol glycosides in sample SCJ20170220-24 (sample weight 147.2mg/10ml)
Steviol glycosides in sample SCJ2017625-26 (sample weight 149.3mg/10ml)
The 9 sample batches of SG starting material were glycosylated according to the method described in example 61. Each of the 9 sample lots, specifically, EPC-178-05-01, EPC-174-73-01, EPC-174-73-02, 150207, EPC-171-38-01, 141118, EPC-171-36-01, EPC-171-34-01 and S150311, represents a different starting composition. Glycosylation of these starting compositions, RA40+ RB8, RA30/RC15, RA50/RC5, RA95, RA90, RA80, RA70, RA60, RA50, respectively, gave glycosylation compositions corresponding to GSG- (RA40+ RB8), GSG- (RA30+ RC15), GSG-RA50/RC5, GSG-RA95, GSG-RA90, GSG-RA80, GSG-RA70, GSG-RA60, GSG-RA 50. The distribution and percentage (wt/wt) of the particular unreacted SG and reacted SG (i.e., GSG) in these sample lots was determined using the method described in example 67.
The starting compositions are commercially available from Sweet Green Fields. The content of each component of the raw material composition is listed as follows:
RA90 was prepared by mixing RA80 and RA95 in a ratio of 1: 2.
Table 160 shows the results of the analysis of RA40+ RB8 (EPC-178-05-01).
Watch 160
Watch 160 (continuation)
Table 161 shows the results of the analysis of RA30+ RC15 (EPC-174-73-01).
Table 161
Watch 161 (continuation)
Table 162 shows the results of the analysis of RA50+ RC5 (EPC-174-73-02).
Watch 162
Watch 162 (continuation)
Table 163 shows the results of the analysis of GSG-RA95 (batch No. 150207).
Watch 163
Watch 163 (continue)
Table 164 shows the results of the analysis of GSG-RA90 (batch number EPC 171-38-01).
Table 164
Watch 164 (continuation)
Table 165 shows the results of the analysis of GSG-RA80 (batch No. 141118).
Watch 165
Watch 165 (continuation)
Table 166 shows the results of the analysis of GSG-RA70 (batch number EPC 171-36-01).
Watch 166
Watch 166 (continuation)
Table 167 shows the results of the analysis of GSG-RA60 (batch number EPC 171-34-01).
Watch 167
Watch 167 (continuation)
Table 168 shows the results of the analysis of GSG-RA50 (batch S150311).
Watch 168
Watch 168 (continuation)
Table 169 provides a summary of descriptive statistics corresponding to the 9 sample lots tested in experiment 2 (n-9).
Watch 169
Watch 169 (continue)
Glycosylation was performed according to the method described in example 59, resulting in two sample lot numbers GSG (EPC-230-36-03, EPC-230-36-06). The reaction conditions, including the starting stevia glycosides and the reaction time, are adjusted to obtain the desired product, and glycosylation of the two starting compositions results in a glycosylated composition corresponding to new flavor I and new flavor II. The distribution and percentage (wt/wt) of the particular unreacted SG and reacted SG (i.e., GSG) in these sample lots was determined using the method described in example 67.
These two stock compositions are commercially available from Sweet Green Fields. The content of each component
The following are listed:
the technical effect of the two sample lot numbers GSG (EPC-230-36-03, EPC-230-36-06) was the same as that of example 59.
Table 170 shows the results of the analysis of New flavor I (batch number EPC-230-36-03).
Watch 170
Watch 170 (continuation)
Table 171 shows the results of the analysis of New flavor II (batch number EPC-230-35-06).
Watch 171
Watch 171 (continue)
Example 69. GSG composition No. 2 was evaluated for sweetness and flavor enhancing properties.
GSG sample lot number (EPC-230-36-02, forming GSG-composition No. 2) was prepared according to the method described in example 59.
Given that it is unlikely that composition 2 would be used only in water without other flavor systems, it would be of interest to explore its use with other test media such as lemon carbonate and lime soda. Therefore, the sweetness concentration thresholds in lemon and lime test media were determined using the protocol recommended by ASTMS E679 and ASTMS E1432.
In this case, the sweetness concentration threshold of sucrose in lemon and lime Carbonated Soft Drinks (CSD) was first determined by FEMA regulations. In carbonated lemon and lime beverages, 12 consumer panelists tasted sucrose, stevia and a combination of sucrose/stevia in the beverage gave coded samples containing 1.0%, 1.5%, 2.0% and 2.5% or 3.0% by weight. Samples are given in a random order, with the order randomized among the individual panelists. On a simple yes/no record sheet, if the sample is deemed to lack any detectable sweetness, a "yes" is circled and a "no" is circled if the panelist is instructed to identify sweetness in the sample. The panelists further reminded that the initial taste impression was generally considered to be the most accurate. The panelists were allowed to spend as much time as possible deciding on all samples.
Table 172 shows the results of individual panelist selection. The "yes" answer is encoded as "1" and the "no" answer is encoded as "0". The right column in table 172 represents the percentage of panelists who may or may not detect sweetness at a particular sucrose concentration. As shown in table 172, at 2.0% sucrose, 42% of the panelists could detect sweetness, while at 2.5% sucrose, 67% of the panelists could detect sweetness.
Table 172
Based on these results, a sweetness concentration threshold was determined to be between 2.0-2.5% sucrose. The threshold concentration was considered to be the concentration at which 50% of the panelists detected sweetness, and 50% of the panelists did not detect sweetness. To determine the sweetness concentration threshold, the percentage of panelists who detected sweetness or did not detect sweetness was plotted on a graph against the concentration shown in figure 84. The sweetness concentration threshold in the carbonated lemon and lime beverages was determined to be about 2.2% from figure 84.
Test 1: functional sweetness at the average maximum use level was determined for composition 2.
To determine the functional sweetness of composition 2 at the average maximum use level, FEMA guidelines were used in sensory experiments to determine whether 100ppm of composition 2 in lemon and calcium carbonate beverages was considered significantly lower than 1.5% sucrose. 11 consumer panelists with prior experience tasting sucrose, stevia and sucrose/stevia combinations in beverages were given a coded sample containing 100ppm of composition 2 in carbonated lemon and lime beverages. They were also provided with control samples containing 1.5% sucrose in lemon and lime carbonated beverages.
Panelists were instructed to try to taste each sample with the control and to circle a "yes" if the sample was sweeter than the control and a "no" if the sample was the same or sweeter than the control. The panelists further reminded that the initial taste impression was generally considered to be the most accurate. The panelists were allowed to spend as much time as possible deciding on all samples. Taste comparison for each panelist was repeated 3 separate times for each test sample (using different sample codes).
Table 173 shows the results determined by each panelist, where "1" represents "yes" (sweetness lower than control) and "0" represents "NO" (same or sweeter than control).
Watch 173
As shown in table 173, 30 out of 33 independent trials (90.9%) showed that 100ppm composition 2 was less sweet than the 1.5% sucrose control.
Using the Qi Statistical software package (http:// www.qistatistics.co.uk/software-downloads. asp), two-item Statistical analysis of beta showed that the gamma values of this dataset were very close to 0(1x 10)-8). Thus, in Bi and Ennis, 1999(8)The use of this value in the β -binomial table of the 2-AFC method (two-sided) of the publication with the values in table 1.2 provides the minimum number of significant selective responses when α ≦ 0.05, γ ≦ 23 or γ ≦ 0.1. Thus, in this case, the results of 30 provide clear statistical evidence that the test sample is significantly less sweet than the control sample.
And (3) testing 2: sweetness enhancement Properties of composition 2 were determined at the expected maximum usage level
FEMA guidelines were used in sensory experiments to determine whether composition 2 improved sweetness at the 100ppm average maximum use level of non-alcoholic beverages. In this case, control lemon carbonate and lime beverages containing 5 wt% sucrose were used as comparative controls. Whereas test 1 above showed that 100ppm of composition No. 2 was not a functional sweetener, this amount was added to the control and then compared to the control for sweetness. A 12 consumer panelist with prior experience in tasting sucrose, stevia and sucrose/stevia combinations in beverages was given a randomly coded sample containing 100ppm composition No. 2 or a comparative control sample containing 5% sucrose, a lemon and lime carbonated beverage without composition No. 2.
With respect to the enhanced sweetness test, panelists were instructed to try each sample to taste with a control, a "yes" was circled if the sample was sweeter than the control sample, and a "no" was circled if the sample was the same or sweeter than the control sample to further alert that the initial taste impression was generally considered most accurate. The taste comparison for each test sample was repeated 3 times for different sample codes (different sample codes).
Table 174 shows the results of this analysis.
Watch 174
As shown in table 174, 27 out of 36 parts (75%) of the separate trials indicated that 100ppm composition 2 was sweeter than the 5% sucrose sweetened control.
Using the Qi Statistical software package (http:// www.qistatistics.co.uk/software-downloads. asp), two-item Statistical analysis of beta showed that the gamma value of this dataset was very close to 0(1x 10-8). Thus, the use of this value in the β -binomial table of the 2-AFC method (dual sided) of the publication by Bi and Ennis, 1999(8) with the values in Table 1.2 provides the minimum number of significant selective responses for α ≦ 0.05, with γ ≦ 0 or γ ≦ 0.1 of 25. Thus, in this case, the results of 27 provide clear statistical evidence that the test sample is significantly sweeter than the 5% sucrose sweetened control sample.
And (3) testing: the flavor enhancing properties of composition No. 2 were determined at the expected average maximum use level.
Composition No. 2 was compared to a control sample to determine whether it had flavor enhancing properties using the same methods outlined above and used for the sweetness enhancement test described above. For the flavor enhancement test, panelists were instructed to taste each sample and chose a "yes" if the sample was deemed to have more flavor than the 5% sucrose sweetened control sample and a "no" ratio control if the sample was deemed to have less flavor. The panelists further reminded that the initial taste impression was generally considered to be the most accurate. Taste comparison for each panelist (n-12) was repeated 3 separate times for each test sample (using different sample codes). The results of this analysis are shown in table 175.
Table 175
As shown in table 175, 31 out of 36 parts (86%) of the separate trials indicated that 100ppm composition No. 2 had more flavor than the 5% sucrose sweetened control.
Using the Qi Statistical software package (http:// www.qistatistics.co.uk/software-downloads. asp), two-item Statistical analysis of beta showed that the gamma values of this dataset were very close to 0(1x 10)-8). Thus, the use of this value in the β -binomial table of the 2-AFC method (dual sided) of the publication by Bi and Ennis, 1999(8) with the values in Table 1.2 provides the minimum number of significant selective responses when α ≦ 0.05, γ ≦ 25 or γ ≦ 0.1. Thus, in this case, the results of 31 provide clear statistical evidence that the test sample had significantly more flavor than the 5% sucrose sweetened control sample.
The sensory tests described above proved to be of high statistical significance, i.e. the glucosylated composition 2 extract qualifies as a sweetness and flavor enhancer in non-alcoholic beverages.
Example 70 evaluation of sweetness and flavor enhancing Properties of GSG RA20
A sample lot of SG starting material (lot #12261967) was glycosylated according to the method described in example 61 to form a GSG-20 composition. Given that GSG-20 is unlikely to be used only in water and no other flavor systems, it is of interest to explore its use with other test media such as lemon carbonate and lime soda. Therefore, the sweetness concentration thresholds in lemon and lime test media were determined using the protocol recommended by ASTMS E679 and ASTMS E1432.
First, the sweetness concentration threshold of sucrose in lemon and lime Carbonated Soft Drinks (CSD) was determined as described in example 69. From figure 84, it can be determined that the sweetness concentration threshold in the carbonated lemon and lime beverages is about 2.2%.
Another method of determining a sweetness concentration threshold is to determine the sucrose concentration directly below the concentration at which the panelist can detect that the sample is sweet. Using this method, the threshold average sweetness concentration was 1.92% (SE (SD/√ n) ═ 0.21%). FEMA determines guidelines for identifying threshold concentrations that allow for upward adjustment of concentrations by one standard error (reference 2, section 1.4.2). Therefore, the sweetness concentration threshold value was set to 2.13%.
Test 1: the functional sweetness of GSG-RA20 was determined at the mean maximum use level.
To determine the functional sweetness of GSG-RA20 at the average maximum use level, FEMA guidelines were used in sensory experiments to determine whether 250ppm GSG-20 was considered significantly lower than 2.13% sucrose in lemon and lime carbonated beverages. To 12 previously experienced consumer panelists with tasting sucrose, stevia and a sucrose/stevia combination in beverages, coded samples containing 250ppm GSG-20 in carbonated lemon and lime beverages were provided. They were also provided with control samples containing 2.13% sucrose in lemon and lime carbonated beverages.
The panelists were instructed to attempt to taste each sample with the control, a "yes" was circled if the sample was sweeter than the control, a "no" was circled if the sample was sweeter or sweeter than the control, the panelists were further reminded that the initial taste impression was generally considered to be the most accurate, the panelists were allowed to spend as much time as possible to decide on all samples, and the taste comparison of each panelist was repeated 3 different sample codes for each test sample.
Table 177 shows the results determined by each panelist, where "1" represents "yes" (sweetness lower than control) and "0" represents "NO" (sweetness the same or more than control).
Watch 177
As shown in Table 177, 30 out of 36 separate trials (83.3%) showed 250ppm GSG-20 sweeter than the 2.13% sucrose control.
Using the Qi statistical software package (http:// www.qistatistics.co.uk/software-downloads. asp), two-item statistical analysis of beta showed the gamma value for this dataset to be 0.2329. Thus, the use of this value in the β -binomial table of the 2-AFC method (two-sided) of the publication by Bi and Ennis, 1999(8) with the values in Table 1.2 provides a significant minimum selective response number α ≦ 0.05, γ ≦ 0.2 of 25. Thus, in this case, the results of 30 provide clear statistical evidence that the test sample is significantly less sweet than the control sample.
And (3) testing 2: determining sweetness or flavor enhancing properties of GSG-20 at average maximum use level
FEMA guidelines were used in sensory experiments to determine whether 250ppm GSG-20 was considered sweet or flavor enhancement at the 250ppm mean maximum usage level.
Control lemon carbonate and lime beverages containing 5 wt% sucrose were used as comparative controls. Given that 250ppm of GSG-20 did not show functional sweetener in test 1 above, this amount was added to a control and then compared to the control sweetness. To 12 previously experienced consumer panelists with tasting sucrose, stevia and a sucrose/stevia combination in the beverage, samples were provided randomly encoding a beverage containing 250ppm GSG-20 in carbonated lemon and lime beverages containing 5 wt% sucrose. The panelists were also provided with comparative control samples containing 5% sucrose in lemon and lime carbonated beverages without RA 20.
Panelists were asked to measure the sweetness and flavor intensity of the test beverages compared to the control group, which had been labeled 5 and 9 points for both attributes, and scored for intensities from 1 to 9 on a scoring table. The taste comparison was repeated three times for each test compound (GSG-20) and the order of replication for each panelist was randomized so that the panelists did not all receive the same samples at the same time or in the same order.
Table 178 shows a summary of the results for each nominal flavor profile compared to the control.
Watch 178
Standard deviation of SE ═
Statistical significance of comparison of individual samples to controls.
A p-values <0.05 (95% confidence level) were considered statistically significant.
As shown in Table 178, the addition of 250ppm GSG-20 to carbonated lemon and lime beverages containing 5 wt.% sucrose caused a highly statistically significant increase in perceived sweetness and flavor.
Although the various aspects of the present application have been described with reference to preferred embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. The present specification, including references cited in the background, is incorporated by reference in its entirety. Those of ordinary skill in the art will recognize, or be able to ascertain, many equivalents to the specific embodiments described herein. Such equivalents are intended to be encompassed by the following claims.
Claims (51)
1. A composition comprising one or more Glycosylated Steviol Glycosides (GSG) and/or one or more Steviol Glycosides (SG), wherein one or more SG is selected from table a or table B, wherein the one or more SG corresponds to at least one SG group selected from SG-1G, SG-2G, SG-3G, SG-4G, SG-5G, SG-6G, SG-1G1R, SG-2G1R, SG-3G1R, SG-4G1R, SG-5G1R, SG-6G1R, SG-1G1X, SG-2G1X, SG-3G1X, SG-4G1X, SG-5G1X, and combinations thereof, wherein the total content of the one or more SG in the composition is 0.1 to 99.5 wt%; the total content of the one or more GSGs in the composition is 0.1-99.5 wt%, wherein the one or more GSGs are glycosylation products of one or more SGs in table a, wherein the one or more GSGs comprise one or more rhamnose moieties, one or more deoxyhexose moieties, or a combination thereof.
2. The composition according to claim 1, wherein the one or more SG comprises at least one SG selected from the group consisting of: related SG #1, SG-4, isosteviolbioside, related SG #3, rebaudioside R1, stevioside F, SG-Unk1, dulcoside B, SG-3, isorebaudioside B, isosteviolbioside, rebaudioside KA, SG-13, stevioside B, rebaudioside R, SG-Unk2, SG-Unk3, rebaudioside F3, rebaudioside F2, rebaudioside C2, stevioside E2, SG-10, rebaudioside L1, SG-2, rebaudioside A3, isorebaudioside A2, rebaudioside A2, rebaudioside E, rebaudioside H1, related SG #2, related SG #5, rebaudioside U2, rebaudioside T, rebaudioside W2, rebaudioside W3, rebaudioside W68612, SG # 9-K8653, SG-828653, rebaudioside K8653, rebaudioside K5, rebaudioside K-82 3, rebaudioside A, rebaudioside D-4, rebaudioside D, rebaudioside A, rebaudioside D-K-5, rebaudioside D-4, rebaudioside A, rebaudioside D-I, rebaudioside E-D-, SG-Unk6, rebaudioside Q2, rebaudioside Q3, rebaudioside I2, rebaudioside T1, related SG #4, rebaudioside V2, rebaudioside Y, 15 α -OH-rebaudioside M, rebaudioside O2, and combinations thereof.
3. The composition of claim 1, wherein one or more SG are present in a composition selected from the group consisting of: RA20, RA40, RA50, RA60, RA80, RA90, RA95, RA97, RA98, RA99, RA99.5, RB8, RB10, RB15, RC15, RD6, and combinations thereof.
4. The composition of any of claims 1-3, wherein the one or more SGs comprise at least one SG having a molecular weight of less than or equal to 965 daltons.
5. The composition of any of claims 1-3, wherein the one or more SGs comprise at least one SG having a molecular weight of less than or equal to 804 daltons.
6. The composition according to claim 1, wherein the one or more SG comprises 25-35 wt% Reb-a, 0.4-4 wt% Reb-B, 5-15 wt% Reb-C, 1-10 wt% Reb-D, 2-5 wt% Reb-F, 1-5 wt% Reb-K, and 20-40 wt% stevioside.
7. The composition of claim 6, wherein the one or more SG include one or more selected from the group consisting of 1-5 wt% rubusoside, 1-3 wt% dulcoside A, 0.01-3 wt% steviolbioside, 0.2-1.5 wt% dulcoside B, 00.01-2 wt% Reb-O, 0.01-2 wt% Reb-S, 0.01-1.2 wt% Reb-T, 0.01-0.8 wt% Reb-R, 0.01-0.7 wt% Reb-J, 0.01-0.7 wt% Reb-W, 0.01-0.7 wt% Reb-V, 0.01-0.6 wt% Reb-V2, 0.01-0.5 wt% Reb-G, 0.01-0.5 wt% Reb-H, 0.01-0.5 wt% Reb-V2, 0.01-0.5 wt% Reb-5 wt% Reb-G, 0.01-0.5 wt% Reb-5 wt% Reb-H, 0.5 wt% Reb-3-5 wt% Reb-3U # 3-5U 3-5, 0.01-0.5 wt% Rel SG #5, 0.01-0.4 wt% Reb-M, 0.01-0.4 wt% Reb-N, 0.01-0.4 wt% Reb-E, 0.01-0.4 wt% Reb-F1, 0.01-0.4 wt% Reb-Y, and combinations thereof.
8. The composition of claim 7, wherein said one or more SG' S comprises at least 20, at least 21, at least 22, at least 23, or at least 24 selections from 1-5 wt% rubusoside, 1-3 wt% dulcoside A, 0.01-3 wt% steviolbioside, 0.2-1.5 wt% dulcoside B, 00.01-2 wt% Reb-O, 0.01-2 wt% Reb-S, 0.01-1.2 wt% Reb-T, 0.01-0.8 wt% Reb-R, 0.01-0.7 wt% Reb-J, 0.01-0.7 wt% Reb-W, 0.01-0.7 wt% Reb-V, 0.01-0.6 wt% Reb-V2, 0.01-0.5 wt% Reb-G, 0.01-0.5 wt% Reb-H, 0.01-0.5 wt% Reb-V2, 0.01-0.5 wt% Reb-3U-2, 0.01-0.5% Reb-I, 0.01-0.5% Rel SG #4, 0.01-0.5% Rel SG #5, 0.01-0.4% Reb-M, 0.01-0.4% Reb-N, 0.01-0.4% Reb-E, 0.01-0.4% Reb-F1, and 0.01-0.4% Reb-Y.
9. The composition according to claim 1, wherein the one or more SG comprises 45-55 wt% Reb-a, 20-40 wt% stevioside, 2-6 wt% Reb-C, 0.5-3 wt% Reb-B, and 0.5-3 wt% Reb-D.
10. The composition according to claim 9, wherein the one or more SGs further comprise one or more components selected from the group consisting of 0.1-3 wt% related SG #5, 0.05-1.5 wt% Reb-R1, 0.0.05-1.5 wt% Reb-K2, 0.05-1.5 wt% Reb-E, 0.01-1 wt% dulcoside a, 0.01-1 wt% dulcoside B, 0.01-1 wt% rubusoside, 0.01-1 wt% steviol bioside, 0.01-1 wt% isosteviolbioside, 0.01-1 wt% stevioside-B, 0.01-1 wt% related SG #3, 0.01-1 wt% related SG #2, 0.01-1 wt% Reb-G, 0.01-1 wt% Reb-F, and 0.01-1 wt% Reb-W.
11. The composition according to claim 10, wherein the one or more SGs further comprise at least 12, at least 13, at least 14, or at least 15 ingredients selected from the group consisting of 0.1-3 wt% related SG #5, 0.05-1.5 wt% Reb-R1, 0.0.05-1.5 wt% Reb-K2, 0.05-1.5 wt% Reb-E, 0.01-1 wt% dulcoside a, 0.01-1 wt% dulcoside B, 0.01-1 wt% rubusoside, 0.01-1 wt% steviolbioside, 0.01-1 wt% isosteviolbioside, 0.01-1 wt% stevioside-B, 0.01-1 wt% related SG #3, 0.01-1 wt% related SG #2, 0.01-1 wt% Reb-G, 0.01-1 wt% stevioside-G, 0.01-1 wt% and 0.01-1 wt% Reb-F.
12. The composition according to claim 1, wherein the one or more SG comprises 35-45 wt% Reb-a, 10-25 wt% stevioside, 4-12 wt% Reb-B, 4-12 wt% dulcoside a, 0.5-4 wt% Reb-C, and 0.1-4 wt% Reb-O.
13. The composition of claim 12, wherein the one or more SGs further comprise one or more ingredients selected from the group consisting of 0.3-3 wt% rubusoside, 0.1-3 wt% Reb-D, 0.1-3 wt% Reb-G, 0.1-3 wt% Reb-I, 0.1-3 wt% stevioside B, 0.1-3 wt% related SG #3, 0.05-1.5 wt% Reb-E, 0.05-2 wt% Reb-R, 0.05-1 wt% dulcoside B, 0.01-1 wt% Reb-N, 0.01-1 wt% Reb-Y, 0.01-1 wt% steviol bioside, 0.01-1 wt% dulcoside B, and combinations thereof.
14. The composition according to claim 13, wherein the one or more SGs further comprise at least 10, at least 11, at least 12, or at least 13 ingredients selected from the group consisting of 0.3-3 wt% rubusoside, 0.1-3 wt% Reb-D, 0.1-3 wt% Reb-G, 0.1-3 wt% Reb-I, 0.1-3 wt% stevioside B, 0.1-3 wt% related SG #3, 0.05-1.5 wt% Reb-E, 0.05-2 wt% Reb-R, 0.05-1 wt% dulcoside B, 0.01-1 wt% Reb-N, 0.01-1 wt% Reb-Y, 0.01-1 wt% steviol bisoside, and 0.01-1 wt% dulcoside B.
15. The composition of claim 1, wherein the one or more GSGs are one or more SG further glycosylation products selected from the group consisting of: related SG #1, SG-4, isosteviolbioside, related SG #3, rebaudioside R1, stevioside F, SG-Unk1, dulcoside B, SG-3, isorebaudioside B, isosteviolbioside, rebaudioside KA, SG-13, stevioside B, rebaudioside R, SG-Unk2, SG-Unk3, rebaudioside F3, rebaudioside F2, rebaudioside C2, stevioside E2, SG-10, rebaudioside L1, SG-2, rebaudioside A3, isorebaudioside A2, rebaudioside A2, rebaudioside E, rebaudioside H1, related SG #2, related SG #5, rebaudioside U2, rebaudioside T, rebaudioside W2, rebaudioside W3, rebaudioside W68612, SG # 9-K8653, SG-828653, rebaudioside K8653, rebaudioside K5, rebaudioside K-82 3, rebaudioside A, rebaudioside D-4, rebaudioside D, rebaudioside A, rebaudioside D-K-5, rebaudioside D-4, rebaudioside A, rebaudioside D-I, rebaudioside E-D-, SG-Unk6, rebaudioside Q2, rebaudioside Q3, rebaudioside I2, rebaudioside T1, related SG #4, rebaudioside V2, rebaudioside Y, 15 α -OH-rebaudioside M, rebaudioside O2, and combinations thereof.
16. The composition of claim 1, wherein the one or more GSGs comprise at least one GSG selected from the group consisting of GSG-1G-1, GSG-1G-2, GSG-1G-3, GSG-1G-4, GSG-1G-5, GSG-2G-1, GSG-2G-2, GSG-2G-3, GSG-2G-4, GSG-3G-1, GSG-3G-2, GSG-3G-3, GSG-4G-1, GSG-4G-2, GSG-5G-1, and combinations thereof.
17. The composition according to claim 1, wherein said one or more GSGs comprise at least one GSG selected from the group consisting of GSG-3G-2, GSG-3G-3, GSG-3G-4, GSG-3G-7, GSG-3G-8, GSG-4G-1, GSG-4G-2, GSG-4G-3, GSG-4G-7, GSG-5G-1, GSG-5G-2, GSG-5G-3, GSG-5G-4, GSG-5G-5, GSG-6G-3, and combinations thereof.
18. The composition of claim 1, wherein the one or more GSGs are selected from the group consisting of: GSG-1G1R-1, GSG-1G1R-2, GSG-2G1R-1, GSG-1G1R-3, GSG-2G1R-2, GSG-3G1R-1, GSG-1G1R-4, GSG-2G1R-3, GSG-3G1R-2, GSG-4G-1R-1, GSG-1G1R-5-1, GSG-2G1R-4, GSG-3G1R-3a, GSG-3G1R-3b, GSG-4G1R-2, GSG-5G1R-1 and combinations thereof.
19. The composition of claim 1, wherein the one or more GSGs are selected from the group consisting of: GSG-3G1R-3a, GSG-3G1R-3b, GSG-4G1R-2, GSG-4G1R-3, GSG-4G1R-4, GSG-4G1R-6, GSG-5G1R-4, GSG-6G1R-1a, GSG-6G1R-1b, GSG-6G1R-2 and combinations thereof.
20. The composition of any one of claims 1-19, wherein the one or more GSGs comprise one or more xylose moieties, arabinose moieties or a combination thereof.
21. The composition of claim 20, wherein the one or more GSGs are selected from the group consisting of: GSG-1G1X-1, GSG-1G1X-2, GSG-1G1X-3, GSG-1G1X-4, GSG-2G1X-1, GSG-2G1X-2, GSG-2G1X-3, GSG-3G1X-1, GSG-3G1X-2, GSG-4G1X-1 and combinations thereof.
22. The composition of claim 20, wherein the one or more GSGs are selected from the group consisting of: GSG-3G1X-4, GSG-3G1X-5, GSG-4G1X-1, GSG-4G1X-2, GSG-4G1X-3, GSG-4G1X-4 and combinations thereof.
23. The composition of any one of claims 1-22, wherein at least one of the one or more GSGs has a molecular weight of less than or equal to 804 daltons.
24. The composition of any one of claims 1 to 22, wherein at least one of the one or more GSGs has a molecular weight greater than or equal to 1922 daltons.
25. The composition of any of claims 1-22, comprising a plurality of GSGs and a plurality of SGs, wherein the plurality of GSGs is present at 10-80 wt% of the total composition, and wherein the plurality of SGs is present at 1-40 wt% of the total composition.
26. The composition according to claim 1, comprising 10-30 wt% SG, 50-70 wt% GSG, and 60-90 wt% total glycosides.
27. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.2-5 wt% GSG-3G-7, and 1-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-15 wt% GSG-4G-1, 1-2 wt% GSG-4G-2, 0.5-2.5 wt% GSG-4G-3, and 2-10 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.1-0.5 wt% GSG-5G-1, 0.05-0.5 wt% GSG-5G-2, 0.5-3 wt% GSG-5G-3, 0.05-0.5 wt% GSG-5G-4, and 0.2-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.5-5.5 wt% GSG-3G1R-33a and 2-6 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-5 wt% GSG-4G1R4, and 0.5-10 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.2-1.2 wt% GSG-6G1R-1a,0.2-2 wt% GSG-6G1R-1b and 0.3-3 wt% GSG-6G 1R-2;
(i) one or more SG-3G-1X group components selected from the group consisting of 2-8 wt% GSG-3G1X-4 and 0.5-3 wt% GSG-3G 1X-5;
(j) One or more SG-4GX group components selected from the group consisting of 0.5-3 wt% GSG-4G1X-1, 0.5-3 wt% GSG-4G1X-2, 1-6 wt% GSG-4G1X-3, and 0.2-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
28. The composition according to claim 27, further comprising at least 5, 6, 7 or 8 unreacted steviol glycosides selected from the group consisting of 1 to 8 wt% Reb-a, 0.1 to 1.5 wt% Reb-B, 0.05 to 3 wt% Reb-C, 0.05 to 1 wt% Reb-D, 0.05 to 0.3 wt% Reb-F, 0.05 to 0.25 wt% Reb-K, 0.05 to 0.5 wt% rubusoside, and 0.05 to 3 wt% stevioside.
29. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 2-10 wt% GSG-3G-2, 2-6 wt% GSG-3G-3, 0.5-2 wt% GSG-3G-4, 0.2-3 wt% GSG-3G-7, and 1-4 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.3-1.5 wt% GSG-4G-2, 0.5-1.5 wt% GSG-4G-3, and 2.5-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.4 wt% GSG-5G-2, 0.75-2 wt% GSG-5G-3, 0.05-0.3 wt% GSG-5G-4, and 0.4-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) One or more GSG-3G1R-3 group components selected from the group consisting of 0.2-3 wt% GSG-3G1R-3a and 1.5-5 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.05-0.75 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.5-6.5 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.5-2.5 wt% GSG-6G1R-1 and 0.3-1.5 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) at least one SG-4GX group component selected from the group consisting of 0.5-2 wt% GSG-4G1X-1, 0.5-2 wt% GSG-4G1X-2, 1.5-5 wt% GSG-4G1X-3, and 0.2-1.5 wt% GSG-4G 1X-4; and
(k)1-2.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
30. The composition of claim 29, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of 1.5-12.5 wt% Reb-a, 0.2-1.5 wt% Reb-B, 0.5-4 wt% Reb-C, 0.3-1 wt% Reb-D, 0.1-2.5 wt% Reb-F, 0.05-2.5 wt% rubusoside, and 1.5-6.5 wt% stevioside.
31. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 3-6 wt% GSG-3G-2, 1.5-3.5 wt% GSG-3G-3, 1-3 wt% GSG-3G-4, 2-5 wt% GSG-3G-7, and 2-5 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 6-10 wt% GSG-4G-1, 0.5-1.5 wt% GSG-4G-2, 1-3 wt% SG-4G3, and 3-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.2-0.4 wt% GSG-5G-1, 0.05-0.3 wt% GSG-5G-2, 1-2 wt% GSG-5G-3, 0.08-0.2 wt% GSG-5G-4, and 1.5-4.5 wt% GSG-5G-5;
(d)0.5-1.5wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 2-5 wt% GSG-3G1R-3a and 2-4 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.3-1 wt% GSG-4G1R2, 0.2-0.6 wt% GSG-4G1R3, 1.5-4 wt% GSG-4G1R4, and 3-10 wt% GSG-4G1R 6;
(g)2.5-5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.5-1.5 wt% GSG-6G1R-1 and 0.5-2 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) At least one SG-4GX group component selected from the group consisting of 0.3-1.5 wt% GSG-4G1X-1, 1-3.5 wt% GSG-4G1X-2, 1.5-4 wt% GSG-4G1X-3, and 0.5-2 wt% GSG-4G 1X-4; and
(k)1.5-3wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
32. The composition according to claim 31, further comprising at least 4, 5, 6 or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of 0.5-2.5 wt% Reb-a, 0.2-1 wt% Reb-B, 0.2-0.8 wt% Reb-C, 0.2-0.6 wt% Reb-D, 0.05-0.25 wt% Reb-F, 0.05-0.6 wt% rubusoside, and 0.05-2 wt% stevioside.
33. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 5-15 wt% GSG-3G-2, 1-6 wt% GSG-3G-3, 0.5-3.5 wt% GSG-3G-4, 0.5-3.5 wt% GSG-3G-7, and 1.5-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 10-18 wt% GSG-4G-1, 0.5-3.5 wt% GSG-4G-2, 0.5-3.5 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.15-1.5 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.5-3.5 wt% GSG-5G-3, 0.05-0.35 wt% GSG-5G-4, and 0.1-1.5 wt% GSG-5G-5;
(d)0.3-2.5wt%GSG-6G-3;
(e) One or more SG-3G1R group components selected from the group consisting of 0.5-2 wt% GSG-3G1R-3a and 3-5 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.25-2.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-4 wt% GSG-4G1R4, and 0.3-3 wt% GSG-4G1R 6;
(g)1.5-7.5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.1-2 wt% GSG-6G1R-1a,0.1-2 wt% GSG-6G1R-1b and 0.1-2 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 2-5 wt% GSG-3G1X-4 and 1-3 wt% GSG-3G 1X-5;
(j) at least one SG-4G1X group component selected from the group consisting of 0.5-5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1.5-6 wt% GSG-4G1X-3, and 0.5-2.5 wt% GSG-4G 1X-4; and
(k)0.5-4.5wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
34. The composition of claim 33, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of, 8-15 wt% Reb-a, 0.2-2 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.05-2 wt% Reb-F, 0.05-1 wt% rubusoside, and 0.05-3.5 wt% stevioside.
35. The composition according to claim 33, further comprising at least 4, 5, 6 or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of 3 to 10 wt% Reb-a, 0.05 to 2 wt% Reb-C, 0.05 to 2 wt% Reb-D, 0.05 to 1.5 wt% Reb-G, 0.05 to 0.5 wt% Reb-O, 0.05 to 0.5 wt% rubusoside, and 0.05 to 4 wt% stevioside.
36. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-5 wt% GSG-3G-2, 1-5 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-4 wt% GSG-3G-7, and 2-6 wt% GSG-3G-8;
(b) one or more SG-4G group components selected from the group consisting of 5-12 wt% GSG-4G-1, 0.2-3 wt% GSG-4G-2, 0.2-3 wt% SG-4G3, and 2-6 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1.5 wt% GSG-5G-1, 0.05-1.5 wt% GSG-5G-2, 0.1-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.5-4 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 1-3 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R-2, 0.05-1 wt% GSG-4G1R-3, 1-3 wt% GSG-4G1R-4, and 5-10 wt% GSG-4G 1R-6;
(g)2-6wt%GSG-5G-1R4;
(h) One or more SG-6G-1R group components selected from the group consisting of 0.1-1 wt% GSG-6G1R-1A,0.1-1 wt% GSG-6G1R-1b and 0.2-2 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) at least one SG-4G1X group component selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 1-3 wt% GSG-4G1X-3, and 0.3-2 wt% GSG-4G 1X-4; and
(k)1-4wt%GSG-5G1X-1,
wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
37. The composition of claim 36, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of 6-12 wt% Reb-a, 0.1-1.5 wt% Reb-B, 0.5-3.5 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.8-3 wt% Reb-F, 0.5-2.5 wt% rubusoside, and 2-6 wt% stevioside.
38. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-4 wt% GSG-3G-2, 1-4 wt% GSG-3G-3, 0.5-3 wt% GSG-3G-4, 0.5-3 wt% GSG-3G-7, and 0.5-3.5 wt% GSG-3G-8;
(b) One or more SG-4G group components selected from the group consisting of 3-8 wt% GSG-4G-1, 0.1-2 wt% GSG-4G-2, 0.1-2 wt% SG-4G3, and 1-4 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1 wt% GSG-5G-1, 0.05-1 wt% GSG-5G-2, 0.3-3 wt% GSG-5G-3, 0.01-0.4 wt% GSG-5G-4, and 0.1-2 wt% GSG-5G-5;
(d)0.1-2wt%GSG-6G-3;
(e) one or more SG-3G1R group components selected from the group consisting of 0.2-2 wt% GSG-3G1R-3a and 1-3 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-3 wt% GSG-4G1R4, and 1-3 wt% GSG-4G1R 6;
(g)2-6wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.05-1 wt% GSG-6G1R-1a,0.05-1 wt% GSG-6G1R-1b and 0.1-1.2 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 1-4 wt% GSG-3G1X-4 and 0.5-2 wt% GSG-3G 1X-5;
(j) at least one SG-4G1X group component selected from the group consisting of 0.2-1.5 wt% GSG-4G1X-1, 0.5-2.5 wt% GSG-4G1X-2, 0.5-2.5 wt% GSG-4G1X-3, and 0.2-2 wt% GSG-4G 1X-4; and
(k)1-3wt%GSG-5G1X-1,
Wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
39. The composition according to claim 38, further comprising at least 4, 5, 6, or 7 unreacted steviol glycosides, an ingredient selected from the group consisting of 15-25 wt% Reb-a, 0.05-1 wt% Reb-B, 1-3 wt% Reb-C, 0.1-1.5 wt% Reb-D, 0.8-3 wt% Reb-F, 0.3-2 wt% rubusoside, and 6-12 wt% stevioside.
40. A method of increasing the sweetness of an orally consumable composition comprising adding an effective amount of the composition of any one of claims 1-39 to the orally consumable composition.
41. A method of improving the taste profile or flavor of an orally consumable composition comprising adding an effective amount of the composition of any one of claims 1-39 to the orally consumable composition.
42. A method of preparing a GSG composition comprising the steps of:
(a) dissolving a glucose donor material in water to form a dissolved glucose donor material;
(b) adding a SG composition to the dissolved glucose donor material to obtain a reaction mixture;
(c) adding an effective amount of an enzyme to the reaction mixture, wherein the enzyme facilitates the transfer of glucose from the glucose donor molecule to SG added to the SG composition in the mixture;
(d) Incubating at the desired temperature for a predetermined reaction time to glycosylate the SG of the SG composition with the glucose moiety present in the glucose donor material;
(e) inactivating the enzyme;
(f) removing the enzyme from the reaction mixture; and
(g) the resulting solution of GSG, residual SG and dextrin was dried.
43. The method of claim 42, wherein the glucose donor material is dextrin.
44. The method of claim 42, wherein the water is reverse osmosis pure water.
45. The method of claim 42, wherein the SG composition is a stevia extract.
46. The method according to claim 42, wherein the weight ratio of glucose donor molecule to SG is 10:90-90:10, 20:80-80:20, 30:70-70:30, or 40:60-60: 40.
47. The method of claim 42, wherein the enzyme is a cyclodextrin glycosyltransferase (CGTase).
48. The method according to claim 42, further comprising decolorizing the reaction mixture between steps (f) and (g).
49. The method of claim 42, wherein step (f) is carried out by spray drying the solution.
50. A composition according to claim 1, comprising:
(a) one or more SG-3G group components selected from the group consisting of 1-10 wt% GSG-3G-2, 1-6 wt% GSG-3G-3, 0.5-3.5 wt% GSG-3G-4, 0.2-5 wt% GSG-3G-7, and 0.5-6 wt% GSG-3G-8;
(b) One or more SG-4G group components selected from the group consisting of 3-15 wt% GSG-4G-1, 0.1-3.5 wt% GSG-4G-2, 0.1-3.5 wt% SG-4G-3, and 1-10 wt% GSG-4G-7;
(c) one or more SG-5G group components selected from the group consisting of 0.05-1.5 wt% GSG-5G-1, 0.05-1.5 wt% GSG-5G-2, 0.1-3.5 wt% GSG-5G-3, 0.01-0.5 wt% GSG-5G-4, and 0.1-4 wt% GSG-5G-5;
(d)0.1-2.5wt%GSG-6G-3;
(e) one or more SG-3G-1R group components selected from the group consisting of 0.2-5.5 wt% GSG-3G1R-3a and 1-6 wt% GSG-3G1R-3 b;
(f) one or more SG-4G-1R group components selected from the group consisting of 0.1-2.5 wt% GSG-4G1R2, 0.05-1 wt% GSG-4G1R3, 1-5 wt% GSG-4G1R4, and 0.3-10 wt% GSG-4G1R 6;
(g)1.5-7.5wt%GSG-5G-1R4;
(h) one or more SG-6G-1R group components selected from the group consisting of 0.05-2.5 wt% GSG-6G1R-1a,0.0-2 wt% GSG-6G1R-1b and 0.1-3 wt% GSG-6G 1R-2;
(i) at least one SG-3G-1X group component selected from the group consisting of 1-8 wt% GSG-3G1X-4 and 0.5-3 wt% GSG-3G 1X-5;
(j) at least one SG-4G1X group component selected from the group consisting of 0.2-5 wt% GSG-4G1X-1, 0.5-3 wt% GSG-4G1X-2, 0.5-6 wt% GSG-4G1X-3, and 0.2-2.5 wt% GSG-4G 1X-4; and
(k)0.5-4.5wt%GSG-5G1X-1,
Wherein the composition comprises more than one GSG from at least 8, 9, 10 or 11 groups of (a) - (k).
51. The composition according to claim 38, further comprising at least 5, 6, 7 or 8 unreacted steviol glycosides, an ingredient selected from the group consisting of 1-15 wt% Reb-a, 0.05-3 wt% Reb-B, 0.05-4 wt% Reb-C, 0.05-1.5 wt% Reb-D, 0.05-3 wt% Reb-F, 0.05-2.5 wt% rubusoside, and 0.05-12 wt% stevioside.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862668553P | 2018-05-08 | 2018-05-08 | |
| US62/668,553 | 2018-05-08 | ||
| PCT/US2019/031196 WO2019217474A1 (en) | 2018-05-08 | 2019-05-07 | Compositions of steviol glycosides and/or multiglycosylated derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112135528A true CN112135528A (en) | 2020-12-25 |
Family
ID=68468362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980030635.7A Pending CN112135528A (en) | 2018-05-08 | 2019-05-07 | Composition of steviol glycoside and/or polysaccharide derivative thereof |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3813546A4 (en) |
| CN (1) | CN112135528A (en) |
| WO (1) | WO2019217474A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114875054A (en) * | 2022-06-24 | 2022-08-09 | 南京工业大学 | A kind of enzymatic method for preparing glycosylated steviol glycoside compound and its derivative |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220104524A1 (en) * | 2017-06-02 | 2022-04-07 | Givaudan, S.A. | Compositions |
| CA3148054A1 (en) | 2019-08-09 | 2021-02-18 | Suntory Holdings Limited | Beverage having foam retentivity and method for improving foam retentivity of beverage |
| US20250081996A1 (en) * | 2021-08-05 | 2025-03-13 | Corn Products Development, Inc. | Flavor modifying composition |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120058247A1 (en) * | 2010-08-23 | 2012-03-08 | Zhejiang Green World Bio-Tech Engineering Co., Ltd . | Rebaudioside a and stevioside compositions |
| US20130071537A1 (en) * | 2011-03-17 | 2013-03-21 | E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd | Rebaudioside b and derivatives |
| US20140017378A1 (en) * | 2011-02-17 | 2014-01-16 | Purecircle Usa Inc. | Glucosylated steviol glycoside as a flavor modifier |
| US20150359251A1 (en) * | 2014-06-16 | 2015-12-17 | Sweet Green Fields USA LLC | Rebaudioside a and stevioside with improved solubilities |
| US20170006906A1 (en) * | 2015-07-10 | 2017-01-12 | Sweet Green Fields USA LLC | Compositions of steviol multiglycosylated derivatives and stevia components |
| WO2017214026A1 (en) * | 2016-06-06 | 2017-12-14 | Tate & Lyle Ingredients Americas Llc | Glycosylated steviol glycoside compositions and methods of preparing glycosylated steviol glycoside compositions |
| US20180116266A1 (en) * | 2016-11-02 | 2018-05-03 | Sweet Green Fields, Llc | Compositions comprising mogrosides, steviol glycosides and glycosylated derivatives thereof and methods of enhancing the mouthfeel or sweetness of consumables |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013010690A (en) * | 2011-03-22 | 2014-04-30 | Purecircle Usa | GLOSSOSIDE COMPOSITION OF GLUCOSILATED ESTEVIOL AS A TASTE AND TASTE INCREASER. |
-
2019
- 2019-05-07 CN CN201980030635.7A patent/CN112135528A/en active Pending
- 2019-05-07 WO PCT/US2019/031196 patent/WO2019217474A1/en not_active Ceased
- 2019-05-07 EP EP19800867.4A patent/EP3813546A4/en not_active Withdrawn
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120058247A1 (en) * | 2010-08-23 | 2012-03-08 | Zhejiang Green World Bio-Tech Engineering Co., Ltd . | Rebaudioside a and stevioside compositions |
| US20140017378A1 (en) * | 2011-02-17 | 2014-01-16 | Purecircle Usa Inc. | Glucosylated steviol glycoside as a flavor modifier |
| US20130071537A1 (en) * | 2011-03-17 | 2013-03-21 | E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd | Rebaudioside b and derivatives |
| US20150359251A1 (en) * | 2014-06-16 | 2015-12-17 | Sweet Green Fields USA LLC | Rebaudioside a and stevioside with improved solubilities |
| US20170006906A1 (en) * | 2015-07-10 | 2017-01-12 | Sweet Green Fields USA LLC | Compositions of steviol multiglycosylated derivatives and stevia components |
| CN107846948A (en) * | 2015-07-10 | 2018-03-27 | 甜美绿色田野有限责任公司 | Composition of steviol glycoside polyglycosylated derivatives and stevia ingredients |
| WO2017214026A1 (en) * | 2016-06-06 | 2017-12-14 | Tate & Lyle Ingredients Americas Llc | Glycosylated steviol glycoside compositions and methods of preparing glycosylated steviol glycoside compositions |
| US20180116266A1 (en) * | 2016-11-02 | 2018-05-03 | Sweet Green Fields, Llc | Compositions comprising mogrosides, steviol glycosides and glycosylated derivatives thereof and methods of enhancing the mouthfeel or sweetness of consumables |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114875054A (en) * | 2022-06-24 | 2022-08-09 | 南京工业大学 | A kind of enzymatic method for preparing glycosylated steviol glycoside compound and its derivative |
| CN114875054B (en) * | 2022-06-24 | 2023-11-17 | 南京工业大学 | A method for enzymatic preparation of glycosylated steviol glycoside compounds and their derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3813546A1 (en) | 2021-05-05 |
| WO2019217474A1 (en) | 2019-11-14 |
| EP3813546A4 (en) | 2023-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1959755B1 (en) | High-potency sweetener composition with c-reactive protein reducing substance and compositions sweetened therewith | |
| KR101531202B1 (en) | Method of improving sweetness qualities of stevia extract | |
| AU2006318700B2 (en) | High-potency sweetener composition with antioxidant and compositions sweetened therewith | |
| EP1959762B1 (en) | High-potency sweetener composition for treatment and/or prevention of autoimmune disorders, compositions and beverages sweetened therewith | |
| JP5759998B2 (en) | High purity rebaudioside D and its application | |
| TWI402040B (en) | High-potency sweetener composition with vitamin and compositions sweetened therewith | |
| JP7474201B2 (en) | Sweetener and flavor compositions, methods of making and methods of using them | |
| CN111031805A (en) | Sweetness and taste improvement of dihydrochalcones on steviol glycosides and mogroside sweeteners | |
| CN101312662A (en) | High-potency sweetener composition with antioxidant and compositions sweetened therewith | |
| WO2019217258A1 (en) | A tasteful natural sweetener and flavor | |
| JP2010508823A (en) | High-sweetness sweetener composition having long-chain primary aliphatic saturated alcohol and composition sweetened thereby | |
| JP2010508821A (en) | High intensity sweetener composition having phytoestrogens and composition sweetened thereby | |
| CN112135528A (en) | Composition of steviol glycoside and/or polysaccharide derivative thereof | |
| CN115835784A (en) | Sweetener and flavor composition | |
| US20190289890A1 (en) | Compositions of steviol glycosides and/or multiglycosylated derivatives thereof | |
| US20190350242A1 (en) | Steviol glycosides with improved solubilities, taste profiles and flavoring effects | |
| EP3768098A1 (en) | Steviol glycosides with improved solubilities, taste profiles and flavoring effects | |
| WO2019238010A1 (en) | A naturally sweet enhancer composition | |
| CN112135527B (en) | Steviol glycoside compositions with improved flavor | |
| WO2022206689A1 (en) | Sweetener and flavoring compositions prepared by glycosylated mogrosides or monk fruit extracts, method of making and method of use thereof | |
| US20190307154A1 (en) | Steviol glycoside compositions with improved flavor | |
| AU2013201603A1 (en) | High-potency sweetener composition with antioxidant and compositions sweetened therewith | |
| CN117529237A (en) | Composition containing stevioside, preparation method and application thereof | |
| HK40028167A (en) | Sweetness and taste improvement of steviol glycoside and mogroside sweeteners with dihydrochalcones | |
| HK40003217A (en) | Sweetness and taste improvement of steviol glycoside or mogroside sweeteners |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |